2008
- FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C: Advanced test for increased blood safety is first to add the detection of HIV-1 Group O RNA and HIV-2 RNA
- PRNewswire - December 31, 2008
- PLEASANTON, Calif., Dec. 31 /PRNewswire/ -- The United States Food & Drug Administration ( FDA ) today approved a new nucleic acid test from Roche to screen donated blood for HIV-1 Group M RNA, hepatitis C RNA and hepatitis B DNA in a single, automated assay. The test, called the cobas TaqScreen MPX Test for use on
- Mylan's Matrix Receives Final FDA Approval for the Generic Version of the Antiretroviral Zerit(R) Capsules
- PRNewswire - December 30, 2008
- PITTSBURGH, Dec. 30 /PRNewswire-FirstCall/ -- Mylan Inc. (NASDAQ:MYL) today announced that Matrix Laboratories Limited, its India-based subsidiary in which it holds a 71.5% controlling interest, received final approval from the U.S. Food and Drug Administration ( FDA ) on December 29, for its Abbreviated New Drug Appli
- ImQuest Presentations at International HIV Meeting Highlight Significant Progress in Their Therapeutic and Microbicide Development Programs
- PRNewswire - December 23, 2008
- FREDERICK, Md., Dec. 23 /PRNewswire/ -- ImQuest Life Sciences presented important new results on the continued development of their small molecule pyrimidinedione inhibitors of HIV-1 at the bi-annual HIV-DART meeting held this week in Puerto Rico . The presentations highlighted the development of a second generation th
- Frost & Sullivan Accolade for CK Scientific's Outstanding Customer Service
- PRNewswire - December 22, 2008
- LONDON, Dec. 22 /PRNewswire/ -- The 2008 Frost & Sullivan Zambian Hospital Medical Equipment Customer Service Leadership Award is presented to the CK Scientific Group Zambia Ltd. in recognition of its outstanding customer-focused strategies. An end-user analysis conducted recently by Frost & Sullivan, First Wor
- Glenmark Expects Launch of Crofelemer in ROW Countries(Developing Economies) by 2010 - Potential First-in-Class for HIV-Associated Diarrhea: Molecule Currently in Phase 3 Trials, Granted Fast Track Designation by US-FDA
- PRNewswire - December 22, 2008
- -- Potential First-in-Class Anti-Secretory Anti-Diarrheal Agent for Multiple Indications Including HIV-Associated Diarrhea -- Glenmark has Crofelemer Rights for diarrhea Indications in 140 Countries; Molecule Currently in Phase 3 trials. ROW Sales Market Opportunity of US $ 80 Million for HIV-Associated Diarrhea -- C
- The Female Health Company Receives USAID | DELIVER PROJECT Order for 8.1 Million Units
- PRNewswire - December 22, 2008
- CHICAGO, Dec. 22 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Alternext: FHC) announced it has received an order for the delivery of 8.1 million female condoms (FC) from John Snow, Inc., which implements the USAID | DELIVER PROJECT, a U.S. Agency for International Development (USAID)- funded project, worki
- PTC Therapeutics Initiates Two Clinical Trials of PTC299 in Cancer Patients
- PRNewswire - December 18, 2008
- SOUTH PLAINFIELD, N.J., Dec. 18 /PRNewswire/ -- PTC Therapeutics, Inc. (PTC) today announced the initiation of two clinical trials of the company s product candidate PTC299 in adult patients with solid tumor cancers and Kaposi Sarcoma, a HIV-related cancer. PTC299 is an orally delivered, investigational new drug that o
- Rotary Action Group Helps Launch Major Public-Private HIV Prevention Initiative in Kenya: Rotarians for Fighting AIDS joins PEPFAR, Nike Foundation, Coca-Cola Africa Foundation and others in Partnership for an HIV-Free Generation
- PRNewswire - December 15, 2008
- NAIROBI, Kenya , Dec. 15 /PRNewswire-USNewswire/ -- A new public-private HIV-prevention initiative aimed at disadvantaged young people in Nairobi will rely on Rotarians for Fighting AIDS (RFFA) to help improve access to health care and provide educational and economic development opportunities. Those efforts, in tu
- Recruitment Ongoing in Europe for Two Tibotec Phase III Clinical Trials Studying TMC278 in Treatment-Naïve HIV-Infected Adults
- PRNewswire - December 15, 2008
- -- Once-Daily TMC278 is the Third Anti-HIV Compound to be Developed in Tibotec Virology Portfolio CORK, Ireland , December 15/PRNewswire/ -- Tibotec Pharmaceuticals is currently recruiting HIV-positive, treatment-naïve adults (or those who have never taken antiretroviral medication before) in Europe for two major phase
- New Roche Dual Target HIV-1 Test Approved for Use in European Union
- PRNewswire - December 15, 2008
- -- Extra confidence and security with an innovative Roche solution PLEASANTON, Calif., Dec. 15 /PRNewswire/ -- Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. The COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HIV
- FDA Advisory Committee Votes Unanimously that FC2 Female Condom(R) is Approvable
- PRNewswire - December 12, 2008
- CHICAGO, Dec. 12 /PRNewswire-FirstCall/ -- The Female Health Company (NYSE Alternext: FHC) has announced that the U.S. Food and Drug Administration s ( FDA ) Obstetrics and Gynecology Devices Advisory Committee has unanimously voted that the company s second-generation female condom, the FC2 Female Condom(R), is approv
- Napo Pharmaceuticals Announces License of Crofelemer to Salix Pharmaceuticals: Leading GI Specialty Pharma Company to Commercialize Novel Anti-Secretory Anti-diarrheal Agent
- PRNewswire - December 10, 2008
- -- Crofelemer to address mortality and morbidity issues for millions of sufferers on a global basis SAN FRANCISCO, Dec. 10 /PRNewswire/ -- Napo Pharmaceuticals, Inc. ( Napo ) is pleased to announce a collaboration with Salix Pharmaceuticals, Inc. ( Salix ) for the license of crofelemer for all indications in North Amer
- Two New Studies in the New England Journal of Medicine Show Malaria Vaccine Candidate Advancing in Africa: Data in infants and young children reinforce case for phase III trial of RTS,S/AS
- PRNewswire - December 8, 2008
- NEW ORLEANS, Dec. 8 /PRNewswire/ -- Results published online today in the New England Journal of Medicine revealed that the world s most clinically advanced malaria vaccine candidate provides both infants and young children with significant protection against malaria. Two separate phase II trials reaffirmed earlier stu
- Dynamic Outlines Initial Target Markets for Pharmaceutical Cannabinoid Products
- PRNewswire - December 5, 2008
- PALM SPRINGS, Calif., Dec. 5 /PRNewswire-FirstCall/ -- Dynamic Alert Limited (BULLETIN BOARD: DYMC) is pleased to announce that it has now identified its target markets for its pharmaceutical product line-up. The modalities will include a lozenge with some capacity for enhancing rapid onset through oromucosal absorptio
- RHEI Pharmaceuticals Announces the Initiation of the Final Clinical Study for Approval of Tibozole in China: New Product will Fill Void in the Local Treatment of Oral Candidiasis in Immunosuppressed Patients in China
- PRNewswire - December 5, 2008
- PLAINSBORO, N.J., Dec. 5 /PRNewswire/ -- RHEI Pharmaceuticals, Inc. today announced that the final clinical trial for Tibozole, a locally active antifungal with low dose miconazole in a patented mucoadhesive system, has been initiated in China. This will be the last clinical trial conducted for submission of the New Dr
- On World AIDS Day, Russell Simmons and Special Guests Attended 'Empowerment for Africa' Dinner
- PRNewswire - December 4, 2008
- -- Support the Diamond Empowerment Fund by purchasing the Green Bracelet at www.simmonsjewelryco.com NEW YORK, Dec. 4 /PRNewswire/ -- The Diamond Empowerment Fund (D.E.F.), Hearst Magazines, and A Diamond is Forever banded together to host the exclusive Empowerment for Africa dinner held at Hearst Tower in Manhattan Mo
- European Commission Approval of New Indication for Roche's Pegasys(R) (peginterferon alfa-2a) Offers Hepatitis C Patients a Second Chance for a Cure
- PRNewswire - December 4, 2008
- -- Pegasys is the First and Only Pegylated Interferon to be Approved for Treatment of up to 72 Weeks in Treatment-Experienced Patients BASEL, December 4/PRNewswire/ -- Roche announced today that the European Commission has approved Pegasys(R) (peginterferon alfa-2a (0 KD)) plus Copegus(R) (ribavirin) for the retreatmen
- Tibotec and Emcure Collaborate on Access to Darunavir for India
- PRNewswire - December 3, 2008
- COUNTY CORK, Ireland , Dec. 3 /PRNewswire/ -- Tibotec Pharmaceuticals today announced that it has signed a royalty-free, non-exclusive license agreement with Emcure Pharmaceuticals Limited of India to distribute the protease inhibitor darunavir (DRV) in India.
- PREZISTA(R) (darunavir) Receives Expanded Marketing Authorisation in the European Union for Treatment-Experienced Adults With HIV-1
- PRNewswire - December 3, 2008
- -- PREZISTA now Indicated for the Broad Range of Treatment-Experienced Patients in the 27 EU Member States CORK, Ireland , December 3/PRNewswire/ -- Tibotec Pharmaceuticals announced today that the European Commission adopted the decision to broaden the indication for PREZISTA(R) (darunavir), a protease inhibitor, in c
- The Balm In Gilead Joins Saddleback Church in Thanking President Bush for His Leadership on Addressing HIV and AIDS Around the World
- PRNewswire - December 3, 2008
- RICHMOND, Va., Dec. 3 /PRNewswire-USNewswire/ -- Pernessa Seele, Founder/CEO of The Balm In Gilead, joined Rick Warren, pastor of Saddleback Church, his wife, Kay and approximately 300 faith and community leaders at a Civic Forum on Global Health for a World AIDS Day ceremony recognizing President George W. Bush and Fi
- TorreyPines Therapeutics Muscarinic Agonist NGX267 Meets Primary Endpoint in a Phase II Clinical Trial in Patients with Xerostomia
- PRNewswire - December 2, 2008
- LA JOLLA, Calif., Dec. 2 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (NASDAQ:TPTX) today announced positive results from a 26 patient Phase II trial evaluating three doses of NGX267 as a treatment for xerostomia, or dry mouth, in patients with Sjogren s syndrome. NGX267 met the primary endpoint of a statistically si
- Mary Ann Liebert, Inc. Provides Free Online Journal Access in Recognition of World AIDS Day
- PRNewswire - December 1, 2008
- NEW ROCHELLE, N.Y., Dec. 1 /PRNewswire/ -- Due to the urgent need to disseminate authoritative information in the field of AIDS/HIV research and clinical care, publisher Mary Ann Liebert, Inc. will provide complimentary access to all archival online issues of the company s AIDS journals through the end of December in h
- President George W. Bush Receives 'International Medal of PEACE' That Coincides With PEPFAR Milestone on World Aids Day: Dr. Rick Warren Presents Award, Engages with President on U.S. HIV/AIDS Initiatives and Accomplishments at Home and Abroad During Saddleback Civil Forum on Global Health
- PRNewswire - December 1, 2008
- WASHINGTON, Dec. 1 /PRNewswire/ -- President George W. Bush was honored on the 20th anniversary of World AIDS Day today, with the International Medal of PEACE given by Dr. Rick Warren on behalf of the Global PEACE Coalition during the Saddleback Civil Forum on Global Health. The award, given in recognition of the Presi
- DAI Launches New Health Sector
- PRNewswire - December 1, 2008
- BETHESDA, Md., Dec. 1 /PRNewswire-USNewswire/ -- International development firm DAI today announced the launch of a new Health sector that will lead the company s provision of integrated health services and expertise to donors, governments, and philanthropies worldwide. This is an exciting expansion for DAI, and it s f
- Statement of DNC Chairman Howard Dean on World AIDS Day
- PRNewswire - December 1, 2008
- WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- Democratic National Committee Chairman Howard Dean today issued the following statement commemorating World AIDS Day on its 20th Anniversary: It s been 20 years since the first World AIDS Day, and while we have made strides, much work remains to be done to tackle this epide
- PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing
- PRNewswire - December 1, 2008
- HARRISBURG, Pa., Dec. 1 /PRNewswire-USNewswire/ -- As part of the Dec. 1 observance of World AIDS Day, Acting Secretary of Health Everette James today urged Pennsylvanians to be tested for HIV - the virus that causes AIDS. He also highlighted ongoing efforts to educate the public about the disease and how it is prevent
- Video: Magic Johnson Foundation and Abbott Call for Greater Prevention, Testing and Treatment on World AIDS Day
- PRNewswire - December 1, 2008
- ABBOTT PARK, Ill., Dec. 1 /PRNewswire-FirstCall/ -- Today, on the 20th anniversary of World AIDS Day, the Magic Johnson Foundation and Abbott are calling on the public to educate themselves, their family and friends about HIV/AIDS and its impact on the African-American community. A new social networking tool allows Fac
- In Support of World AIDS Day, FHSSA Announces New Partnerships That Include the First In-Country Partnerships in Namibia and The Gambia
- PRNewswire - December 1, 2008
- ALEXANDRIA, Va., Dec. 1 /PRNewswire-USNewswire/ -- Today, more than 740 children will die of AIDS. In fact, nearly 7,000 people die each day due to HIV/AIDS. December 1 is World AIDS Day, a day of awareness and outreach to help people worldwide understand the impact of HIV/AIDS. A central theme for World AIDS Day 2008
- Global Financial Crisis Fuels Need for Greater HIV and AIDS Assistance for Children
- PRNewswire - December 1, 2008
- JOHANNESBURG, South Africa , Dec. 1 /PRNewswire-USNewswire/ -- The following is a statement from Martha Newsome, director of World Vision International s Global Health and HIV & AIDS Hope Initiatives: This World AIDS Day is being commemorated against the backdrop of a debilitating global financial crisis that threa
- 109 Medicines and Vaccines Now in Development for HIV/AIDS
- PRNewswire - December 1, 2008
- WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- America s pharmaceutical research companies are testing 109 medicines and vaccines to treat or prevent HIV/AIDS and related conditions, according to a report released today by the Pharmaceutical Research and Manufacturers of America (PhRMA). December 1 marks the 20th annive
- Latin American and U.S. Latina Women Unite to Demand Access to the Female Condom: World AIDS Day Statement Highlights Women's Unmet Needs for HIV Prevention, Calls on Governments to Increase Investment in Family Planning Methods
- PRNewswire - December 1, 2008
- (Para tener acceso a una copia completa de la declaracion en castellano, vaya al sitio www.preventionnow.net.) WASHINGTON, Dec. 1 /PRNewswire/ -- An international coalition of organizations that represent Latin American women and Latina women in the United States is demanding increased access to the female condom as an
- Southern AIDS Living Quilt Coming to Washington, D.C.: Web-based project educates and empowers through personal stories across the South
- PRNewswire - December 1, 2008
- WASHINGTON, Dec. 1 /PRNewswire-USNewswire/ -- Washington D.C. s AIDS rate is more than ten times higher than the national average in the United States . Of people living with AIDS in Washington, D.C., 82 percent are African American. On Thursday, December 4, in connection with World AIDS Day earlier in the week, the So
- GeoVax's Phase 2a HIV/AIDS Vaccine Human Trials to Begin in North and South America: 'World Aids Day' Commemorated by GeoVax with Hope and Promise
- PRNewswire - December 1, 2008
- ATLANTA, Dec. 1 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based biotechnology company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today that the launch of its Phase 2a Human Vaccine Trials will take pl
- ON WORLD AIDS DAY ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION CALLS ON THE CONGRESS AND PRESIDENT OBAMA TO FULLY FUND PEPFAR
- PRNewswire - December 1, 2008
- NEW YORK, December 1 /PRNewswire/ -- THIS REPORT BROUGHT TO YOU BY THE ELIZABETH GLASER PEDIATRIC AIDS FOUNDATION. A THOUSAND CHILDREN ACROSS THE GLOBE ARE INFECTED WITH HIV EACH DAY - MOST THROUGH MOTHER-TO-CHILD TRANSMISSION. THAT NUMBER USED TO BE HIGHER, BUT THE PRESIDENT S EMERGENCY PLAN FOR AIDS RELIEF - OR PEPFA
- In Recognition of WORLD AIDS DAY, Charlotte Bobcats' Power Forward, Emeka Okafor, Launches Mobile Texting Campaign in Support of the One Million African Lives Initiative
- PRNewswire - December 1, 2008
- CHARLOTTE, N.C., Dec. 1 /PRNewswire-USNewswire/ -- In recognition of World AIDS Day, Charlotte Bobcats , Emeka Okafor, will be launching a mobile texting campaign to raise money for the One Million African Lives Initiative (OMALI), a program of the Safe Blood for Africa Foundation (SBFA). The goal of the Initiative is
- On Twentieth Anniversary of World AIDS Day, Expert Urges Greater Global Emphasis on Preventing Pediatric AIDS
- PRNewswire - December 1, 2008
- -- A Generation Free of HIV Is Possible, Barnes Says WASHINGTON, December 1/PRNewswire/ -- On the twentieth anniversary of World AIDS Day, the Elizabeth Glaser Pediatric AIDS Foundation is urging the global community to reach more pregnant mothers with medicines to protect their infants from HIV, and to speed treatment
- World's Greatest Artists Help Launch (RED)WIRE, (RED)(TM)'s New Music Service That Fights AIDS in Africa
- PRNewswire - December 1, 2008
- -- MSN HOSTS EXCLUSIVE LAUNCH EVENT TODAY AT RED.MSN.COM -- iLIKE CHOSEN EXCLUSIVELY TO UNLEASH VIRAL DISTRIBUTION VIA ARTIST-TO-FAN SOCIAL NETWORKING -- PREMIER ISSUE DEBUTS WEDNESDAY, DECEMBER 10 NEW YORK, Dec. 1 /PRNewswire/ -- Today, World AIDS Day, many of the greatest artists on the globe will world-premiere excl
- German Innovation for HIV/AIDS Diagnostics Has Been Used 2.5 Million Times in 2008
- PRNewswire - December 1, 2008
- -- CyFlow From Partec Expands Leadership in Developing and Emerging Countries GORLITZ, Germany , December 1/PRNewswire/ -- German biotech company Partec is expanding its global leadership in specialized HIV monitoring and AIDS patient follow-up diagnostics for developing and emerging countries. In the year 2008, 2.5 mi
- From USAID Administrator, Henrietta H. Fore: Renewed Commitment On World AIDS Day
- PRNewswire - November 28, 2008
- WASHINGTON, Nov. 28 /PRNewswire-USNewswire/ -- December 1 marks the 20th global observance of World AIDS Day, a time during which citizens all over the world recognize the courage of the 33 million people living with and affected by the pandemic of HIV/AIDS, as well as a time to remember those whose lives have been los
- World AIDS Day December 1st: Obama Needs to Lead
- PRNewswire - November 28, 2008
- WASHINGTON, Nov. 28 /PRNewswire-USNewswire/ -- In anticipation of World AIDS Day on Monday, December 1, the Global AIDS Alliance is calling on the incoming Obama Administration to intensify the US effort against HIV/AIDS, both at home and abroad, and to resist AIDS fatigue. Over 100 global health advocacy organizations
- European Committee for Human Medicinal Products (CHMP) Issues Positive Opinion for Once-Daily PREZISTA(R) (Darunavir) as Part of Combination Therapy for Treatment-Naive Adults With HIV-1
- PRNewswire - November 27, 2008
- CORK, Ireland , November 27/PRNewswire/ -- The Committee for Human Medicinal Products (CHMP) has issued a positive opinion recommending approval for once-daily dosing of 800 mg PREZISTA(R) (darunavir) with low-dose ritonavir as part of combination therapy in treatment-n
- Kaiser Family Foundation Partners With Media Around The Globe to Address HIV/AIDS: New Programming Announced in Lead Up to World AIDS Day (Dec. 1)
- PRNewswire - November 26, 2008
- MENLO PARK, Calif., Nov. 26 /PRNewswire-USNewswire/ -- For more than ten years, the Kaiser Family Foundation has partnered with leading media in the U.S. and abroad to reach the public with information about HIV/AIDS and related issues and to challenge the stigma surrounding the disease. The Foundation s media partners
- EpiVax Receives NIH Grant for $390,000 to Optimize HIV Vaccine Delivery
- PRNewswire - November 26, 2008
- PROVIDENCE, R.I., Nov. 26 /PRNewswire/ -- EpiVax, Inc., a leader in the field of computational immunology, announced today that it has received a grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to optimize delivery of an HIV vaccine. N
- BET Networks Joins the International Call to Stop the Spread of HIV on World AIDS Day Monday, December 1 with a Special Episode of '106 & PARK' Followed by BET News Exclusive 'ARE YOU POSITIVE?'
- PRNewswire - November 26, 2008
- NEW YORK, Nov. 26 /PRNewswire/ -- Of the more than one million people in the United States that are living with HIV/AIDS, nearly half are African American. On Monday, December 1 at 6:00 p.m.*, World AIDS Day, BET shines a bright light on these alarming statistics by dedicating a full episode of the network s hit music
- HHS' AIDS.gov to Use Blogs, Virtual Worlds, and Social Networks to Deliver HIV Information for World AIDS Day 2008
- PRNewswire - November 25, 2008
- WASHINGTON, Nov. 25 /PRNewswire-USNewswire/ -- The HHS Office of HIV/AIDS Policy s AIDS.gov will recognize the 20th annual World AIDS Day on Dec. 1 with a special focus on reducing HIV/AIDS-related stigma and promoting HIV testing through blogs, virtual worlds, and social networks. This World AIDS Day will also mark th
- Peregrine Pharmaceuticals Awarded Broad New U.S. Patent for Anti-Viral Applications of Phospholipid-Targeting Antibodies
- PRNewswire - November 25, 2008
- -- Patent for Antibodies that Directly Bind to Phospholipid Targets Covers All Viral Infections and All Combination Regimens -- Patent Issuance Follows Nature Medicine Publication Confirming the Broad Anti-Viral Potential of Anti-Phospholipid Approaches TUSTIN, Calif., Nov. 25 /PRNewswire-FirstCall/ -- Peregrine Pharma
- The Latino Commission on AIDS will release report 'Shaping the New Response: HIV/AIDS and Latinos in the Deep South' on December 1st/World AIDS Day, 2008
- PRNewswire - November 25, 2008
- The Report is the result of a two-year fact-finding and cooperative project on the state of HIV/AIDS prevention and care services for Latinos in the Deep South: North Carolina, South Carolina, Georgia , Alabama, Tennessee, Mississippi and Louisiana. The Commission s report describes serious lack of access to prevention
- Experts Address State of HIV/AIDS Care in the Region Following Landmark Assessment Showing Widening Gaps in Social Services
- PRNewswire - November 25, 2008
- PITTSBURGH, Nov. 25 /PRNewswire/ -- Medical and social service officials convened today at a briefing hosted by the Pittsburgh AIDS Task Force (PATF) to discuss the results, implications and recommendations of the Southwestern PA Regional HIV/AIDS Needs Assessment study. The region s top HIV/AIDS experts in attendance
- Las Vegas Charities Mark World AIDS Day by Asking Residents to 'THINK': New Website, Fundraising Dinner Raise HIV/AIDS Awareness
- PRNewswire - November 25, 2008
- LAS VEGAS, Nov. 25 /PRNewswire/ -- Stop and think. That is what Las Vegas-based HIV/AIDS charities Aid for AIDS of Nevada (AFAN) and Golden Rainbow are asking Las Vegas to do this World AIDS Day. The organizations, along with the Nevada State Health Division, are marking the day with a fundraising dinner to re-launch a
- Teen Pop Star, Chantel 'Chani' Christie, Launches the Chani Girl Foundation to Bring Education/Awareness on HIV/AIDS
- PRNewswire - November 25, 2008
- -- Chani Set to Launch Her Foundation on World AIDS Day HOLLYWOOD, Calif., Nov. 25 /PRNewswire/ -- Chantel Chani Christie, teen pop star, and daughter of NBA power couple Doug and Jackie Christie, is set to launch her new Chani Girl Foundation on December 1, 2008 which is World AIDS Day. To kick off her new charity she
- M*A*C AIDS Fund Bolsters South Africa HIV Care, Prevention with $2.5 Million USD: Program grants were raised by consumers in 16 countries to benefit women and children-focused programs at UNICEF and NOAH
- PRNewswire - November 24, 2008
- JOHANNESBURG, South Africa , Nov. 24 /PRNewswire/ -- A new grant program from the M*A*C AIDS Fund has gifted $2.5 million to fight HIV and AIDS in South Africa. The grant will go to UNICEF South Africa and Nurturing Orphans of AIDS for Humanity (NOAH) to fund testing and treatment for pregnant women and strengthen the
- Happiness Spreads Through African Villages Thanks to Growing Contributions from Long Term Care Insurance Professionals: Small 'Bootstrap' Program Mushrooms in Spite of Down Economy, Cheering U.S. Givers as Well as African Recipients
- PRNewswire - November 24, 2008
- KIRKLAND, Wash., Nov. 24 /PRNewswire/ -- AIDS-plagued Kenya isn t on the big-bailout list, but an efficient, grass-roots movement is afoot that could produce more results than mountains of poorly-managed money. The movement is powered by human spirit and enough cash to ignite self-sufficiency and unstoppable progress.
- Accordia Global Health Foundation Receives $12.5 Million Grant From Bill & Melinda Gates Foundation: Research Will Help Mid-Level Health Providers Respond to Infectious
- PRNewswire - November 24, 2008
- WASHINGTON, Nov. 24 /PRNewswire/ -- Accordia Global Health Foundation, formerly the Academic Alliance Foundation, has received a $12.5 million grant from the Bill & Melinda Gates Foundation to support a landmark study to identify the most effective and cost-efficient way to prepare healthcare workers in sub-Saharan
- Data Published in Nature Medicine Highlights Ability of Peregrine Pharmaceuticals' Bavituximab to Cure Lethal Virus Infections: -- PS-Targeting Antibodies May Represent a Completely New Class of Drugs with Broad Potential to Treat Life-Threatening Viral Infections
- PRNewswire - November 24, 2008
- -- Peregrine s Clinical-Stage Anti-PS Agent Bavituximab and Equivalent Antibodies Cured Lethal Viral Infections in Preclinical Models -- Data Confirms PS is a Druggable Target Common to a Number of Serious Viral Infections TUSTIN, Calif., Nov. 24 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) t
- ALDO Supports World AIDS Day by Donating 100% of Proceeds for Newest 'ALDO Fights Aids' Product: ALDO Continues the Fight Against AIDS with their "Love for Life" Limited Edition Bracelets
- PRNewswire - November 24, 2008
- MONTREAL, Nov. 24 /PRNewswire/ -- ALDO, a global fashion footwear and accessories brand, in partnership with YouthAIDS, an HIV/AIDS education and prevention program of the global health organization Population Services International, continues their fight against AIDS by offering Love for Life bracelets. ALDO has given
- AIDS in America: First 100 Days Media Conference Call
- PRNewswire - November 24, 2008
- WHO: Carl Schmid, Director of Federal Affairs, The AIDS Institute Christine Lubinski, HIV Medicine Association of IDSA Rebecca Haag, Executive Director, AIDS Action Council WHAT: Media briefing conference call on recommendations from AIDS community leaders to President-elect Obama on actions he and his Administration c
- Saddleback Civil Forum on Global Health to Honor President George W. Bush on World AIDS Day: President to Receive First 'International Medal of PEACE' for Humanitarian Initiatives
- PRNewswire - November 24, 2008
- WASHINGTON, Nov. 24 /PRNewswire/ -- Dr. Rick Warren will present President George W. Bush with the first International Medal of PEACE from the Global PEACE Coalition in recognition of his unprecedented contribution to the fight against HIV/AIDS and other diseases during the Saddleback Civil Forum on Global Health, to b
- Southern AIDS Living Quilt Raises Awareness at National HIV Summit: Women empower others by sharing personal stories of living with HIV/AIDS
- PRNewswire - November 21, 2008
- WASHINGTON, Nov. 21 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS L
- Roche Holds Sixth Annual Children's Walk in Nutley
- PRNewswire - November 21, 2008
- -- More than 800 Employees Volunteer to Support Children Affected by HIV/AIDS in New Jersey and Africa NUTLEY, N.J., Nov. 21 /PRNewswire/ -- Today, more than 800 local Roche employees are participating in the Sixth Annual Roche Children s Walk to raise funds to support children infected and affected by HIV/AIDS in New
- Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
- PRNewswire - November 20, 2008
- -- Nearly 90 Percent of Patients Achieve Undetectable Viral Load in Phase IIa Trial Within 28 Days of Combined Treatment With Standard of Care CORK, Ireland , November 20/PRNewswire/ -- New clinical data demonstrate the safety and antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed
- Tibotec Begins Enrollment in Europe for Phase III Trial of Telaprevir in HCV Patients who Failed Prior Treatment
- PRNewswire - November 20, 2008
- -- Telaprevir Data Presented at AASLD CORK, Ireland , November 20/PRNewswire/ -- Tibotec BVBA today announced that it has begun enrolling patients in its phase III study of telaprevir (VX-950), an investigational protease inhibitor (PI), in patients with chronic genotype 1 hepatitis C virus (HCV) for whom the current s
- Green Family Foundation Sponsors Alicia Keys' Keep a Child Alive College Student AIDS Summit
- PRNewswire - November 20, 2008
- -- Kimberly Green Joins KCA College in Welcoming 400 Student AIDS Activists and Partner Schools to Combat HIV/AIDS NEW YORK, Nov. 20 /PRNewswire/ -- On November 15th, Green Family Foundation (GFF) (www.greenff.org) president Kimberly Green joined Keep a Child Alive (KCA) Co-Founder and Global Ambassador Alicia Keys and
- Faith and Civil Society Leaders Call for Truth and Leadership in U.S. HIV Prevention Efforts
- PRNewswire - November 20, 2008
- WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- The following is being released by Center for Health & Gender Equity: WHAT: World AIDS Day Audio Media Conference WHEN: Tuesday, November 25, 2008 -- 11:00 a.m. EST Call-in number: 1-800-949-8476 RSVP strongly encouraged: https://cc.readytalk.com/r/1xe41i2yre8rs WH
- Miami Physicians Sentenced to Prison for Their Roles in a $6.8 Million Medicare Fraud Scheme
- PRNewswire - November 20, 2008
- WASHINGTON, Nov. 20 /PRNewswire-USNewswire/ -- Miami physicians Carlos Contreras, 61, and Ramon Pichardo, 58, were sentenced today to 37 months and 48 months in prison, respectively, for defrauding the Medicare program in connection with a $6.8 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthe
- NO/AIDS Task Force Awarded Internship in Leadership Development by R. Scott Hitt Foundation: 2009 Application Process Opens December 1st
- PRNewswire - November 18, 2008
- NEW ORLEANS, Nov. 18 /PRNewswire-USNewswire/ -- This month, the world watched history happen as the United States elected it s first African-American president. Overshadowed by that, but no less historical, was that over 111 openly gay, lesbian, bisexual and transgender candidates were on ballots across the country and
- Miami HIV Clinic Administrator and Two Miami Residents Sentenced for Their Roles in a $14 Million Medicare Fraud Scheme
- PRNewswire - November 18, 2008
- WASHINGTON, Nov. 18 /PRNewswire-USNewswire/ -- Miami residents Dilcia Marinez, Juan Carlos Castaneda and Luis Frias each were sentenced to prison today for their roles in defrauding the Medicare program and laundering the illegal proceeds in connection with a $14 million HIV infusion fraud scheme, Acting Assistant Atto
- Long-Term TITAN Study Evaluates PREZISTA(R)/ritonavir vs. lopinavir/ritonavir as Part of HIV Combination Therapy in Treatment-Experienced Adults
- PRNewswire - November 18, 2008
- BRIDGEWATER, N.J., Nov. 18 /PRNewswire/ -- Tibotec recently announced long-term study results from a phase 3 clinical trial, which compared PREZISTA(R) (darunavir)/ ritonavir to lopinavir /ritonavir, as part of HIV combination therapy, in lopinavir/r-naive, treatment-experienced HIV-1 infected adults.
- Record Number of Youth Dancing Worldwide to Take a Stand Against HIV and AIDS
- PRNewswire - November 17, 2008
- -- Archbishop Desmond Tutu Kicks off Live Connection AMSTERDAM, November 17/PRNewswire/ -- More than 50.000 young people will take a stand on the 29th of November during Dance4Life events in 19 countries. The worldwide Dance4Life movement is growing rapidly. This year 150,000 extra youth were reached with Dance4Life Sc
- GLEH LA, a Nonprofit Affiliate of Gay & Lesbian Elder Housing, Announces New Program Director
- PRNewswire - November 13, 2008
- LOS ANGELES, Nov. 13 /PRNewswire/ -- Gay & Lesbian Elder Housing- Los Angeles (GLEH LA) and the managing general partner of the nation s first nonprofit, affordable, multicultural housing development that includes a community service center supporting the needs of GLBT elders, for both residents and non-residents,
- Gilead to Topple GSK as the Top Player in the Anti-Infectives Drug Market in 2014: Stringent, Yet Ill-Defined, Approval Standards Make it Difficult for Companies to Bring Hospital Antibiotics to Market, According to a New Report from Decision Resources
- PRNewswire - November 12, 2008
- WALTHAM, Mass., Nov. 12 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that Gilead will topple GlaxoSmithKline (GSK) as the top player in the anti-infectives drug market in 2014. According to the new report entitled Comm
- Miami Clinic Owner Sentenced to 30 Months in Prison for $10.9 Million Medicare Fraud
- PRNewswire - November 12, 2008
- WASHINGTON, Nov. 12 /PRNewswire-USNewswire/ -- Miami clinic owner Nayda Freire, 61, was sentenced today to 30 months in prison for defrauding the Medicare program in connection with a $10.9 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney
- Kenneth Cole Releases New Book 'AWEARNESS: Inspiring Stories About How To Make a Difference': Commemorates 25th Anniversary by launching initiative to encourage acts of service, volunteerism and social change
- PRNewswire - November 12, 2008
- NEW YORK, Nov. 12 /PRNewswire-FirstCall/ -- Designer and activist Kenneth Cole today released a book that celebrates the heritage of Kenneth Cole Productions, marrying his long term social mission with his new AWEARNESS initiative for empowering, encouraging and supporting acts of service, volunteerism and social chang
- Tibotec Data Presented at ICAAC and HIV9 Follow key Regulatory Approvals for Anti-HIV Compounds
- PRNewswire - November 12, 2008
- -- New Findings From ARTEMIS and TITAN Studies Demonstrate Growth of the Tibotec Virology Franchise GLASGOW, Scotland, November 12/PRNewswire/ -- New data on PREZISTA(R) (darunavir), a protease inhibitor from Tibotec, will be presented at the Ninth International Congress on Drug Therapy in HIV Infection (HIV9) in Glasg
- MANHUNT Leads Fight Against Spread of Sexually Transmitted Infections with Launch of MANHUNT Cares; Hires Senior Public Health Strategist from CDC
- PRNewswire - November 11, 2008
- CAMBRIDGE, Mass., Nov. 11 /PRNewswire/ -- Ken Herron, Chief Marketing Executive at Online Buddies Inc., the parent company of MANHUNT, announced today that David S. Novak of the Centers for Disease Control and Prevention (CDC) will join the team at Online Buddies, Inc. as the site s first Senior Public Health Strategis
- GeoVax Labs, Inc. Announces Third Quarter 2008 Financial Results and Provides Operational Update
- PRNewswire - November 10, 2008
- ATLANTA, Nov. 10 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) ( GeoVax or the Company ), a biopharmaceutical firm developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its third quarter 2008 financial results and provided
- MTV's Staying Alive Marks Ten Years of Empowering Young People in Their Fight against HIV and AIDS
- PRNewswire - November 10, 2008
- -- MTV GLOBALLY PREMIERES ORIGINAL HIV/AIDS PROGRAMMING ON WORLD AIDS DAY -- HOUR LONG SPECIAL: THE DIARY OF KELLY ROWLAND It s about education. It s about empowerment. It s about opening dialogue. LIVERPOOL, N.Y., Nov. 10 /PRNewswire-FirstCall/ -- To mark 10 years of dedication and commitment in the fight against HIV/
- World Vision Urges Obama Administration and New Congress to Make Poverty Alleviation a Top Foreign Policy Priority: U.S. leadership in global financial crisis must include focus on the world's poor
- PRNewswire - November 10, 2008
- -- Extreme poverty one of greatest terrors facing our world today, World Vision warns WASHINGTON, Nov. 10 /PRNewswire-USNewswire/ -- World Vision, a leading international humanitarian aid agency, congratulates President-elect Barack Obama on his win as the 44th President of the United States , and urges his leadersh
- Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
- PRNewswire - November 10, 2008
- PRINCETON, N.J., Nov. 10 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) , Roche and InterMune, Inc. (NASDAQ:ITMN) today announced that the first patients have been dosed in an innovative clinical trial in patients chronically infected with the hepatitis C virus (HCV). The trial (run in centers in
- 'Project Runway' Designer Brings Living Positive By Design Campaign to New York to Educate About Living With HIV and Combat Stigma Associated With the Disease
- PRNewswire - November 7, 2008
- -- Jack Mackenroth to debut signature campaign scarf at Gay Men s Health Crisis Fashion Forward fundraiser event NEW YORK, Nov. 7 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is nationally debuting an HIV and AIDS education campaign called Living Positive By Design, in New Yor
- Obama Could Inherit Weaker Global Health Fund
- PRNewswire - November 7, 2008
- WASHINGTON, Nov. 7 /PRNewswire-USNewswire/ -- As the clock runs out on the Bush Administration, key US officials are working overtime to undermine a crucial international health program, the Global Fund to Fight AIDS, Tb and Malaria. US officials are attending a meeting of the Fund s Board in India , where
- Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
- PRNewswire - November 7, 2008
- PHILADELPHIA, Nov. 7 /PRNewswire/ -- Data from an investigational, open-label, randomized study assessing extended dosing regimens of PROCRIT(R) (Epoetin alfa) in treating anemia in subjects with Stages 3 - 4 chronic kidney disease (CKD) were presented today at the American Society of Nephrology 41st Annual Meeting.
- 50,000 Young People Dance to Celebrate Achievements in Pushing Back HIV and AIDS
- PRNewswire - November 7, 2008
- AMSTERDAM, November 7/PRNewswire/ -- Archbishop Desmond Tutu, Kofi Annan and Nafis Sadik Support Global Initiative Dance4Life On the 29th of November, fifty thousand young people will make a worldwide statement against HIV and AIDS. Connected live via satellite, young people in 19 countries will dance in unity and soli
- Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
- PRNewswire - November 6, 2008
- KVISTGARD, Denmark , November 6/PRNewswire-FirstCall/ -- Bavarian Nordic has completed a clinical safety report from a large Phase II study with IMVAMUNE(R) in HIV infected subjects that confirms the excellent safety profile of IMVAMUNE(R). Within the next few days the safety report of this study will be submitted to t
- The Female Health Company Confirms Guidance for FY Ended September 30, 2008
- PRNewswire - November 6, 2008
- CHICAGO, Nov. 6 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today confirmed its guidance for the fiscal year ended September 30, 2008. We are very pleased to confirm that our August 2008 guidance regarding fiscal year 2008 growth in uni
- Global AIDS Alliance Welcomes Election of Barack Obama
- PRNewswire - November 5, 2008
- WASHINGTON, Nov. 5 /PRNewswire-USNewswire/ -- The Global AIDS Alliance today welcomed the election of Senator Barack Obama as President of the United States . We look forward to working with President-elect Obama as he confronts that challenge of HIV/AIDS, which every day kills over 5,000 people and infects another 7,5
- Stars to 'Tell It Like It Is' at MTV's European Music Awards: MTV and SpinVox team up to talk sex secrets, one night stands and condoms
- PRNewswire - November 5, 2008
- LONDON and NEW YORK, Nov. 5 /PRNewswire/ -- MTV S Staying Alive Foundation and SpinVox have teamed up with Lapeno, Mervin and Ed the notorious puppet from MTV s Fur TV show to promote sexual health amongst young people. The Telling It Like It Is campaign is a groundbreaking initiative that encourages young people to sp
- Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at The AASLD Liver Meeting 2008
- PRNewswire - November 3, 2008
- -- Nearly 90 percent of patients achieve undetectable viral load in Phase IIa trial within 28 days of combined treatment with standard of care SAN FRANCISCO, Nov. 3 /PRNewswire/ -- New clinical data show antiviral activity of TMC435, an investigational protease inhibitor (PI) being developed by Tibotec BVBA for the tre
- New Study Shows that PEGASYS(R) Regimen Provides Higher Sustained Virological Response Rates for Hepatitis C Patients
- PRNewswire - November 1, 2008
- -- Higher Sustained Virological Response Rates Recognized as Marker of Treatment Success SAN FRANCISCO, Calif., Nov. 1 /PRNewswire/ -- A new, independently-conducted study being presented at the 59th Annual Meeting of the American Association for the Study of Liver Diseases (AASLD) shows that PEGASYS(R) (peginterferon
- Cheap Condoms for a Safer Sex Industry
- PRNewswire - October 31, 2008
- -- Safe4now Foundation Allows Prostitutes to Prevent AIDS or STD Infection AMSTERDAM, The Netherlands , October 31/PRNewswire/ -- Though condom prices are decreasing rapidly all over the world, prostitutes and other women working in the sex industry still have to pay enormous costs to guarantee a safe working environme
- Roche Receives FDA Approval for Hepatitis C Viral Load Test on Its Fully Automated Real-Time PCR Platform: Improved laboratory efficiencies and standardization to personalize patient care
- PRNewswire - October 30, 2008
- PLEASANTON, Calif., Oct. 30 /PRNewswire/ -- Roche Molecular Diagnostics today announced that the U.S. Food & Drug Administration ( FDA ) has approved the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HCV Test for use in the United States . The test uses Roche s proprietary real-time PCR technology to quantify the amount
- Southern AIDS Living Quilt Raises Awareness on the Web: Women across the South share personal stories of living with HIV/AIDS
- PRNewswire - October 30, 2008
- MIAMI, Oct. 30 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS Living
- New Report Finds Rising Risk of Infectious Diseases in America
- PRNewswire - October 29, 2008
- WASHINGTON, Oct. 29 /PRNewswire-USNewswire/ -- Trust for America s Health (TFAH) released a new report today, Germs Go Global: Why Emerging Infectious Diseases Are a Threat to America; which finds that at least 170,000 Americans die annually from newly emerging and re-emerging infectious diseases, a number that could i
- Merck Serono's US Affiliate EMD Serono, Inc. and Theratechnologies Announce Collaboration and Licensing Agreement for Tesamorelin in the United States
- PRNewswire - October 29, 2008
- -- Merck Serono s US Affiliate EMD Serono, Inc. to Acquire Rights in Tesamorelin, a Phase 3 Compound Being Investigated for the Treatment of Excess Abdominal Fat in HIV Patients With Lipodystrophy in the US GENEVA, Switzerland , October 29/PRNewswire/ -- Merck KGaA, Darmstadt, Germany
- House Candidates Jim Himes and Chris Shays Pledge Action on HIV/AIDS Epidemic
- PRNewswire - October 29, 2008
- NEW HAVEN, Conn., Oct. 29 /PRNewswire-USNewswire/ -- Both Jim Himes and Rep. Chris Shays, candidates for US House of Representatives from Connecticut s 4th district, have signed a pledge to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. 14,899 residents of Connecticut are HIV-positiv
- Senator Dean Barkley Pledges Action on HIV/AIDS Epidemic
- PRNewswire - October 28, 2008
- ST. PAUL, Minn., Oct. 28 /PRNewswire-USNewswire/ -- Dean Barkley, candidate for US Senate from Minnesota, has signed a pledge to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. We hope that Al Franken, Norm Coleman and other candidates from Minnesota will also agree to sign the pledge
- Sangamo BioSciences Presents Data at ICAAC Demonstrating 'In Vivo' Protection Against HIV Infection by CCR5-ZFN Therapeutic
- PRNewswire - October 28, 2008
- -- Preclinical Animal Data Demonstrates Selective Survival Advantage of ZFN-Treated Immune Cells after HIV Infection and Reduced Viral Loads WASHINGTON and RICHMOND, Calif., Oct. 28 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today the presentation of data demonstrating that human CD4 T-
- Bayer and Onyx Launch Educational Program to Raise Awareness About Liver Cancer and Its Risk Factors: New Survey Quantifies Misperceptions about Liver Cancer in the United States
- PRNewswire - October 28, 2008
- WAYNE, N.J. and EMERYVILLE, Calif., Oct. 28 /PRNewswire-FirstCall/ -- A new survey of more than 1,000 American adults revealed that general knowledge regarding liver cancer risk factors and treatment options is limited, even among individuals with a connection to the disease. According to the GfK Roper survey, among th
- Why Are Some Veterans Who Are Coinfected With Hepatitis C and HIV More Likely to Be Treated for HCV Than Others?
- PRNewswire - October 28, 2008
- -- Research to be presented Sunday, November 2, 2008 at this year s liver meeting in San Francisco, California, October 31 - November 4 SAN FRANCISCO, Oct. 28 /PRNewswire/ -- Researchers from the Michael E. DeBakey VA Medical Center, led by Jennifer Kramer, Ph.D., looked at a population of U.S. veterans to determine th
- Town Hall Meeting on Inequities in Clinical Trials Documents Ongoing 'Tuskegee Effect' When Recruiting Minorities for Research Studies: Health Officials/Patient Advocates Link Underrepresentation of Minorities in Clinical Trials with Higher Death Rates
- PRNewswire - October 28, 2008
- HOUSTON, Oct. 28 /PRNewswire-USNewswire/ -- What is keeping so many Americans and especially racial and ethnic minorities from taking part in medical studies for diseases from asthma to cancer? According to more than 100 political leaders, public health officials and patient advocates meeting in Harlem to address the u
- Local Organization Receives Multi-Million Dollar Grants for Natural Family Planning, HIV Testing and Family Planning Services for Men
- PRNewswire - October 28, 2008
- PHILADELPHIA, Oct. 28 /PRNewswire-USNewswire/ -- The Family Planning Council was recently awarded three grants from the U.S. Department of Health & Human Services for a total of $3 million. These grants will support state-of-the-art research in three important health care areas: the use of Natural Family Planning a
- Monogram Announces 2008 Third Quarter Financial Results
- PRNewswire - October 27, 2008
- -- Conference call today at 4:30 p.m. ET - SOUTH SAN FRANCISCO, Calif., Oct. 27 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today reported financial results for the quarter ended September 30, 2008. The Company had revenues of $16.1 million for the third quarter of 2008, 55% higher than $10.4 mil
- Analysis of Long-Term Vicriviroc Data Provides Evidence of Sustained Viral Suppression, Increased CD4 Cell Counts and Tolerability in Treatment-Experienced HIV-Infected Patients
- PRNewswire - October 26, 2008
- -- Data Analysis of Up to Four Years of Treatment Presented at ICAAC/IDSA 2008 Annual Meeting WASHINGTON, Oct. 26 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported a data analysis showing that vicriviroc, its investigational CCR5 receptor antagonist, demonstrated sustained viral suppressio
- Data Reported at ICAAC Indicates Selzentry(TM) Phase III Treatment-Naive Trial Shows Increased Efficacy When Used With Enhanced Trofile(TM) Assay
- PRNewswire - October 26, 2008
- SOUTH SAN FRANCISCO, Calif., Oct. 26 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) announced today that data presented this week demonstrated that in Pfizer Inc s (NYSE:PFE) phase III trial of Selzentry(TM) (maraviroc) in treatment naive individuals with CCR5-tropic HIV-1, increased efficacy was sh
- Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
- PRNewswire - October 26, 2008
- WASHINGTON, Oct. 26 /PRNewswire/ -- Sequoia Pharmaceuticals presented positive results today from two studies on SPI-256, a novel investigational HIV protease inhibitor (PI). One study based on an in vitro analysis demonstrates that the mode of interaction of SPI-256 with HIV protease provides a rationale for its high
- Long-Term Study Evaluates Boosted PREZISTA(R) Vs. Lopinavir/Ritonavir as Part of HIV Combination Therapy in Treatment-Naive Adults: Ninety-six week ARTEMIS data presented at ICAAC
- PRNewswire - October 26, 2008
- BRIDGEWATER, N.J., Oct. 26 /PRNewswire/ -- Ninety-six week results presented today from a phase 3, randomized, open-label, ongoing clinical trial showed that 79 percent of treatment-naive HIV-1 infected adults taking PREZISTA(R) 800 mg (two 400 mg tablets) with 100 mg ritonavir (r) once daily reached an und
- Land O'Lakes Collaborates With Ethiopian Farmers to Create Livelihoods for People Living With HIV/AIDS
- PRNewswire - October 24, 2008
- ARDEN HILLS, Minn., Oct. 24 /PRNewswire/ -- The global fight against HIV/AIDS has received a boost from a partnership between Ethiopian dairy farmers and Land O Lakes, Inc., supported by funding from the President s Emergency Program for HIV/AIDS Relief (PEPFAR). Working together, the Land O Lakes International Develop
- Innovative Sperm Bank Offers Donor Video and Pictures: Fertility Cryobank is First in the World to Offer Video and Pictures of Sperm Donors
- PRNewswire - October 22, 2008
- LOS ANGELES, Oct. 22 /PRNewswire/ -- Gail Taylor, President, today announced the launch of Fertility Cryobank, the world s first sperm bank to offer donor video interviews. Fertility Cryobank is one of the few sperm banks in the country to provide recent photos and a comprehensive genetic evaluation for each donor. It
- U.S. Food and Drug Administration (FDA) Approves PREZISTA(R) Once-Daily as Part of Combination Therapy for Treatment-Naive Adults with HIV-1: PREZISTA also granted traditional approval
- PRNewswire - October 22, 2008
- BRIDGEWATER, N.J., Oct. 22 /PRNewswire/ -- The FDA has granted PREZISTA (darunavir) tablets, a protease inhibitor, approval for an expanded indication for once-daily dosing as part of HIV combination therapy in treatment-naive adults (those who have never taken HIV medication before). The FDA also granted traditional (
- Southern AIDS Living Quilt Raises Awareness on the Web: Women across the South share personal stories of living with HIV/AIDS
- PRNewswire - October 22, 2008
- NEW ORLEANS, Oct. 22 /PRNewswire-USNewswire/ -- AIDS is the leading cause of death for African American women ages 25-34 today. HIV infections could be reduced by 30 percent per year if all HIV infected persons knew of their infection and adopted behavioral changes to limit the spread of the disease. The Southern AIDS
- Gates Foundation Invests in 104 Novel Ideas for Global Health: Scientists from Diverse Set of Disciplines and Regions Receive $100,000 Each to Explore Bold, Untested Projects
- PRNewswire - October 22, 2008
- BANGKOK, Thailand , Oct. 22 /PRNewswire/ -- The Bill & Melinda Gates Foundation today announced 104 grants to explore bold and largely unproven ways to improve global health. The grants of US$100,000 each will be made to scientists from 22 countries and five continents. They mark the first round of funding from Gra
- Class Action Jury Verdict Confirmed and Judgment Entered in Excess of $1.5 Million for Breach of Fiduciary Duties
- PRNewswire - October 22, 2008
- ENGLEWOOD, Colo., Oct. 22 /PRNewswire/ -- The Arapahoe County District Court confirmed a jury verdict and entered final judgment for more than $1.5 million in both compensatory and punitive damages, jointly and severally against a Fort Collins-based private company, PR Pharmaceuticals ( PRP ) and its President, Steven
- Faith-Based Organizations From All Continents Create Global Network to Fight Maternal Death, AIDS, Poverty
- PRNewswire - October 21, 2008
- ISTANBUL, Turkey , Oct. 21 /PRNewswire-USNewswire/ -- More than 75 religious leaders and representatives of Hindu, Buddhist, Sikh, Jewish, Christian and Muslim faith-based organizations today formed a Global Interfaith Network to strengthen cooperation against the global urgencies of maternal death, AIDS and poverty.
- GeoVax's DNA and MVA Vaccines Shipped to HIV Vaccine Trials Network for Use in the Upcoming Phase 2a Trial
- PRNewswire - October 20, 2008
- ATLANTA, Oct. 20 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta based biotechnology company, developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, announced today it has shipped both DNA and MVA components of its AIDS vaccine
- GeoVax Presents Data at AIDS Vaccine 2008 Conference
- PRNewswire - October 16, 2008
- ATLANTA, Oct. 16 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, presented data on their AIDS vaccine (trial HVTN 065) at the AIDS Vaccine 2008 conference, on October 15
- Southern AIDS Living Quilt Project Launch to Break Down Barriers: Web-based project educates and empowers through personal stories of Louisiana women and others across the South
- PRNewswire - October 16, 2008
- NEW ORLEANS, Oct. 16 /PRNewswire-USNewswire/ -- Seventy percent of people living with AIDS in Louisiana are minorities, with AIDS being the leading cause of death for African American women ages 25-34 today. On Wednesday, October 22, The Southern AIDS Coalition (SAC) and Test for Life will launch the Southern AIDS Livi
- Statement of Admiral Joxel Garcia, Assistant Secretary for Health on National Latino AIDS Awareness Day, October 15, 2008
- PRNewswire - October 15, 2008
- WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- Today is National Latino AIDS Awareness Day (NLAAD), which is designed to increase awareness of the devastating and disproportionate effects of HIV/AIDS in the Latino community. NLAAD also encourages HIV testing and supports connecting those living with HIV to care and tre
- Tibotec Begins Enrollment for Phase III Study of Telaprevir, an Investigational Agent, in HCV Patients Who Failed Prior Treatment
- PRNewswire - October 15, 2008
- -- REALIZE is the first phase III study to evaluate a specifically targeted antiviral therapy for hepatitis C (STAT-C) across a full range of HCV-patients who failed prior treatment to current standard of care, including null responders MECHELEN, Belgium , Oct. 15 /PRNewswire-USNewswire/ -- Tibotec BVBA announced today
- Children with Life-Threatening Illnesses Receive Hospice Care: HIV Positive Orphaned Muppet Cheers Soweto Hospice Pediatric Patients
- PRNewswire - October 15, 2008
- WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- With support from the U.S. Agency for International Development (USAID) and funding from the U.S. President s Emergency Plan for AIDS Relief (PEPFAR) and other groups, Soweto Hospice has developed one of South Africa s first children s units to provide specialty care and r
- Florida Congressional Candidate Annette Taddeo Pledges Action on HIV/AIDS Epidemic
- PRNewswire - October 15, 2008
- MIAMI, Oct. 15 /PRNewswire-USNewswire/ -- Annette Taddeo, candidate for US House of Representatives in Florida s 18th district, has pledged to support a comprehensive strategy to fight HIV/AIDS in the US and around the world. She joins Rep. Lincoln Diaz-Balart (R-FL), and twelve other candidates for the US House of Rep
- Qorvis Congratulates YouthAIDS on Raising $1.2 Million+ at Gala: Star-Studded Event Marks Fourth Year of Qorvis/YouthAIDS Collaboration
- PRNewswire - October 15, 2008
- WASHINGTON, Oct. 15 /PRNewswire-USNewswire/ -- Washington, Hollywood and music elite were on hand Friday night at The Ritz-Carlton, Tysons Corner, Virginia for the 2008 Power of Music YouthAIDS Gala. Global Ambassador Ashley Judd hosted the star-studded affair, which raised more than $1.2 million in the fight against t
- 'Project Runway' Fashion Designer Brings Living Positive By Design Campaign to Atlanta to Educate About Living with HIV and Combat Stigma Associated with the Disease
- PRNewswire - October 15, 2008
- -- Jack Mackenroth to kick off AIDS Walk Atlanta weekend with local educational event ATLANTA, Oct. 15 /PRNewswire/ -- Jack Mackenroth, from the hit reality television series Project Runway, is coming to Atlanta to speak about a national HIV and AIDS education campaign called Living Positive By Design that he is involv
- USAID Awards Grants for Development of New Tuberculosis Drugs, Diagnostics, and Management Approaches
- PRNewswire - October 14, 2008
- WASHINGTON, Oct. 14 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) is pleased to announce new grants to The Global Alliance for TB Drug Development and the International Union Against TB and Lung Disease. These grants will support late stage clinical trials for new drugs, diagnostics,
- The Latino Commission on AIDS Call on Presidential Candidates to Honor National Latino AIDS Awareness Day on October 15
- PRNewswire - October 14, 2008
- NEW YORK, Oct. 14 /PRNewswire-USNewswire/ -- On the eve of the last Presidential debate, the Latino Commission on AIDS issued a Call for Endorsement of National Latino AIDS Awareness Day (NLAAD) to Senators John McCain and Barack Obama. We need the commitment of the future President of the United States to bring H
- NBA Star's Daughter is Giving Back by Bringing Joy to Teens: Seattle Teens Gets Unexpected Surprise From Local Teen Star
- PRNewswire - October 14, 2008
- SEATTLE, Oct. 14 /PRNewswire/ -- Chantel Chani Christie, daughter of NBA Power couple Doug and Jackie Christie, gives back to her native state teens. Starting October 14, 2008 Chani plans to visit 20 local middle and high schools to bring joy to teens during this economic crisis. In conjunction with her morale booster
- Nearly Half of Newly Diagnosed HIV/AIDS Cases in Los Angeles County Are Among Latinos: National Latino AIDS Awareness Day Encourages Latinos to Get Tested
- PRNewswire - October 13, 2008
- LOS ANGELES, Oct. 13 /PRNewswire/ -- WHAT -- Latinos make up almost half of all newly diagnosed HIV/AIDS cases reported in Los Angeles County compared to 19 percent nationally. -- A week of activities aimed at raising awareness and encouraging HIV counseling and testing to coincide with National Latino AIDS Awareness D
- Peregrine Pharmaceuticals' anti-PS Technology Platform to Be Discussed at AIDS Vaccine 2008 Conference
- PRNewswire - October 13, 2008
- CAPE TOWN, South Africa and TUSTIN, Calif., Oct. 13 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) a clinical stage biopharmaceutical company developing monoclonal antibodies for cancer and serious viral infections, today reported the company s anti-phosphatidylserine (anti-PS) technology platf
- Walter Reed Evaluation Concludes FirstVue(TM) HBSAG Test is Preferred over Other Rapid Tests
- PRNewswire - October 13, 2008
- -- FirstVue(TM) HBSAG Test Found to Have Higher Sensitivity and Specificity than Other Rapid HBSAG Tests and FirstVue(TM) ...and was the preferred test in all phases of this evaluation CORAL SPRINGS, Fla., Oct. 13 /PRNewswire/ -- AT First Diagnostic LLC an emerging worldwide marketing leader in rapid diagnostic test ki
- Campaign to End Fistula Quadruples In Size, Reaching Over 45 Countries, Says New Report
- PRNewswire - October 13, 2008
- NEW YORK, Oct. 13 /PRNewswire-USNewswire/ -- As the first-ever report by the United Nations Secretary-General, Ban Ki-Moon, on fistula is scheduled to be presented to Member States today, the Campaign to End Fistula announced a fourfold increase in the number of countries it serves. According to its annual report, the
- Inverness Medical Innovations Participates in Meeting on HIV/AIDS with UN Secretary-General
- PRNewswire - October 10, 2008
- WALTHAM, Mass., Oct. 10 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, met yesterday with Ban Ki-moon, the Secretary-General of the United Nations, as part of a group of senior executives of seventeen
- WEDNESDAY, OCTOBER 15TH IS NATIONAL LATINO AIDS AWARENESS DAY: LATINOS ACROSS THE UNITED STATES ARE URGED TO GET TESTED FOR HIV
- PRNewswire - October 9, 2008
- -- Additional Resources: Audio, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/35021/press.html NEW YORK, October 9 /PRNewswire/ -- This Is A Multivu Special Report Brought To You By Gilead Sciences . Last Month The Government Announced That The American Aids Epidemic
- Earvin 'Magic' Johnson Responds to Radio Hosts' Accusations That He 'Faked AIDS'
- PRNewswire - October 9, 2008
- Today, in response to KTLK radio hosts Chris Baker and Langdon Perry s accusations that Magic faked AIDS, Entrepreneur, Philanthropist and NBA Legend Earvin Magic Johnson released the following statement. I am extremely disappointed in KTLK in Minneapolis. I am outraged that Chris Baker and Langdon Perry would minimize
- Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
- PRNewswire - October 9, 2008
- LUDWIGSHAFEN, Germany , Oct. 9 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today announced the opening of new development laboratories and a pilot plant facility that will research groundbreaking technologies and test large-scale production of newly developed drug formulations. The expansion is part of Abbott s global
- First European Survey to Study the Fit and Feel of Condoms: Condomerie Supports Indiana University in Online Survey
- PRNewswire - October 9, 2008
- AMSTERDAM, October 9/PRNewswire/ -- For the first time in Europe a study is being conducted among men to gain information about the fit and feel of condoms. The American Center for Sexual Health Promotion of Indiana University, urges men to participate in this survey and answer questions about their experiences using c
- Miss Universe 2008 Dayana Mendoza Joins the Fight Against AIDS by Getting Tested for HIV
- PRNewswire - October 9, 2008
- NEW YORK, Oct. 9 /PRNewswire-USNewswire/ -- Miss Universe 2008 Dayana Mendoza demonstrates her commitment to the fight against AIDS, by getting publicly tested for HIV at the 6th annual National Latino AIDS Awareness Day 2008 kick-off event on October 9th at 4 p.m. at the Julia de Burgos Cultural Center located at 1680
- In celebration of World Hospice and Palliative Care Day, FHSSA Announces Seven New Partnerships Between U.S. Organizations and African Hospices
- PRNewswire - October 8, 2008
- ALEXANDRIA, Va., Oct. 8 /PRNewswire-USNewswire/ -- The facts are overwhelming. Every day, nearly 7,000 people die from HIV/AIDS in sub-Saharan Africa. More than 35,000,000 women, children, and men in sub-Saharan Africa have already died of AIDS. The Foundation for Hospices in Sub-Saharan Africa is working to ensure the
- Researchers to Evaluate a Once-Daily Investigational Dose of Raltegravir, Merck's Integrase Inhibitor, in an Investigational Population, Patients Previously Untreated for HIV-1
- PRNewswire - October 7, 2008
- -- QDMRK Once-Daily Raltegravir Study to be Conducted in 21 Countries Worldwide WHITEHOUSE STATION, N.J., Oct. 7 /PRNewswire/ -- Merck & Co. , Inc. today announced that researchers will conduct a clinical trial to evaluate the use of raltegravir tablets at a once-daily investigational dose in an investigational pop
- Medicare Fraud Strike Force Indicts Eight Miami-Dade Residents for AIDS/HIV Infusion Fraud
- PRNewswire - October 7, 2008
- WASHINGTON, Oct. 7 /PRNewswire-USNewswire/ -- Eight Miami-Dade County residents have been charged in a 16-count indictment for their alleged roles in a Medicare fraud scheme involving fake HIV infusion treatments, Acting Assistant Attorney General of the Criminal Division Matthew Friedrich and U.S. Attorney for the Sou
- Research Attributes Lack of HIV/AIDS Vaccine to Use of Chimpanzees
- PRNewswire - October 6, 2008
- BOSTON, Oct. 6 /PRNewswire-USNewswire/ -- A return to the use of chimpanzees in AIDS research and vaccine development is without scientific justification, according to a paper released today in the journal Alternatives to Laboratory Animals (ATLA). An Assessment of the Role of Chimpanzees in AIDS Vaccine Research concl
- Sen. McCain Endorses National AIDS Strategy for the United States: Both Presidential candidates have now committed to developing a National AIDS Strategy if elected
- PRNewswire - October 1, 2008
- WASHINGTON, Oct. 1 /PRNewswire-USNewswire/ -- Presidential candidate Senator John McCain has committed to developing a National AIDS Strategy if elected President. The announcement came in written responses to questions from the Washington Blade newspaper. The full interview was posted on the newspaper s website today.
- Improving Safety When Using Bone and Soft Tissue Allograft: Education and Communication are keys to ensuring patient safety and piece of mind
- PRNewswire - October 1, 2008
- ROSEMONT, Ill., Oct. 1 /PRNewswire-USNewswire/ -- Each year in the United States more than 1.3 million donated bone and bone-related allografts are successfully implanted in orthopaedic patients. Musculoskeletal allografts are frequently used in orthopaedic surgery to replace bones, tendons, or other soft tissues damag
- The Death of Matthew Shepard
- PRNewswire - October 1, 2008
- -- TEN YEARS LATER: A FORUM ON GAY JOURNALISM MONDAY, OCTOBER 6, 2008 6:00 P.M. The Commonwealth Club of California 595 Market Street, 2nd Floor, San Francisco SAN FRANCISCO, Oct. 1 /PRNewswire/ -- Ten years ago, October 7, 1998, Matthew Shepard was brutally beaten on a road outside Laramie, Wyoming. Five days later he
- Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
- PRNewswire - September 30, 2008
- PHILADELPHIA, Sept. 30 /PRNewswire-USNewswire/ -- The following is being released by The Philadelphia AIDS Consortium: WHO: Parent Organization: The Philadelphia AIDS Consortium in partnership with its network of eleven (11) community-based organization sites located throughout the tri-state area. WHAT: Swearing-in of
- Foundation for Biomedical Research Provides Free Scientific Enrichment Resources for Students: Downloadable Biomedical Research Puzzle Posters Teach Elementary, Middle and High School Students about the Stages of Research and Development
- PRNewswire - September 30, 2008
- WASHINGTON, Sept. 30 /PRNewswire-USNewswire/ -- The Foundation for Biomedical Research (FBR) announced today it will provide free, downloadable Biomedical Research Puzzle posters on its newly-designed Web site, http://www.fbresearch.org/. The complimentary puzzle posters teach elementary, middle and high school student
- USAID | DELIVER PROJECT Expands Female Condom Order to 10 Million Units
- PRNewswire - September 29, 2008
- CHICAGO, Sept. 29 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) announced that it has received an order from John Snow, Inc., which implements the USAID | DELIVER PROJECT, for the delivery of up to 10 million female condoms (FC) for the United States Agency for International Development (USAID) support
- AIDS Action Committee's MALE Center Salutes Creators and Honors First National Gay Men's HIV/AIDS Awareness Day
- PRNewswire - September 26, 2008
- State s only Sat. and Late-Night Free, Confidential, Rapid HIV Testing Site Serves Gay and Bisexual Men BOSTON, Sept. 26 /PRNewswire-USNewswire/ -- AIDS Action Committee of Massachusetts, Inc. (AAC) and its MALE Center in Boston s South End salute the National Association of People with AIDS (NAPWA) and AIDS Action Cou
- Friends of the Global Fight Lauds Large-scale Actions Outlined at Today's 2008 MDG Malaria Summit
- PRNewswire - September 25, 2008
- The Global Fund Requests Approval of $1.62 Billion for Malaria Programs - If Granted, Universal Access to Bed Nets Achievable by 2010 NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Friends of the Global Fight applauds commitments made at the 2008 MDG Malaria Summit, held in tandem with the annual United Nations assembly
- Prix Galien USA Recognizes Biotech, Pharmaceutical Industries for Innovative Medical Treatments
- PRNewswire - September 25, 2008
- Awards for best biotechnology and best pharmaceutical agents honored outstanding drugs for treating cancer, HIV/AIDS and other life-altering diseases NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Prix Galien USA 2008 (http://www.prix-galien-usa.com/) last night recognized the innovations and ingenuities of biotechnolog
- Landmark Campaign Reaches Rural Kenyans with Tools to Prevent Malaria, Diarrhoeal Disease and HIV
- PRNewswire - September 25, 2008
- -- Voluntary HIV Counseling and Testing Campaign Provides Affordable and Efficient Approach to Preventing Disease Identified KAKAMEGA, Kenya , Sept. 25 /PRNewswire/ -- An important new approach to fighting malaria, diarrhoeal disease and HIV among adult men and women aged 15-49 has successfully been demonstrated for th
- Obama and McCain Pledge Action on Global Poverty and Disease, Says Global AIDS Alliance Fund
- PRNewswire - September 25, 2008
- WASHINGTON, Sept. 25 /PRNewswire-USNewswire/ -- Today at the Clinton Global Initiative, Senators Obama and McCain spoke about why Americans, even in the context of financial crisis, should back bold action to end global disease and expand access to primary education. Each explained how aid was essential to strengthenin
- Napo Pharmaceuticals Will Provide Pediatric Formulation of Crofelemer at Cost to Developing Nations to Help Treat Life-Threatening Diarrhoel Diseases (Subject to FDA Approval)
- PRNewswire - September 25, 2008
- -- Total Value of the Commitment to the CGI is an Estimated $210 Million -- Crofelemer, Once Approved for Children, Could Aid in Treating Diarrhoel Diseases That Kill An Estimated 2.5 million Children Each Year NEW YORK, Sept. 25 /PRNewswire-USNewswire/ -- Napo Pharmaceuticals, Inc., ( Napo ) of South San Francisco, Ca
- Clinton Global Initiative Announces BD's Commitment to Biamba Marie Mutombo Hospital: BD collaborates with Dikembe Mutombo Foundation to improve healthcare system in the Democratic Republic of the Congo
- PRNewswire - September 25, 2008
- NEW YORK, Sept. 25 /PRNewswire-FirstCall/ -- The Clinton Global Initiative recognized BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, for its commitment to the Dikembe Mutombo Foundation (DMF) to enhance immune system monitoring and healthcare worker safety at the Biamba Mari
- AIDS Activists from Across the Country Converge on Oxford, Mississippi, to Call on McCain and Obama to Commit to National AIDS Strategy
- PRNewswire - September 24, 2008
- OXFORD, Miss., Sept. 24 /PRNewswire-USNewswire/ -- As Senators Barack Obama and John McCain arrive in Oxford, Mississippi for their first presidential debate, they will be greeted by AIDS activists from across the country demanding that the next president develop a National AIDS Strategy within his first 100 days in of
- Golf Legend Betsy King and LPGA Star Lorena Ochoa Help Raise More Than $130,000 For African Children: Next Stop Kilimanjaro
- PRNewswire - September 24, 2008
- -- Golf Fore Africa and World Vision Team Up for Fundraiser Betsy King Now Planning Fundraising Climb SEATTLE, Sept. 24 /PRNewswire-USNewswire/ -- At a weekend fundraiser at the Pine Canyon Club in Flagstaff, Arizona, LPGA legend Betsy King and her non-profit organization, Golf Fore Africa raised more than $130,000 to
- Safe Blood for Africa Focuses on Rural DRC: Helping to Stop the Spread of HIV/AIDS by Providing Safe Blood for Transfusions to Rural Populations
- PRNewswire - September 23, 2008
- WASHINGTON, Sept. 23 /PRNewswire-USNewswire/ -- The Safe Blood for Africa Foundation (SBFA), a US-based non-profit organization, today released more details of its USAID-funded project to help improve the safety of blood used for transfusion in the Democratic Republic of the Congo (DRC). Begun one year ago, the DRC
- AdvanDx Receives FDA 510(k) Clearance for Yeast Traffic Light PNA FISH(TM): New Product Provides First Capability To Rapidly Identify Five Candida Species Directly From Positive Blood Cultures In One Test
- PRNewswire - September 23, 2008
- WOBURN, Mass., Sept. 23 /PRNewswire/ -- AdvanDx today announced it received FDA 510(k) clearance of the Yeast Traffic Light PNA FISH(TM) to identify Candida yeast species directly from positive blood cultures. The Yeast Traffic Light(TM) is the latest addition to AdvanDx s easy-to-use, molecular-based PNA FISH(TM) diag
- Canadian-Made Life Saving HIV/AIDS Drug Heading To Africa Under Canada's Access To Medicines Regime (CAMR)
- PRNewswire - September 23, 2008
- TORONTO, Sept. 23 /PRNewswire/ -- Apotex Inc, the largest Canadian-owned pharmaceutical company, is pleased to announce that Apo-TriAvir, a triple combination HIV/AIDS drug, approved under Canada s Access to Medicines Regime (CAMR), is ready to ship to Rwanda , the only country to make a request through a program tende
- Arisyn Therapeutics Inc. Acquires Highly Novel Portfolio of Therapeutic Small Molecules for Infectious Disease and Cancer
- PRNewswire - September 23, 2008
- FREDERICK, Md., Sept. 23 /PRNewswire/ -- Arisyn Therapeutics Inc. (Arisyn) announced today day that it has successfully acquired from UAF Technologies and Research, L.L.C. (UTR) a series of highly novel small molecule inhibitors with a well-defined preclinical efficacy spectrum against a variety of infectious organisms
- Napo Announces Positive Clinical Data Indicating Crofelemer, Could Effectively Treat Cholera
- PRNewswire - September 22, 2008
- SAN FRANCISCO, Sept. 22 /PRNewswire/ -- Napo Pharmaceuticals today announces positive clinical data on the effectiveness of crofelemer from a study for CRO-ID in treating severely ill cholera patients in conjunction with an antibiotic and rehydration therapy. A double-blind placebo-controlled study was conducted in one
- AIDS Activists from Across the Country Converge on Oxford to Call on Presidential Candidates to Commit to National AIDS Strategy; Press Conference 9/23
- PRNewswire - September 22, 2008
- OXFORD, Miss., Sept. 22 /PRNewswire/ -- On Tuesday, September 23, caravans of AIDS activists from around the country will arrive in Oxford and greet hundreds of people who have walked 172 miles from Jackson - all to call on Sens. Barack Obama and John McCain to commit to a National AIDS Strategy within their first 100
- CDC Expands Testing Recommendations for Chronic Hepatitis B Virus Infection: New Guidance Also Issued on Patient Management for Those Infected
- PRNewswire - September 18, 2008
- Sept. 18/PRNewswire-USNewswire - The U.S. Centers for Disease Control and Prevention (CDC) today published new recommendations for health care providers that are designed to increase routine testing in the United States for chronic hepatitis B, a major cause of liver disease and liver cancer. CDC recommends testing al
- The Kaiser Family Foundation and Univision Launch First National Spanish-Language Media Campaign Featuring HIV-Positive Latinos and Loved Ones
- PRNewswire - September 18, 2008
- -- Groundbreaking Ads Confront Stigma and Debunk Myths in Response to Latino AIDS Crisis FORT LAUDERDALE, Fla., Sept. 18 /PRNewswire-USNewswire/ -- The Kaiser Family Foundation and Univision Communications Inc, the nation s leading Spanish-language media company today unveiled SOY... ( I AM... ), a groundbreaking Spani
- Nation's Largest Human AIDS Ribbon Ceremony at the 2008 United States Conference on AIDS
- PRNewswire - September 18, 2008
- FORT LAUDERDALE, Fla., Sept. 18 /PRNewswire/ -- Who: The National Minority AIDS Council (NMAC) at the United States Conference of AIDS What: The group will attempt to create the Nation s Largest Living/Human AIDS Ribbon as Part Of their Annual Conference s Opening Ceremonies to Honor Those Working on the Frontlines of
- Hundreds of AIDS Activists to March Across Brooklyn Bridge and Rally at City Hall to Demand National AIDS Strategy from Obama and McCain
- PRNewswire - September 16, 2008
- -- March and rally are part of national caravan to Mississippi for first presidential debate; activists will protest HIV/AIDS budget cuts in New York NEW YORK, Sept. 16 /PRNewswire-USNewswire/ -- On Thursday, September 18, 2008 hundreds of AIDS activists will march across the Brooklyn Bridge and hold a rally at New Yor
- Unique Experiment Finds Health Content Placed in Grey's Anatomy Episode Quadrupled Awareness Among Audience, Over Eight Million People Absorbed Key Health Message From the Show
- PRNewswire - September 16, 2008
- -- Broader Analysis of Three Years of Top Ten Prime Time Television Shows Indicates Nearly Six in Ten Episodes Featured a Health Storyline WASHINGTON, Sept. 16 /PRNewswire-USNewswire/ -- Most viewers who tune in each night to television s top-rated sitcoms and dramas do so because they want to be entertained, but accor
- Successful Results for Mymetics Corporation's Mucosal HIV/AIDS Vaccine Viral Challenge Significantly Exceeds Expectations
- PRNewswire - September 16, 2008
- NYON, Switzerland , September 16/PRNewswire-FirstCall/ -- Mymetics Corporation (OTCBB: MYMX), a vaccine development company, is pleased to announce their preliminary SHIV challenge results on non-human primates previously immunized with the Company s mucosal HIV-AIDS vaccine designed for triggering mucosal protection.
- U.S. Surrogacy Firm to Provide Private Consultations in the UK for Prospective Parents
- PRNewswire - September 16, 2008
- LOS ANGELES, Sept. 16 /PRNewswire/ -- Growing Generations, the largest U.S. based surrogacy agency, is coming to London, England in October to perform private consultations with prospective clients. The agency has successfully worked with 15 UK-based families who now have children, and an additional 12 who are going th
- 'Project Runway' Fashion Designer Launches Living Positive By Design Campaign in Miami/Ft. Lauderdale to Educate About Living with HIV and to Combat Stigma
- PRNewswire - September 15, 2008
- Jack Mackenroth, from the hit reality television series Project Runway will kick-off a national HIV and AIDS education campaign called Living Positive By Design in Miami/Ft. Lauderdale during an exclusive event held at the 2008 United States Conference on AIDS (USCA), sponsored by the National Minority AIDS Council (NM
- Integrated Prevention Demonstration Campaign Launched in Western Kenya to Fight HIV, Malaria and Diarrhoeal Disease
- PRNewswire - September 15, 2008
- -- Innovative Campaign Breaks Down Policy and Funding Barriers and Paves Way for Affordable and Efficient Approach KAKAMEGA, Kenya , Sept. 15 /PRNewswire/ -- A new approach to fighting malaria, diarrhoeal diseases and HIV was launched today in the Western Kenyan district of Kakamega in Lurambi division. The new cam
- CDC Reports High HIV Infection Rates in Communities of Color, Men Who Have Sex With Men
- PRNewswire - September 12, 2008
- -- AIDS Action Committee Emphasizes Need for Targeted Prevention Outreach BOSTON, Sep. 12 /PRNewswire-USNewswire/ -- The U.S. Centers for Disease Control and Prevention (CDC) yesterday released a new report showing the uneven and devastating impact of HIV on communities of color and men who have sex with men (MSM). Th
- AIDS Activists to March 172 Miles from Jackson to Oxford Presidential Debate to Demand National AIDS Plan from Next President
- PRNewswire - September 12, 2008
- -- 172-mile march reprises historic 1966 Walk Against Fear that mobilized Black vote; rallies and town hall meetings planned along march route; James Meredith to Speak JACKSON, Miss., Sept. 12 /PRNewswire-USNewswire/ -- People living with HIV/AIDS, their loved ones and other supporters will march from Jackson to Oxford
- ADA Amendments Act Will Restore Vital Civil Rights Protections for Americans With Physical and Mental Disabilities
- PRNewswire - September 11, 2008
- WASHINGTON, Sept. 11 /PRNewswire-USNewswire/ -- The leaders of a national coalition of disability, civil rights and social justice organizations praised the U.S. Senate today for taking bipartisan action to restore vital civil rights protections under the Americans with Disabilities Act (ADA). In recent years, the ADA
- Two Miami Physicians Plead Guilty and Admit Ordering $6.8 Million Worth of Unnecessary HIV Infusion Treatments
- PRNewswire - September 11, 2008
- WASHINGTON, Sept. 11 /PRNewswire-USNewswire/ -- Miami physicians, Carlos Contreras, M.D., and Ramon Pichardo, M.D., each pleaded guilty today to defrauding the Medicare program in connection with a $6.8 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U
- Proposed Class Action Settlement Provides Consumers, Medicare Recipients, and Insurers With Money Back
- PRNewswire - September 11, 2008
- BOSTON, Sept. 11 /PRNewswire-USNewswire/ -- The United States District Court for the District of Massachusetts has granted preliminary approval of a Proposed Settlement related to the average wholesale prices of certain prescription drugs. In the lawsuit, In re: Pharmaceutical Industry Average Wholesale Price Litigatio
- Internews Enlists More Than 1,000 Journalists in Fight Against HIV/AIDS
- PRNewswire - September 10, 2008
- ARCATA, Calif., Sept. 10 /PRNewswire/ -- In some countries, lime juice is thought to ward off HIV/AIDS. In others, homosexuality is not publicly discussed. Against such a backdrop of misinformation and stigma, how can developing countries fight a virus that has already killed tens of millions of people? Part of the ans
- African Diplomat's and Former Olympian's Daughter Suzanne Africa Engo Announces 'Africa 101 Project' - Her 858-Mile Run from New York to Chicago
- PRNewswire - September 10, 2008
- NEW YORK, Sept. 10 /PRNewswire/ -- WHAT: 858-Mile Solo Ultra Marathon Kickoff: CAUSE MEDIA GROUP & NY AIDS FILM FESTIVAL WHO: Hit R&B Artist MAXWELL kicks off event with BERTIL LINDBLAD, Director UNAIDS NYO; KENNETH PODZIBA, NYC Sports Commissioner, on behalf of Mayor Bloomberg; TOBY TANSER, Shoe4Africa; and ce
- Miami HIV Clinic Administrator Pleads Guilty for Role in a $14 Million Medicare Fraud Scheme
- PRNewswire - September 9, 2008
- WASHINGTON, Sept. 9 /PRNewswire-USNewswire/ -- Miami resident Dilcia Marinez, 57, pleaded guilty today to her role in defrauding the Medicare program and laundering the proceeds of the crimes in connection with a $14 million HIV infusion fraud scheme, Acting Assistant Attorney General Matthew Friedrich of the Criminal
- VivaGel(R) Condom: Full Licence Agreement With Durex(R)
- PRNewswire - September 9, 2008
- MELBOURNE, Australia , Sept. 9 /PRNewswire/ -- Starpharma Holdings Limited today announced that a full licence agreement has been signed with SSL International plc in relation to the VivaGel(R) coated condom. SSL manufactures and sells Durex(R) condoms, the market-leading condom brand worldwide. Under the terms of
- NCPS Outraged at HIV/AIDS Medi-Cal Cuts
- PRNewswire - September 9, 2008
- MEMPHIS, Tenn., Sept. 9 /PRNewswire-USNewswire/ -- The National Coalition of Pastors Spouses (NCPS) is outraged at the proposed cuts to the HIV/AIDS Medi-Cal pilot program which was designed to help provide life-sustaining medications for thousands of Californians living with HIV/AIDS. These cuts are especially troubli
- New HIV Protection for Women
- PRNewswire - September 9, 2008
- MANCHESTER, England, September 9/PRNewswire/ -- Vaginal rings, similar to those used for contraception and hormone replacement therapy, could protect women from sexually-transmitted HIV, according to research presented at the British Pharmaceutical Conference (BPC) in Manchester. Researchers from the School of Pharmacy
- Ortho Biotech Files sNDA for DOXIL(R) for the Treatment of Advanced Breast Cancer
- PRNewswire - September 8, 2008
- BRIDGEWATER, N.J., Sept. 8 /PRNewswire/ -- Ortho Biotech Products, L.P. today announced that the Company has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration ( FDA ) for the combination of DOXIL (R) (doxorubicin HCl liposome injection) and Taxotere(R) (docetaxel)* for the t
- Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders
- PRNewswire - September 8, 2008
- -- 90% of genotype 2 or 3 patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus Copegus(R) -- Safety and tolerability comparable to placebo administered with Pegasys plus Copegus PRINCETON, N.J., Sept. 8 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:
- Domestic AIDS Epidemic Ignored at Republican National Convention: Advocates call on John McCain to commit to develop a National AIDS Strategy for the U.S.
- PRNewswire - September 5, 2008
- MINNEAPOLIS and ST. PAUL, Minn., Sep. 5 /PRNewswire-USNewswire/ -- The Republican National Convention concluded last night with no mention of the domestic AIDS epidemic in the United States and only passing reference to the epidemic overseas. Neither Presidential nominee Sen. John McCain nor Vice Presidential nominee G
- The HealthCentral Network Acquires TheBody.com, the Number One Interactive Resource for HIV Communities
- PRNewswire - September 4, 2008
- -- Site brings highest quality, largest audiences of patients concerned about HIV prevention and treatment, and a unique connection with HIV-focused physicians ARLINGTON, Va., Sept. 4 /PRNewswire/ -- The HealthCentral Network, Inc. (www.HealthCentral.com) today announced the acquisition of HIV/AIDS patient resource The
- Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients
- PRNewswire - September 4, 2008
- -- 100 mg cohort demonstrates potent antiviral activity and favorable safety profile CAMBRIDGE, Mass., Sept. 4 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious disease
- More than 1,000 Journalists Enlisted in Fight Against HIV/AIDS
- PRNewswire - September 4, 2008
- WASHINGTON, Sept. 4 /PRNewswire/ -- In some countries, lime juice is thought to ward off HIV/AIDS. In others, homosexuality is not publicly discussed. Against such a backdrop of misinformation and stigma, how can developing countries fight a virus that has already killed tens of millions of people? Part of the answer i
- FDA Approves First Hepatitis B Viral Load Test
- PRNewswire - September 4, 2008
- -- Another Roche first in TaqMan(R) real-time PCR testing for the diagnostic lab PLEASANTON, Calif., Sept. 4 /PRNewswire/ -- The U.S. Food & Drug Administration ( FDA ) has approved the Roche COBAS(R) TaqMan(R) HBV Test, the first assay for quantitating Hepatitis B Virus DNA approved in the U.S. The test uses Roche
- Senator Frist and Convention Delegates Support AIDS-Affected People Around the World, Raise Funds for Gustav Evacuees
- PRNewswire - September 2, 2008
- -- Delegates Join World Vision, ONE to Build Hope and Give Help MINNEAPOLIS, Sept. 2 /PRNewswire-USNewswire/ -- Delegates to the Republican Party Convention are sending a message to the most vulnerable communities around the world including evacuees in the Gulf Coast region and those suffering from HIV and AIDS in deve
- InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche
- PRNewswire - September 2, 2008
- -- $15 million development milestone payment to InterMune -- Roche to lead ITMN-191 program in Phase 2 BRISBANE, Calif., Sept. 2 /PRNewswire-FirstCall/ -- InterMune, Inc. (NASDAQ:ITMN) today announced that InterMune has earned a $15 million development milestone under its development collaboration with Roche for the he
- The Female Health Company Receives Order for 4.3 Million FC2 Female Condoms for Papua New Guinea
- PRNewswire - September 2, 2008
- CHICAGO, Sept. 2 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today announced it has received an order for 4.3 million FC2s from the Papua New Guinea - Australia HIV and AIDS program.
- PhRMA Members Lead the World in Cancer Research Investment
- PRNewswire - September 2, 2008
- WASHINGTON, Sept. 2 /PRNewswire-USNewswire/ -- The Pharmaceutical Research and Manufacturers of America (PhRMA) applauds the leadership of television news anchors Katie Couric, Charles Gibson and Brian Williams and the commitment of their respective networks in donating one hour of primetime programming on Sept. 5 to S
- AIDS Responsibility Project Invites You to Join Us for a Panel Discussion During the RNC Convention: After the Welfare State, and After the Katrina Disaster
- PRNewswire - August 31, 2008
- -- How Social Entrepreneurs and Corporations are Bringing Business Solutions To solve our Nation s Public Policy Challenges MINNEAPOLIS, Aug. 31 /PRNewswire-USNewswire/ -- Monday, September 1, 2008 -- Marquette Hotel, 710 Marquette Ave -- Lunch will be served, Program Begins at 12:30PM Few policy leaders would defend t
- Abbott Fund to Build First Pediatric HIV/AIDS Clinic in Tanzania
- PRNewswire - August 29, 2008
- -- Joint Effort with Baylor International Pediatric AIDS Initiative Will Improve Access to Health Care for Children with HIV/AIDS WASHINGTON, Aug. 29 /PRNewswire-FirstCall/ -- The Abbott Fund joined representatives from the U.S. government, Baylor College of Medicine, the government of Tanzania and other part
- Bill Clinton and Other Leaders Call For 'Renewal of Battle Against AIDS' in the United States at Democratic Convention: Advocates disappointed that Obama failed to address the issue
- PRNewswire - August 29, 2008
- DENVER, Aug. 29 /PRNewswire-USNewswire/ -- Speaking at the Democratic National Convention Wednesday night, Former President Bill Clinton called for a reinvigorated response to the domestic HIV/AIDS epidemic in the United States . In praising Presidential nominee Barack Obama, Clinton said, He will continue and enhance
- Bristol-Myers Squibb Welcomes NICE Guidance Recommending Baraclude(R) (entecavir) as a Treatment Option for Chronic Hepatitis B
- PRNewswire - August 29, 2008
- UXBRIDGE, England, August 29/PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has published guidance that recommends Baraclude(R) (entecavir) as an option for treatment of eligible patients with chronic hepatitis B (CHB). Entecavir is a potent anti-viral treatment for chronic Hepatitis B that
- INTELENCE(TM) (Etravirine) Receives Marketing Authorisation in the European Union for HIV Combination Therapy
- PRNewswire - August 29, 2008
- -- INTELENCE is the First NNRTI to Show Antiviral Activity in Patients With NNRTI-Resistant Virus CORK, Ireland , August 29/PRNewswire/ -- The European Medicines Agency (EMEA) has granted marketing authorisation for the anti-HIV medication INTELENCE(TM) (etravirine). INTELENCE is a next generation non-nucleoside revers
- Preliminary Report of American Biotech Labs HIV Study Featured in Inaugural Issue of Journal of the Science of Healing Outcomes
- PRNewswire - August 29, 2008
- Four-month study detailing effects of treatment of HIV-positive individuals with American Biotech Labs (ABL) ASAP 10 treatment indicates significant improvement in the condition of the subjects after treatment; in-vitro laboratory work shows that ABL nanosilver particles can block entry of the virus into cells, eventua
- Convicted Medicare Fraud Defendant Pleads Guilty to Laundering More Than $3 Million in Fraudulent Proceeds
- PRNewswire - August 29, 2008
- WASHINGTON, Aug. 29 /PRNewswire-USNewswire/ -- Miami resident Juan Carlos Castaneda, 47, pleaded guilty today to participating in a conspiracy to launder approximately $3.8 million in proceeds from several Medicare fraud schemes, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Atto
- New Research Reveals That Mycamine(R) is an Effective Treatment in Children, Young Babies and Premature Infants
- PRNewswire - August 28, 2008
- -- Research Adds to Already Demonstrated Efficacy in Adult Population -- Not for distribution in the United Kingdom STAINES, England, August 28/PRNewswire/ -- Parents and paediatricians are today welcoming the results of new research that adds additional support for an effective and well tolerated treatment for childre
- Panic At The Disco and Plain White T's to Take the Stage at the Rock Band 2 Party to Benefit LIFEbeat Saturday, September 6th at House of Blues in Los Angeles
- PRNewswire - August 28, 2008
- NEW YORK, Aug. 28 /PRNewswire/ -- Rock Band 2 -- the next incarnation of the cultural and video game phenomenon Rock Band -- is teaming up with LIFEbeat to shed some star power over the continued need for HIV/AIDS prevention in the week prior to the game s launch. On Saturday, September 6th at House of Blues in Los Ang
- AIDS Crisis in Communities of Color Prompts Demand for National Plan to Fight HIV/AIDS
- PRNewswire - August 27, 2008
- -- Public Health Advocates Deliver Demand during the Democratic National Convention Calling on Senators Barack Obama and John McCain to Support a Comprehensive National AIDS Strategy LOS ANGELES, Aug. 27 /PRNewswire-USNewswire/ -- In a historically unprecedented move, over 30 national HIV/AIDS organizations and leaders
- Daschle, Convention Delegates, Daughtry Join to Give Help to AIDS-Affected People Around the World
- PRNewswire - August 26, 2008
- -- Delegates Join World Vision, ONE to Build Hope, Give Help Around the World DENVER, Aug. 26 /PRNewswire-USNewswire/ -- Delegates to the Democratic Party Convention are sending a message to people suffering from HIV and AIDS around the world: We want to help. Doing something unconventional at the party s presidential
- Half of Surveyed Physicians Expect to Replace Between 6 Percent and 15 Percent of Their Sustiva Prescriptions with Isentress: Most Surveyed MCO Pharmacy Directors Do Not Place Cost Control Measures on Branded Antiretroviral Drugs, According to a New Report from Decision Resources
- PRNewswire - August 26, 2008
- WALTHAM, Mass., Aug. 26 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues, finds that the expansion of labeling for Merck s Isentress to include use in treatment naive patients will significantly impact sales of the drug for HIV treatment
- Here's Hope and the AIDS Epidemic in the South
- PRNewswire - August 25, 2008
- -- I was working in Miami, renting a room, and getting by alone. Then my body started breaking down. Because of my weak HIV-positive system, my diabetes and my hypertension kicked up and I couldn t work. I couldn t make rent, so I ended up homeless. The South Florida AIDS Network led me to Here s Hope and that s where
- Congressional Leadership Awards at DNC Honor Commitment to Fight HIV/AIDS
- PRNewswire - August 25, 2008
- -- Calls for Congressional Candidates to Support National AIDS Strategy DENVER, Aug. 25 /PRNewswire-USNewswire/ -- Today, Spreading Hope: Congressional Leadership Awards in the Fight Against HIV/AIDS luncheon occurs during the Democratic National Convention at the Hotel Monaco
- Democrats to be Recognized in Denver for Leadership on HIV/AIDS
- PRNewswire - August 25, 2008
- -- All Candidates for Congress Asked to Sign Pledge on AIDS and Poverty DENVER, Aug. 25 /PRNewswire-USNewswire/ -- In a luncheon today in Denver, two leading AIDS organizations are recognizing Democratic members of Congress who have shown extraordinary leadership in the fight against HIV/AIDS, both in the US and around
- WashingtonWatch.com Weekly Update: Senator Biden's Priorities
- PRNewswire - August 25, 2008
- WASHINGTON, Aug. 25 /PRNewswire-USNewswire/ -- This is the WashingtonWatch.com federal legislative update for the week of August 25, 2008. Congress continues its August recess and will not return to Washington for a couple more weeks. This week, the Democratic party convention in Denver will complete the process of sel
- AltaMed Opens First-of-its-Kind Health Care Center in the Nation: 32,000 Sq. Ft. Facility Helps Tackle Health Care Crisis by Providing Sorely Needed Medical, Dental and Senior Services to Critically Underserved Area of Los Angeles County
- PRNewswire - August 22, 2008
- LOS ANGELES, Aug. 22 /PRNewswire/ -- AltaMed Health Services along with community and political leaders, celebrated today the grand opening of the Family Health and Wellness Center located in the heart of El Monte. With a population in critical need of health care services, the Family Health and Wellness Center represe
- Indevus Pharmaceuticals Announces Completion of Enrollment in Phase III Trial of PRO 2000: 9,395 Women Enrolled in Trial Sponsored by Medical Research Council
- PRNewswire - August 22, 2008
- LEXINGTON, Mass., Aug. 22 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) announced today the completion of enrollment in Protocol MDP 301, a Phase III clinical trial of PRO 2000, the Company s candidate vaginal microbicide for the prevention of HIV and other sexually transmitted infections. The t
- Medical Policy Guideline for Trofile(TM) Established By Wellpoint, Inc.: Licensee of Blue Cross/Blue Shield in fourteen states establishes guidelines for use of Trofile
- PRNewswire - August 20, 2008
- SOUTH SAN FRANCISCO, Calif., Aug. 20 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that Wellpoint, Inc. has established a national Medical Policy Guideline for Monogram s Trofile Assay. Wellpoint s guidelines provide that HIV tropism testing with Trofile is considered medically nec
- TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain
- PRNewswire - August 20, 2008
- BLUE BELL, Pa., Aug. 20 /PRNewswire/ -- TheraQuest Biosciences, Inc. a development stage pain management company is presenting data today on TQ-1019, its proprietary topical local anesthetic and on SECUREL(R), its abuse deterrent technology at the World Congress on Pain in Glasgow, Scotland. TheraQuest will present fou
- Rosetta Genomics and the National Institute of Health (NIH) to Identify Potential MicroRNA Drug Targets for HIV: Collaboration Will Seek to Identify microRNAs Implicated in HIV Viral Replication and Their Function
- PRNewswire - August 20, 2008
- -- Samples Will be Screened and Analyzed Using Rosetta Genomics Proprietary microRNA Technologies REHOVOT, Israel and JERSEY CITY, New Jersey, August 20 /PRNewswire-FirstCall/ -- Rosetta Genomics, Ltd. (NASDQ: ROSG) announced today a collaboration with the National Institute of Health to identify microRNAs involved in
- New HIV Prevention/Anti-Stigma Campaign Featuring HIV Positive & Negative Persons 'TOGETHER' Launches Across the Nation
- PRNewswire - August 19, 2008
- SAN FRANCISCO, Aug. 19 /PRNewswire/ -- TOGETHER ... HIV STOPS WITH US is the message of the new media campaign launching today in areas across the country including: Boston, Long Beach and Alameda County, CA. Billboards, transit ads, posters featuring real HIV positive people, and a wide spectrum of HIV negative person
- Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control
- PRNewswire - August 19, 2008
- SAN DIEGO, Aug. 19 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ:VICL) today announced a research collaboration with the Karolinska Institute, a leading European medical university, and the Swedish Institute for Infectious Disease Control (SMI), a governmental expert agency, to evaluate Vical s Vaxfectin(R) adju
- Tobira Therapeutics Inc. Receives US Patent for TBR-652: Clinical trial currently in Phase I
- PRNewswire - August 18, 2008
- PRINCETON, N.J. and SAN DIEGO, Aug. 18 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the issuance of Patent No. 7,371,772 B2 by the U.S. Patent and Trademark
- Aureus Pharma Releases New Unified Knowledge Database: AurSCOPE(R) Global Pharmacology Space and Drug Target Knowledge Databases Related to Nuclear Receptors and Proteases
- PRNewswire - August 18, 2008
- PARIS, August 18/PRNewswire/ -- Aureus Pharma, a leading provider of knowledge management solutions that accelerate life sciences discovery, announced today the release of three new AurSCOPE(R) Target knowledge databases. The new offerings include knowledge databases for the important drug targets Nuclear Receptor and
- Diplomat Specialty Pharmacy Partners With NeedyMeds.com to Increase Drug Access
- PRNewswire - August 18, 2008
- SWARTZ CREEK, Mich., Aug. 18 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that they have entered into a corporate agreement with NeedyMeds.com, an online data base listings of available financial assistance programs for patients requiring support with drug access. The mission of Diplomat s dedicated fund
- The Scientific Business of Thomson Reuters Publishes Three Pharma Matters Reports Covering the First Quarter of 2008
- PRNewswire - August 18, 2008
- -- Quarterly Reports use Market Intelligence and Competitive Analysis from Thomson Reuters to Explore Various Aspects of the Pharmaceutical Pipeline LONDON and PHILADELPHIA, Aug. 18 /PRNewswire/ -- Thomson Reuters, the world s leading source of intelligent information for businesses and professionals, has announced the
- Ardea Biosciences Announces Progress of Clinical Development Programs and Reports Second Quarter and Year-to-Date 2008 Financial Results
- PRNewswire - August 14, 2008
- SAN DIEGO, Aug. 14 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA), a company focused on the discovery and development of small-molecule therapeutics for the treatment of human immunodeficiency virus (HIV), gout, cancer and inflammatory diseases today reported recent accomplishments and financial result
- Nasal Hepatitis B Vaccine Elicits Robust Immunity With a Single Dose; Confers Major Advantages Over Traditional Vaccines: Study reported in August issue of journal PLoS One
- PRNewswire - August 13, 2008
- ANN ARBOR, Mich., Aug. 13 /PRNewswire/ -- A new study has shown that a nasal hepatitis B vaccine elicits a dramatic immune response in animals without requiring three vaccinations, sterile syringes or refrigeration-three factors that impede the delivery of current hepatitis B vaccines. In the study, a single dose of th
- FDA Grants Full Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay - Test Cleared to Screen Donated Blood for Hepatitis B, as well as HIV-1 and Hepatitis C, on Fully and Semi-Automated Instrument Systems
- PRNewswire - August 13, 2008
- SAN DIEGO, Aug. 13 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO) announced today that the US Food and Drug Administration ( FDA ) has approved its supplemental regulatory application to use the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV). The FDA had previously
- National Healthcare for Homeless Day: August 13th, 2008: St. Anthony's Battles Highest Rate of TB Infection in U.S.
- PRNewswire - August 12, 2008
- SAN FRANCISCO, Aug. 12 /PRNewswire/ -- San Francisco has the highest rate of tuberculosis (TB) in the U.S., with recurrent outbreaks among the homeless and marginally housed, according to the most recent study on homelessness and TB by Harvard Medical School. Additionally, the Tenderloin has the highest rates of TB in
- GeoVax Labs, Inc. Announces Six Month Financial Results and Provides Operational Update
- PRNewswire - August 11, 2008
- ATLANTA, Aug. 11 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based, biopharmaceutical firm (the Company), developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Virus) and other infectious agents, today announced its financial results and provided an operation
- Moujan Vahdat Opens Community United Empowerment Pavilion: The Grand Opening Of A New Housing Facility Aims To Improve The Lives Of New Yorkers Living With HIV/AIDS
- PRNewswire - August 11, 2008
- NEW YORK, Aug. 11 /PRNewswire/ -- Each year thousands of New Yorkers are diagnosed with HIV/AIDS leaving them scared and uncertain as to what their future holds. That unfortunate reality prompted New York real estate magnate Moujan Vahdat, one of the largest landowners in New York, to lend a hand by funding a housing f
- Inverness Medical Innovations Features Innovative TB Diagnostic - Clearview(R) TB ELISA at AIDS 2008
- PRNewswire - August 8, 2008
- WALTHAM, Mass., Aug. 8 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, is featuring its new TB diagnostic test, the Clearview TB ELISA, at the International AIDS conference (AIDS 2008). The test, which
- Abbott Study Shows Investigational Heat-Stable Norvir(R) Tablet Provides Similar Drug Levels to Current Norvir Capsule
- PRNewswire - August 7, 2008
- -- Pivotal Study of Norvir Tablet Bioavailability Will Form the Basis of Request for Priority Regulatory Review MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) presented pivotal data at the XVII International AIDS Conference (AIDS 2008) in Mexico City today showing that its investigational Norvir(R) (
- Ardea Biosciences Presents Phase 2a Antiviral Activity Data for Lead HIV Candidate, RDEA806 at XVII International AIDS Conference
- PRNewswire - August 7, 2008
- MEXICO CITY and SAN DIEGO, Aug. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data was presented from its completed Phase 2a proof-of-concept monotherapy study of RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients wit
- Analysis of Six Clinical Trials Finds EPZICOM(R) Effective in Treatment-Naive HIV Patients With Both High and Low Baseline Viral Loads
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) announced that a retrospective analysis of six clinical trials found that anti-HIV regimens containing EPZICOM ( abacavir + lamivudine) were effective in treatment-naive patients regardless of baseline viral loads.
- Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today announced that 96-week data from the HEAT study show that once-daily EPZICOM ( abacavir + lamivudine) provides comparable efficacy to once-daily Truvada (R) (
- Inverness Medical Innovations Announces 4th Generation Rapid HIV Test - Determine(TM) HIV-1/2 Ag/Ab Combo
- PRNewswire - August 7, 2008
- WALTHAM, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Inverness Medical Innovations, Inc. (AMEX:IMA), a leading provider of near-patient diagnostics, monitoring and health management solutions, has announced the introduction of its new 4th generation rapid HIV diagnostic test, the Determine HIV-1/2 Ag/Ab Combo, at the Inter
- Thousands Rally in Mexico City and Call for Human Rights Protections in Global AIDS Response
- PRNewswire - August 7, 2008
- MEXICO CITY, Aug. 7 /PRNewswire/ -- Thousands of AIDS activists gathered today for the first-ever international rally for human rights and HIV/AIDS, a key event of the XVII International AIDS Conference. The activists called on governments to ensure greater human rights protections for people living with HIV and those
- President and Mrs. Bush Visit USAID Programs in Thailand
- PRNewswire - August 7, 2008
- WASHINGTON, Aug. 7 /PRNewswire-USNewswire/ -- The President and First Lady traveled to Thailand to celebrate 175 years of U.S.-Thai relations and to discuss bilateral and regional issues with Prime Minister Samak. During their stay, the President visited an AIDS hospice supported by the U.S. Agency for International De
- Tracleer(R) (bosentan) Receives EU Approval for Treatment of Patients With Mildly Symptomatic Pulmonary Arterial Hypertension
- PRNewswire - August 6, 2008
- ALLSCHWIL and BASEL, Switzerland , August 6/PRNewswire/ -- Actelion Ltd (SWX: ATLN) announced today that Tracleer(R) (bosentan), a dual endothelin receptor antagonist, has been approved in the European Union for the treatment of patients with mildly symptomatic pulmonary arterial hypertension (PAH WHO functional class
- Pooled-Analysis of 54 Clinical Studies Shows No Increased Risk of Heart Attack With Abacavir Therapy
- PRNewswire - August 6, 2008
- MEXICO CITY, Aug. 6 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) (GSK) announced today that a review of data from over 14,600 patients in 54 clinical studies showed no increased risk of myocardial infarction associated with the anti-HIV medication abacavir. GSK conducted this review upon learning that the analy
- ImQuest Receives $6.4 M Five Year Award from NIH to Develop Long-Lasting Combination Topical Microbicides To Prevent HIV Transmission
- PRNewswire - August 6, 2008
- FREDERICK, Md., Aug. 6 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institutes of Health to support the development of a long lasting, safe, and acceptable combination topical microbicide product. ImQuest and a consortium of microbicide researchers from fou
- Pastor Rick & Kay Warren Bring Together Leaders to Discuss Unification of Expertise to Stop HIV/AIDS: Saddleback Church Hosts International AIDS Conference Satellite Session on the Partnership of Government, Business & the Church
- PRNewswire - August 6, 2008
- MEXICO CITY, Aug. 6 /PRNewswire/ -- Kay Warren, HIV/AIDS advocate, author and executive director of the Saddleback HIV/AIDS Initiative, moderated a panel of Rwandan government and church leaders; business and medical experts; and Saddleback HIV/AIDS Initiative directors; along with her husband, Rick Warren, founding pa
- National Quality Forum Endorses National Consensus Standards Promoting Accountability and Public Reporting: Standards emphasize measurement gaps and harmonization
- PRNewswire - August 5, 2008
- WASHINGTON, Aug. 5 /PRNewswire-USNewswire/ -- To fill gaps in assessing clinician performance that can promote higher quality health care, the National Quality Forum (NQF) has endorsed 67 clinician-level consensus standards relating to cancer care, infectious diseases, perioperative care, and care provided by thousands
- Leading AIDS Experts Urge Greater Focus on Behavior-Change Programs to Prevent HIV - Report: Hundreds of Studies Show that Programs to Curb Unsafe Sex and Drug Use are Highly Effective, but Often Overlooked in Global AIDS Response
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire/ -- In a new report released today, an international panel of AIDS experts calls on global leaders to aggressively expand HIV prevention programs aimed at reducing high-risk behaviors, including unsafe sex and drug use. Citing hundreds of clinical trials and observational studies, the re
- Landmark HIV/AIDS Publication Launches at International AIDS Society Conference in Mexico City - "From the Ground Up: Building Comprehensive HIV/AIDS Care Programs in Resource-Limited Settings" Features Work of More Than 230 Global Health Experts
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- The Elizabeth Glaser Pediatric AIDS Foundation, with support from the A Day in the Life of Africa Foundation/Tides Foundation, the U.S. Government, Harvard University and others, unveiled today a comprehensive guide to improving and expanding HIV/AIDS prevention, care and
- amfAR Urges Iran to Release Missing HIV/AIDS Doctors
- PRNewswire - August 5, 2008
- -- CEO of amfAR, The Foundation for AIDS Research, calls the reported detention of two Iranian doctors known for their pioneering work on HIV/AIDS extremely troubling. NEW YORK, Aug. 5 /PRNewswire-USNewswire/ -- Kevin Robert Frost, CEO of amfAR, The Foundation for AIDS Research, expressed deep concern today over the re
- Abbott's Kaletra(R) Tablet Dosed Once-Daily or Twice-Daily Demonstrated Similar Clinical Results Across Race and Gender Lines: HIV-Infected Women and Non-Whites New to Antiretroviral Therapy Respond Similarly to Men and Whites
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire-FirstCall/ -- Initial treatment regimens containing once-daily or twice-daily dosing of Abbott s (NYSE:ABT) protease inhibitor Kaletra (R) ( lopinavir / ritonavir ) tablet provided similar results for controlling the v
- Jesse Milan to Address 2008 International AIDS Conference
- PRNewswire - August 5, 2008
- -- Jesse Milan, Altarum Institute VP and Chairman of the Black AIDS Institute, to be Keynote Speaker at Mexico City Business Council on AIDS WASHINGTON, Aug. 5 /PRNewswire/ -- Jesse Milan, Jr., Vice President of Altarum Institute and a prominent leader and advocate on HIV/AIDS issues, will address the 2008 Mexico City
- Ninety-Six Week Data on Tibotec Investigational NNRTI, TMC278, Presented at AIDS 2008: Phase IIb study examines efficacy and safety of once-daily TMC278 in treatment-naive adults with HIV-1
- PRNewswire - August 5, 2008
- MEXICO CITY, Aug. 5 /PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. provides additional information on the safety and efficacy of TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), as part of HIV combination therapy in treatment-naive adults. T
- TMC278 Demonstrates Long-Term Efficacy and Tolerability in Treatment-Naïve Adults With HIV: Ninety-Six-Week Data on Tibotec Investigational NNRTI Presented at AIDS 2008
- PRNewswire - August 5, 2008
- MEXICO CITY, Mexico, August 5/PRNewswire/ -- New phase IIb data from Tibotec Pharmaceuticals Ltd. show that TMC278, the company s once-daily, investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), provides long-term efficacy and tolerability in treatment-naïve adults with HIV. Ninety-six-week study res
- New Report Finds Investment in AIDS Vaccine and Microbicide R&D Continues to Increase Incrementally in 2007
- PRNewswire - August 5, 2008
- -- Calls for Sustained Funding to Maintain HIV Prevention Research Efforts MEXICO CITY, Aug. 5 /PRNewswire-USNewswire/ -- A new report released today shows that funding for biomedical HIV prevention research and development (R&D), including AIDS vaccines and microbicides, increased dramatically between 2000 and 200
- Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
- PRNewswire - August 5, 2008
- -- 88% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1000mg BID with Pegasys(R) plus Copegus(R) -- Safety and tolerability comparable to placebo administered with Pegasys plus Copegus PRINCETON, N.J., Aug. 5 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) announces t
- Monogram Biosciences Launches First Resistance Assay for HIV Integrase Inhibitors: PhenoSense(R) Integrase Now Enables Clinicians to Monitor Activity of New Class of Potent Antiretroviral Drugs
- PRNewswire - August 4, 2008
- SOUTH SAN FRANCISCO, Calif., Aug. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced the launch of its PhenoSense(R) Integrase assay, built on Monogram s proprietary technology platform, PhenoSense(R). The assay directly measures the susceptibility of HIV to a new and potent class of
- Latest CDC Report on HIV Incidence Grossly Excludes Hispanics in 2006, the Fastest Growing Ethnic Population in the United States and its Territories
- PRNewswire - August 4, 2008
- MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- In an apparent reversal of CDC s January 2008 decision to revise the number of new Hispanic HIV/AIDS diagnoses based on the inclusion of Puerto Ricans as Hispanics, the latest CDC report released in August 2008, entitled Estimation of HIV Incidence in the Unit
- Landmark Global Survey of People Living with HIV and AIDS Shows Concerning Results that Side Effects are Leading Cause for U.S. Respondents to Discontinue or Switch Treatment Regimens
- PRNewswire - August 4, 2008
- -- Despite 25 Years of Pandemic, U.S. Respondents Are Still Concerned about Stigma and Discrimination MEXICO CITY, Aug. 4 /PRNewswire/ -- Results from the groundbreaking AIDS Treatment for Life International Survey (ATLIS), which polled nearly 3,000 HIV-positive patients from 18 countries, show that a concerning number
- JAMA Commentary Opposes Criminal Punishment for HIV Exposure/Transmission: Authors to Discuss Issue at International AIDS Conference, August 3-8
- PRNewswire - August 4, 2008
- CHICAGO, Aug. 4 /PRNewswire/ -- Criminal punishment for exposure to or transmission of HIV does nothing to reduce the spread of the virus. Instead, it increases stigma and drives people away from accessing care, while disproportionately burdening women and other vulnerable groups who are unable to disclose their HIV st
- As AIDS Conference Opens, amfAR Releases Report Exposing Global Failure to Address HIV Among MSM
- PRNewswire - August 4, 2008
- -- Ban Ki-moon, Margaret Chan, and presidents from Africa and Latin America call for governments to target epidemic among men who have sex with men MEXICO CITY, Aug. 4 /PRNewswire-USNewswire/ -- A day after leaders from the United Nations and the World Health Organization called attention to the need to combat AIDS amo
- AIDS Action Committee Applauds Legislature for Taking Action to Protect Patient Privacy Within New Electronic Medical Records System
- PRNewswire - August 4, 2008
- -- Measures on privacy and data security set foundation for future systems BOSTON, Aug. 4 /PRNewswire-USNewswire/ -- AIDS Action Committee of Massachusetts, Inc. (AAC) commends state lawmakers for passing legislation that includes privacy and data security protections within a statewide electronic medical records syste
- New AVAC Report on Pre-Exposure Prophylaxis Calls for Immediate Planning to Anticipate Study Results of Potential New HIV Prevention Option
- PRNewswire - August 3, 2008
- -- Now is the time to anticipate and plan for various study outcomes MEXICO CITY, Aug. 3 /PRNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report, Anticipating the Results of PrEP Trials, calling for increased action from governments, global health institutions, donors, researchers, and ad
- Growing Epidemic in Gay and Bisexual Men in the United States Heightens the Call for a National AIDS Strategy Bridging Race and Sexuality
- PRNewswire - August 3, 2008
- MEXICO CITY, Aug. 3 /PRNewswire-USNewswire/ -- In the wake of disturbing news about higher HIV rates in the United States , people living with HIV and allies are calling for a national AIDS strategy that confronts the homophobia, violence and bias at the heart of the U.S. epidemic. The Centers for Disease Control and P
- Estimate of Annual HIV Incidence Increases to 56,300: Release Of New Estimate Shows Need For A National Aids Strategy
- PRNewswire - August 2, 2008
- WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections was revealed today in a paper published in the Aug. 6, 2008 issue of the Journal of the American Medical Association (JAMA). The revise
- New HIV Infection Figures from CDC Underscore Need for National AIDS Strategy for the U.S.
- PRNewswire - August 2, 2008
- -- Announcement of increased new infections in 2006 follows nearly two-year delay in releasing data WASHINGTON, Aug. 2 /PRNewswire-USNewswire/ -- The new HIV infection figures by the Centers for Disease Control and Prevention (CDC) increase the estimate of new HIV infections in 2006 from 40,000 to 56,300. Though the ag
- Estimate of Annual HIV Incidence Increases Significantly; New Estimate Will Show Need For a National AIDS Strategy
- PRNewswire - August 1, 2008
- WASHINGTON, Aug. 1 /PRNewswire-USNewswire/ -- The federal Centers for Disease Control and Prevention s (CDC) long anticipated revised estimate of annual new cases of HIV infections will be revealed on Aug. 3 in a paper published in the Journal of the American Medical Association (JAMA). The revised estimated number of
- Kay Warren Reveals Solution to Gender-Based Violence: The Worldwide Church, Which Offers Hope to the World;
- PRNewswire - August 1, 2008
- -- Warren Presents Church-based Strategy of Hope and Healing in Plenary, Workshop at Ecumenical Alliance Conference in Mexico City MEXICO CITY, Aug. 1 /PRNewswire/ -- Kay Warren, international AIDS advocate, author and director of the HIV/AIDS Initiative at Saddleback Church in Lake Forest, Calif., today addressed the
- Ford Foundation Says Rights and Opportunity Are Critical for People Living Longer with HIV: Advanced Treatment is Extending Lives, but Social Progress is Needed for People to Live Full Lives with the Disease
- PRNewswire - August 1, 2008
- MEXICO CITY, Aug. 1 /PRNewswire-USNewswire/ -- As millions of people across the globe begin accessing treatment and care for HIV/AIDS, the Ford Foundation today said that creating a world where people with HIV/AIDS can lead full lives with dignity, purpose and access to opportunity is a critical priority in the global
- International AIDS Conference an 'Expensive Talking Shop' Unless More Done for Children: World Vision calls for action to protect, care for children impacted by HIV and AIDS
- PRNewswire - August 1, 2008
- -- Mexico City event a chance to spur help for millions of orphans and vulnerable children MEXICO CITY, Aug. 1 /PRNewswire/ -- A leading humanitarian agency has today warned that the world s biggest conference on HIV and AIDS will miss the mark unless attendees come away making firm commitments to end mother-to-child t
- Ann Lion Coleman Joins Abt Associates to Direct USAID Health Systems 20/20 Project
- PRNewswire - July 31, 2008
- CAMBRIDGE, Mass., July 31 /PRNewswire/ -- HIV/AIDS and health systems expert Ann Lion Coleman will join Abt Associates as Director for the Health Systems 20/20 project in August 2008. Health Systems 20/20 is the USAID Bureau of Global Health s flagship project working to strengthen health systems by using an integrated
- African American-Owned Condom Company Fears the Widening AIDS Epidemic
- PRNewswire - July 31, 2008
- WEST MEMPHIS, Ark., July 31 /PRNewswire/ -- When Kirk Manuel speaks, you hear anguish in his voice. You hear the heartbreak of a man who has see one too many members of his community impacted by HIV and AIDS. When Kirk Manuel speaks, you hear courage in his voice, too. You hear a man who believes in his product, Head S
- Higher Number of HIV Infections Must Translate Into Leadership & Action by U.S. Government
- PRNewswire - July 31, 2008
- -- Additional Funding for HIV Prevention & Sound Public Policies Needed WASHINGTON, July 31 /PRNewswire-USNewswire/ -- As the world s attention turns to the global HIV/AIDS epidemic with the convening of the International AIDS Conference in Mexico City, the U.S. Centers for Disease Control and Prevention (CDC) is a
- Catholics at International AIDS Conference XVII Tell Pope: End Ban on Condoms
- PRNewswire - July 31, 2008
- MEXICO CITY, July 31 /PRNewswire-USNewswire/ -- As thousands gather in Mexico City for the 17th International AIDS Conference August 3-8, 2008, Catholics for Choice and its Latin American sister organizations, Catolicas por el Derecho a Decidir, will be highlighting Catholic opposition to the Vatican s ban on condoms u
- The Latino Commission on AIDS Releases Report on the State of HIV/AIDS in Latino/Hispanic Communities in the United States on the Eve of the International AIDS Conference in Mexico City
- PRNewswire - July 30, 2008
- -- A National Delegation of the Commission will dialogue with leaders at the Conference to share and learn about successful strategies in response to the HIV/AIDS pandemic NEW YORK, July 30 /PRNewswire-USNewswire/ -- Hispanics in the United States are the second most affected community, it is estimated that more than 2
- Bill & Melinda Gates Congratulate President Bush on Signing of AIDS, TB, and Malaria Funding Reauthorization Bill
- PRNewswire - July 30, 2008
- SEATTLE, July 30 /PRNewswire-USNewswire/ -- President George W. Bush today signed legislation that reauthorizes the President s Emergency Plan for AIDS Relief (PEPFAR) and other global health funding. In response, Bill and Melinda Gates, co-chairs of the Bill & Melinda Gates Foundation, made the following statement
- National Medical Association Installs 109th President at Atlanta Convention: New NMA President to Address Cancer and Mental Health Disparities
- PRNewswire - July 30, 2008
- ATLANTA, July 30 /PRNewswire-USNewswire/ -- Delivering her inaugural address as the 109th president of the National Medical Association (NMA), Carolyn Barley Britton, M.D., M.S., shared her plans to focus on cancer and mental health disparities during her administration. The NMA is the nation s premier organization for
- AIDS Action Applauds Introduction of a New Bill Allowing Federal Funds to Support Syringe Exchange Programs
- PRNewswire - July 30, 2008
- WASHINGTON, July 30 /PRNewswire-USNewswire/ -- On Wednesday, July 30th, Representative Jose Serrano (D-NY) introduced the Community AIDS and Hepatitis Prevention Act, a bill which, if passed, will remove all legal barriers to States and local jurisdictions to spend federal funding that they receive for prevention of di
- Ramsell Pharmacy Solutions and Mirixa Announce National Pharmacy Initiative to Serve People Living with HIV/AIDS
- PRNewswire - July 30, 2008
- -- Innovative HIV/AIDS Program for Public Health Insured Patients to be Delivered by Community Pharmacists using Mirixa technology RESTON, Va. and OAKLAND, Calif., July 30 /PRNewswire/ -- Mirixa Corporation and Ramsell Pharmacy Solutions jointly announced today the launch of a pharmacist-delivered medication therapy ma
- Bush to Sign AIDS Bill Today, but Funding Still Missing
- PRNewswire - July 30, 2008
- WASHINGTON, July 30 /PRNewswire-USNewswire/ -- Today President Bush will sign into law a major new piece of legislation on global AIDS, tuberculosis and malaria, but Congress is not providing the money to implement it for fiscal year 2009. We deeply appreciate the hard work of everyone involved, in the Congress and the
- New 'From-the-Ground' Report Reformulates Simplistic Argument About HIV/ AIDS and Health Care Systems in a Fundamental Way
- PRNewswire - July 30, 2008
- -- Dr. Jim Kim of Harvard School of Public Health joins International Treatment Preparedness Coalition to release new report and call for broad, systematic approach to HIV/AIDS and health care scale up NEW YORK and HARARE, Zimbabwe and BOSTON and SAO PAULO, Brazil , July 29 /PRNewswire-USNewswire/ -- T
- ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
- PRNewswire - July 29, 2008
- FREDERICK, Md., July 29 /PRNewswire/ -- ImQuest BioSciences announced today the successful acquisition of funding from the National Institute of Allergy and Infectious Disease (NIAID/NIH) to support the development of pyrimidinedione inhibitors as topical microbicides to prevent the sexual transmission of HIV. The two
- Three Rs and HIV/AIDS Mark New Haiti Literacy Plan
- PRNewswire - July 29, 2008
- WASHINGTON, July 29/PRNewswire-USNewswire/ -- Increasing literacy and curbing HIV/AIDS is the centerpiece of the U.S. Agency for International Development s (USAID) new three-year effort designed to stabilize parts of Haiti plagued by community unrest. The Haiti Basic Education Project -- a $19 million investment -- wi
- Idenix Pharmaceuticals Advances HCV Discovery Program to Clinic
- PRNewswire - July 29, 2008
- -- Initiates IDX184 Phase I Clinical Study and Advances HCV Protease Inhibitor and Non-Nucleoside Polymerase Inhibitor Clinical Candidates into IND-Enabling Preclinical Studies ~ CAMBRIDGE, Mass., July 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the di
- Abbott Fund and the Government of Tanzania Celebrate Milestone in Strengthening Nation's Health Care System
- PRNewswire - July 28, 2008
- Partnership Will Modernize All Regional Hospital Laboratories to Improve Access to Care Across the Country DAR ES SALAAM, Tanzania , July 28 /PRNewswire-FirstCall/ -- At a ceremony today, the Ministry of Health and Social Welfare, United Republic of Tanzania, and Abbott Fund commemorated the latest step in a nationwide
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at ICAAC/IDSA Joint Meeting
- PRNewswire - July 28, 2008
- SAN DIEGO, July 28 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data will be presented on RDEA806, the Company s novel investigational non-nucleoside reverse transcriptase inhibitor (NNRTI) for patients with human immunodeficiency virus (HIV) at the 48th Annual ICAAC/IDSA 46th An
- AIDS Vaccines: Where Do We Go From Here?
- PRNewswire - July 28, 2008
- The International AIDS Vaccine Initiative (IAVI) and Key Thought Leaders Explore Critical Next Steps for AIDS Vaccine Research at the 17th International AIDS Conference in Mexico City NEW YORK, July 28 /PRNewswire-USNewswire/ -- The following was released today by the International AIDS Vaccine Initiative: WHAT: To
- Media Advisory (Telephone Press Conference): Is Donor AIDS Money Strengthening Health Systems? New Study Finds Missed Opportunities
- PRNewswire - July 28, 2008
- The Center for Global Development will hold a telephone press conference on July 29, 2008 to introduce new research ahead of the official launch event at the International AIDS Conference in Mexico City. The report, Seizing the Opportunity on AIDS and Health Systems, finds that billions of dollars in donor money being
- HIV Prevention Expert Dr. Timothy Mastro Speaks on Future of Pre-Exposure Prophylaxis at International AIDS Conference
- PRNewswire - July 27, 2008
- RESEARCH TRIANGLE PARK, N.C., July 27 /PRNewswire/ -- Timothy Mastro, MD, FACP, DTM&H, who joins Family Health International (FHI) on August 1st as Senior Director of Research, will share information on promising research into pre-exposure prophylaxis (PrEP) for HIV prevention at the International AIDS Conference i
- Congress Sends Global HIV/AIDS Legislation to the President
- PRNewswire - July 24, 2008
- WASHINGTON, July 24 /PRNewswire-USNewswire/ - The landmark U.S. effort to fight HIV/AIDS around the world will be expanded and extended by five years thanks to legislation that Congress passed today. By a vote of 303 to 115, the House approved Senate amendments to the Tom Lantos and Henry J. Hyde United Stat
- Pelosi Statement on House Passage of Global AIDS Legislation
- PRNewswire - July 24, 2008
- WASHINGTON, July 24 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi released the following statement this evening in support of the Tom Lantos and Henry J. Hyde Global Leadership Against HIV/Aids, Tuberculosis, and Malaria Reauthorization Act of 2008. The bill, which passed the Senate last week, passed the House this e
- Webcast Alert: JAMA Media Briefing on HIV/AIDS
- PRNewswire - July 24, 2008
- MEXICO CITY, July 24 /PRNewswire/ -- New research from the Journal of the American Medical Association (JAMA) theme issue on HIV/AIDS will be released to the media, coinciding with the International AIDS Conference. Four of the world s top HIV/AIDS researchers will present their findings on new therapies, treatment gui
- Studies Assessed by European Health Authority Conclude That Impurity in Roche's Viracept(R) (nelfinavir mesylate) Did Not Increase Patient's Risk of Cancer
- PRNewswire - July 24, 2008
- Basel, Switzerland (PRNewswire) - The European Committee for Human Medicinal Products (CHMP) has confirmed that the presence of an impurity called ethyl methanesulfonate (EMS) in Roche s Viracept (nelfinavir mesylate) did not increase patients risk of developing cancer.
- Latino Commission on AIDS Welcomes Miss Universe 2008 Dayana Mendoza as its Newest 'Madrina' in the Fight Against AIDS
- PRNewswire - July 24, 2008
- NEW YORK, July 24 /PRNewswire-USNewswire/ -- Miss Universe 2008 Dayana Mendoza is the newest Madrina of the Latino Commission on AIDS, announced Dennis deLeon, President of the Latino Commission on AIDS. Dayana Mendoza visited the offices of the Commission in New York on July 23rd and received a comprehensive briefing
- GeoVax Partners with Vivalis for Use of Its Revolutionary EBx(R) Technology to Manufacture Its MVA HIV/AIDS Vaccine
- PRNewswire - July 22, 2008
- -- Partnership creates worldwide strategic collaboration between Vivalis and GeoVax ATLANTA and NANTES, France , July 22 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, biopharmaceutical company developing human vaccines for diseases caused by HIV-1 (Human Immunodeficiency Viru
- Cavidi Calls for Greater Access to HIV Monitoring at AIDS 2008 Conference in Mexico
- PRNewswire - July 22, 2008
- UPPSALA, Sweden , July 22 /PRNewswire/ -- Cavidi is attending the XVII International AIDS Conference in Mexico City, August 3-8, 2008 to spread its message of the need for greater access to HIV viral load monitoring. Lately the supply of HIV medicines (ARVs) to the developing world has been increasing. This is a wonder
- Presumed Presidential Nominees McCain and Obama to Make First Joint Campaign Appearance on August 16 at Saddleback Church
- PRNewswire - July 21, 2008
- Pastor Rick Warren to Host Saddleback Civil Forum on Leadership and Compassion and Question Candidates on Faith and the Common Good LAKE FOREST, Calif., July 21 /PRNewswire-USNewswire/ -- Sens. John McCain and Barack Obama, respective presumed Republican and Democratic presidential nominees, will end the primary season
- VIRxSYS to Host a Web Conference to Announce Clinical Trial Update: Summary of data from five 2008 conferences
- PRNewswire - July 21, 2008
- GAITHERSBURG, Md., July 21 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, will present an update on the VRX496 Phase I and Phase II clinical trials for the media and members of the advocacy community. VRX496 is an investigational gene therapy for th
- Catholics Asked to Tell Their Bishops to End Ban on Contraception
- PRNewswire - July 21, 2008
- -- July 25th Marks 40th Anniversary of Vaticans Devastating Decision WASHINGTON, July 21 /PRNewswire-USNewswire/ -- Forty years ago, a decision was announced that has had a catastrophic impact on the poor and powerless around the world. On July 25, 1968, Pope Paul VI slammed the door on the hopes of the vast majority o
- Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
- PRNewswire - July 17, 2008
- -- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec virology portfolio YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in tre
- Senate Committee Approves $1.4 Million for Development of National AIDS Strategy
- PRNewswire - July 17, 2008
- WASHINGTON, July 17 /PRNewswire-USNewswire/ -- Last week, the Senate Appropriations Committee passed the Financial Services appropriations bill for the coming fiscal year that includes $1.4 million to the White House Office of National AIDS Policy for the development of a National AIDS Strategy. The House of Representa
- Ardea to Present Data on Lead HIV Candidate, RDEA806, at XVII International AIDS Conference
- PRNewswire - July 17, 2008
- SAN DIEGO, July 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA - News) today announced that Dr. Graeme Moyle, Director of HIV Research, Chelsea and Westminster Hospital, will present results from the Phase 2a proof-of-concept monotherapy study of RDEA806, during an oral presentation at a late breake
- Diplomat's 2008 Patient Satisfaction Survey Sets the Bar for Specialty Pharmacy Industry
- PRNewswire - July 17, 2008
- SWARTZ CREEK, Mich., July 17, 2008 /PRNewswire via COMTEX/ -- Diplomat Specialty Pharmacy, the nation s largest independent specialty pharmacy, released today results of their Spring 2008 Patient Satisfaction Survey. The national survey was mailed to 1500 patients, randomly selected from its own database of approximate
- Senate Passes Landmark AIDS, TB and Malaria Bill, Says Global AIDS Alliance
- PRNewswire - July 16, 2008
- WASHINGTON, July 16 /PRNewswire-USNewswire/ -- Today the U.S. Senate passed a crucial bill, backed by President Bush, that reauthorizes the U.S. program on global HIV/AIDS while also authorizing much greater funding for programs to address tuberculosis and malaria. The bill is a tremendous achievement, and I commend Se
- AIDS Action Commends Senate Passage of PEPFAR Reauthorization
- PRNewswire - July 16, 2008
- WASHINGTON, July 16 /PRNewswire-USNewswire/ -- AIDS Action applauds the Senate for overwhelming, bipartisan passage of the Lantos/Hyde U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act (S 2731), which reauthorizes the President s Emergency Plan For AIDS Relief (PEPFAR). The organiza
- Online Coverage of International AIDS Conference Includes Daily Webcasts, Podcasts and Interviews
- PRNewswire - July 16, 2008
- -- INTERNATIONAL AIDS SOCIETY AND KAISER FAMILY FOUNDATION PARTNER TO OFFER DAILY, COMPREHENSIVE COVERAGE OF CONFERENCE FOR FREE MENLO PARK, Calif., and GENEVA, July 16 /PRNewswire-USNewswire/ -- The International AIDS Society (IAS) and the Kaiser Family Foundation will provide worldwide online access to the XVII Inter
- 25,000 AIDS Walk San Francisco Participants; 25,000 Reasons Why
- PRNewswire - July 16, 2008
- For every walker, there is a story ... SAN FRANCISCO, July 16 /PRNewswire/ -- I walk because ... is a simple idea that explains the motivation behind one of the world s most successful fundraising events. Virtually all walkers have at least one story to explain their participation in AIDS Walk San Francisco (AWSF), whi
- Peregrine Pharmaceuticals Reports Financial Results for Fiscal Year 2008
- PRNewswire - July 14, 2008
- -- Achieves Record Revenues While Advancing Three Major Clinical Programs and Securing 5-Year Contract With U.S. Defense Threat Reduction Agency Worth Up to $44.4 Million TUSTIN, Calif., July 14 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (Nasdaq: PPHM - News), today announced financial results for fiscal
- Senator Vitter Threatens Crucial AIDS Bill
- PRNewswire - July 14, 2008
- To: POLITICAL EDITORS WASHINGTON, July 14 /PRNewswire-USNewswire/ -- Millions of lives are at stake today as the Senate prepares to vote on crucial global AIDS, TB and malaria legislation (S. 2731). The debate on the Senate floor is expected to begin this afternoon, and this is the last chance for the bill to be approv
- Putting Health Before Politics: How the United States Senate Can Fix Global HIV/AIDS Funding
- PRNewswire - July 11, 2008
- To: NATIONAL EDITORS WASHINGTON, July 11 /PRNewswire-USNewswire/ -- In a letter to the Senate, forty-five leading human rights and global health organizations urge policymakers to address critical shortfalls in legislation that would reauthorize the Presidents Plan for AIDS Relief (PEPFAR). With the Senate poised to vo
- HIV Infusion Clinic Administrator Sentenced to 30 Months in Prison For Health Care Fraud
- PRNewswire - July 10, 2008
- To: NATIONAL EDITORS WASHINGTON, July 10 /PRNewswire-USNewswire/ -- Miami resident Aisa Perera, 42, was sentenced today to 30 months in prison for her role in an $11 million scheme to defraud the Medicare program, Acting Assistant Attorney General Matthew Friedrich of the Criminal Division and U.S. Attorney R. Alexande
- ImQuest Awarded SBIR Grant to Define the Mechanism of Action of Their Lead Anti-HIV Therapeutic Compound IQP-0410
- PRNewswire - July 9, 2008
- FREDERICK, Md., July 9 /PRNewswire/ -- ImQuest Life Sciences announced today the successful acquisition of funding from the National Institutes of Health to define the mechanism of action of their dual-acting pyrimidinedione HIV inhibitor IQP-0410. The objective of this one-year Small Business Innovative Research (SBIR
- Ardea Biosciences' Advances RDEA806 Into Phase 2a Proof-of-Concept Study for Gout
- PRNewswire - July 9, 2008
- -- Dr. Fernando Perez-Ruiz Joins Ardea s Inflammatory Disease Scientific Advisory Board SAN DIEGO, July 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA - News) today announced that it has received regulatory approval to begin a Phase 2a proof-of-concept clinical trial evaluating RDEA806 in gout patien
- Sangamo BioSciences and Sigma-Aldrich Announce Research and License Agreement With Roche for the Use of ZFN Technology for Generation of Transgenic Animals
- PRNewswire - July 9, 2008
- -- Transgenic Animals to be Developed for Therapeutic and Diagnostic Applications ST. LOUIS and RICHMOND, Calif., July 9 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL - News) and Sangamo BioSciences, Inc. (Nasdaq: SGMO - News) today announced a research and license agreement to provide Roche (SWX: R
- Gates Foundation Welcomes G8 Commitments and Urges Follow Through to Address Problems Affecting the World's Poor
- PRNewswire - July 8, 2008
- -- Foundation announces additional US$150 million for Polio Eradication SEATTLE, July 8 /PRNewswire/ -- The Bill & Melinda Gates Foundation released the following statement regarding the G8 Summit: The Bill & Melinda Gates Foundation welcomes the renewed commitment by leaders of the Group of Eight countries to
- Nurse Practitioner Healthcare Foundation Fellows Have an Impact on Public Health and Health Policy: Nurse Practitioners at the Office of the Surgeon General Address Obesity and Health Communication
- PRNewswire - July 8, 2008
- BELLEVUE, Wash., July 8 /PRNewswire/ -- At a time when questions surround the U.S. health care system, two Nurse Practitioner Healthcare Foundation (NPHF) Senior Health Fellows are working to influence U.S. health policy. Mary Beth Bigley, DrPH, MSN, ANP, and Catherine Wisner, PhD, FNP, nurse practitioners (NPs) and re
- Pharmasset Announces Initiation of Combination Study of Clevudine and Viread(R) for HBV by French National Agency for Research on AIDS and Viral Hepatitis (ANRS)
- PRNewswire - July 7, 2008
- -- 96-week comparative study of Clevudine versus Viread (R) versus Clevudine+Viread(R) in 150 patients with chronic hepatitis B PRINCETON, N.J., July 8 /PRNewswire-FirstCall/ -- The French National Agency for Research on AIDS and Viral Hepatitis (ANRS), with the support of Pharmasset, Inc. (Nasdaq: VRUS) and
- AIDS Walk San Francisco Takes Big Green Step Forward: San Francisco's Largest AIDS Fundraising Event Goes GREEN with Online Communications, Recycling and Awareness
- PRNewswire - July 7, 2008
- SAN FRANCISCO, July 7 /PRNewswire/ -- The San Francisco AIDS Foundation and AIDS Walk San Francisco announced today key initiatives to Green the HIV fundraising event that is already a San Francisco institution. The initiatives include the introduction of Green Walkers, composting, and enhanced recycling. With the Foun
- GeoVax Reports Progress on Its AIDS Vaccine Technology
- PRNewswire - July 7, 2008
- ATLANTA, July 7 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta based, publicly traded biopharmaceutical company specializing in the prevention and treatment of infectious diseases, today provided an operational update on the company s progress towards entering Phase 2 preventative hu
- Leading Vaccine Expert Joins IAVI
- PRNewswire - July 3, 2008
- NEW YORK, July 3 /PRNewswire-USNewswire/ -- Dr. Thomas Hassell, former global vice president of process development at sanofi pasteur, a leading vaccine company, has joined IAVI as vice president for vaccine development. In his new role, Dr. Hassell will lead IAVI s product development efforts that are aimed at rapidly
- USAID Announces Youth-Focused HIV/AIDS Programs in Ethiopia
- PRNewswire - July 1, 2008
- Contact: U.S. Agency for International Development Press Office, +1-202-712-4310 ADDIS ABABA, Ethiopia , July 1 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) awarded a $500,000 grant to the YMCA of the USA to combat HIV/AIDS in Ethiopia. The program will provide youth access to basic
- (RED) to Launch New Way for People to Get Music in Their Lives; Weekly Delivery of Great Music Helps to Save Lives in Africa - Led by Don MacKinnon, Founder of HEAR Music
- PRNewswire - June 30, 2008
- NEW YORK, June 30 /PRNewswire/ -- In the fall of 2008, (RED) will unveil a simple, seamless way for people to receive music from artists they love and artists they will discover through (RED). By applying the (RED) idea to music this new model will create a new revenue stream for artists and labels and buy life-saving
- Tobira Therapeutics Inc. Announces Senior Management Team: Senior management team possessing over 130 years of cumulative expertise
- PRNewswire - June 30, 2008
- PRINCETON, N.J. and SAN DIEGO, June 30 /PRNewswire/ -- Tobira Therapeutics Inc., a clinical stage biotechnology company committed to the research and product discovery against life-threatening and life-altering infectious diseases, today announced the organization of the company s senior management team. Tobira Therape
- Sangamo BioSciences Announces Nature Biotechnology Study Demonstrating the Use of Zinc Finger Nucleases to Generate HIV Resistant T Cells: Preclinical Animal Data Demonstrates Promising Therapeutic Strategy for HIV/AIDS
- PRNewswire - June 30, 2008
- RICHMOND, Calif., June 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating that human immune system cells (CD4 T-cells) can be made resistant to HIV infection by treatment with zinc finger DNA-binding protein nucleases (ZFN(TM)). The data suggest t
- Earvin 'Magic' Johnson and Abbott Bring 'I Stand with Magic' Program: Part of the Campaign to End Black HIV/AIDS to Facebook Community
- PRNewswire - June 27, 2008
- ABBOTT PARK, Ill., June 27 /PRNewswire-FirstCall/ -- Summary -- In conjunction with National HIV Testing Day, the Magic Johnson Foundation, http://www.magicjohnson.org/ and Abbott (NYSE:ABT) , http://www.abbott.com/, launched a new Facebook group to further engage young adults in the I Stand With Magic , http://istandw
- AIDS Action Expresses Deep Disappointment With Proposed Congressional Funding Levels for HIV Prevention on National HIV Testing Day, June 27
- PRNewswire - June 27, 2008
- WASHINGTON, June 27 /PRNewswire-USNewswire/ -- AIDS Action criticizes Congress on National HIV Testing Day for substantially under-funding domestic HIV/AIDS prevention programs at the Centers for Disease Control and Prevention (CDC). House and Senate Appropriators have both proposed HIV/AIDS spending bills that allocat
- Montblanc Supports 46664 and The Nelson Mandela Foundation
- PRNewswire - June 26, 2008
- Lutz Bethge, CEO Montblanc International Announces Brand as Worldwide Sales Partner of the Exclusive Mandela 46664 Bangle NEW YORK, June 26 /PRNewswire/ -- Montblanc announced today their partnership with The Nelson Mandela Foundation, signing on as the first retailer that will support sales of their signature 46664 ba
- European Approval for Roche's Pegasys Personalises Treatment for a Subgroup of Hepatitis C Patients: Chance for Cure With Only Four Months of Treatment
- PRNewswire - June 26, 2008
- BASEL, Switzerland , June 26/PRNewswire/ -- Roche Also Announces Start of NCORE Study to Determine Best Length of Treatment in Patients who do not Experience a Rapid Response Roche announced today that the European Commission has approved a shortened, 16-week course of treatment with Pegasys (peginterferon alfa-2a (40
- National HIV Survey Finds Support for Routine Testing
- PRNewswire - June 26, 2008
- WASHINGTON, June 26 /PRNewswire-USNewswire/ -- In recognition of National HIV Testing Day, Friday, June 27th, Test for Life released a national survey on attitudes surrounding HIV and AIDS as part of its national campaign to prevent the spread of HIV/AIDS and ensure access to care for those who test positive. At least
- Ranbaxy Gains Tentative Approval to Manufacture and Market Valganciclovir Hydrochloride Tablets
- PRNewswire - June 25, 2008
- -- First-to-File Status Will Provide 180-Day Marketing Exclusivity Upon Final Approval PRINCETON, N.J., June 25 /PRNewswire/ -- Ranbaxy Laboratories Limited (RLL), announced today that the company has received tentative approval from the U.S. Food and Drug Administration to manufacture and market Valganciclovir Hydroch
- Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
- PRNewswire - June 25, 2008
- -- Once-daily dosing with enteric-coated tablet produced robust antiviral activity -- RDEA806 was well tolerated during one week of dosing in HIV patients SAN DIEGO, June 25 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced additional positive results from its completed Phase 2a proof-of-c
- The National Latino AIDS Action Agenda Network (NLAAN) Releases Federal Policy Recommendations - Addressing the Latino AIDS Crisis
- PRNewswire - June 25, 2008
- -- Elected Officials and Community Leaders Officially Announce Federal Policy Recommendations NEW YORK, June 25 /PRNewswire/ -- The Latino Commission on AIDS and its community partners join eight cities across the United States (Los Angeles, New York, Washington, DC, Philadelphia, Pu
- NICE Issues Final Appraisal Determination (FAD) Which Recommends Baraclude(R) (Entecavir) as a Treatment Option for Eligible Chronic Hepatitis B Patients
- PRNewswire - June 25, 2008
- UXBRIDGE, England, June 25/PRNewswire/ -- NICE (National Institute for Health and Clinical Excellence) has announced today, in its Final Appraisal Determination (FAD), that Baraclude(R) (entecavir) is recommended as an option for treatment of eligible patients with chronic hepatitis B (CHB). Entecavir is a potent anti-
- European Commission Approves REYATAZ(R) (Atazanavir Sulfate 100mg, 150mg, 200mg, 300mg), in Combination With Other Antiretroviral Medicinal Products, for use in Treatment Naïve HIV-1 Infected Adults
- PRNewswire - June 24, 2008
- -- REYATAZ(R), Taken With Ritonavir , Provides an Additional Therapy Option in Treatment-Naïve HIV-1 Infected Adults in the European Union PARIS, June 24/PRNewswire/ -- The European Commission has granted marketing authorization for REYATAZ(R) (atazanavir sulfate 300mg once daily), administered with ritonavir 100 mg on
- New Aptivus(R) (tipranavir) Oral Solution Approved for Treatment-Experienced Pediatric and Adolescent HIV Patients
- PRNewswire - June 24, 2008
- -- APTIVUS Oral Solution Also Approved for Treatment-Experienced Adult Patients RIDGEFIELD, Conn., June 24 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration ( FDA ) granted approval of Aptivus(R) (tipranavir) capsules/oral solution with dosing informat
- A Contribution of Leadership Skills to a Growing African AIDS Group
- PRNewswire - June 24, 2008
- -- The following is an op-ed by Frank Waltmann, Head Corporate Learning, Novartis BASEL, Switzerland , June 24/PRNewswire/ -- Corporate philanthropy in Africa can come in many forms. Financial funding and product donations are often heralded, but perhaps its time for other, more specialized forms of giving to take thei
- MAC Cosmetics Celebrates With Nelson Mandela at the 46664 Concert in Hyde Park
- PRNewswire - June 23, 2008
- LONDON, June 23/PRNewswire/ -- MAC Cosmetics is proud to announce its involvement in the 46664 Concert honouring Nelson Mandela at 90 taking place in Hyde Park on the 27th June 2008. Many of the world s most powerful and instantly recognisable figures and a concert audience of 46,664 will pay their tributes to one of t
- Verizon Wireless Continues Support of National HIV Testing Awareness Campaign: Company Working with Education and Public Health Experts to Raise Public Awareness Via Mobile Media
- PRNewswire - June 23, 2008
- ALPHARETTA, Ga., June 23 /PRNewswire/ -- The message about the importance of HIV testing is getting out to the general public, thanks to the innovative use of wireless communications. Verizon Wireless, the company with the nation s most reliable wireless voice and data network, announced today its continued effort to d
- Family Health International Awarded USAID 'Progress' Project to Improve Family Planning and Reproductive Health Programs in Developing Countries
- PRNewswire - June 20, 2008
- -- USAID to Invest US $50 Million over a Five-Year Period to Improve Access and Availability to Family Planning RESEARCH TRIANGLE PARK, N.C., June 20 /PRNewswire-USNewswire/ -- The U.S. Agency for International Development (USAID) has announced that Family Health International (FHI) -- a global public health and develo
- Hall of Fame Baseball Legend Mike Schmidt Speaks Out for the First Time About Common Health Problem in Older Men
- PRNewswire - June 19, 2008
- -- Schmidt teams up with Minor League Baseball(TM) to raise awareness of Benign Prostatic Hyperplasia (BPH), a condition affecting more than 8 million men in the U.S. BRIDGEWATER, N.J., June 19 /PRNewswire-FirstCall/ -- Hall of Fame third baseman and Philadelphia Phillies legend Mike Schmidt and Minor League Baseball(T
- Monogram Biosciences Collaborates with Gilead Sciences for Elvitegravir Phase III Studies: PhenoSense GT(TM) and PhenoSense Integrase(TM) assays used to study promising new Integrase inhibitor
- PRNewswire - June 18, 2008
- SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (NASDAQ:MGRM) announced today that the Company has signed an agreement with Gilead Sciences , Inc. to provide resistance testing and consultative services for Gilead s Elvitegravir Phase III studies. Monogram assays will be used
- Patient Data Analysis Report Finds More Than 75 Percent of Chronically Ill Patients Unable to Obtain Needed Healthcare Have Some Form of Insurance: New trend findings of 'underinsured' patients based on successful management of nearly 45,000 cases by national, non-profit Patient Advocate Foundation in 2007
- PRNewswire - June 17, 2008
- NEWPORT NEWS, Va., June 17 /PRNewswire-USNewswire/ -- Patient Advocate Foundation (PAF) -- a national non-profit organization providing direct case management services and healthcare information to millions of patients with life-threatening, debilitating and chronic diseases each year who are unable to obtain access to
- New York City Department of Health & Mental Hygiene Awards 2 Million Unit Bid to The Female Health Company
- PRNewswire - June 17, 2008
- CHICAGO, June 17 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) announced it has received a bid award for two million FC female condoms from the New York City Department of Health and Mental Hygiene. The Company expects shipments to begin immediately, at the direction of the Health Department. The terms
- Dr. Rani G Whitfield, M.D. Unveils 'The Legion of Health': Comic Book Series Delivers Positive Health Messages To Youth Markets
- PRNewswire - June 17, 2008
- BATON ROUGE, La., June 17 /PRNewswire/ -- Dr. Rani G Whitfield, M.D., a family practice and sports medicine physician in Baton Rouge, LA is proud to announce the creation and official release of his comic book series, Volume One Book One Tha Hip Hop Doc - Fed Up! Designed to introduce uniquely packaged health messages
- TalkAIDS: A&PI Wellness Center Launches a New Anti-Stigma Campaign With International Star Joan Chen
- PRNewswire - June 16, 2008
- SAN FRANCISCO, June 16 /PRNewswire-USNewswire/ -- Following a study indicating that strong attitudes against people living with HIV/AIDS exist in the Chinese community, Asian & Pacific Islander Wellness Center has developed a new ad campaign called TalkAIDS to address this issue of stigma in the Chinese community.
- Sensitivity Enhancements to Monogram's Trofile(TM) Assay Demonstrate Improved Power to Select Patients for CCR5 Antagonist Therapy
- PRNewswire - June 16, 2008
- SOUTH SAN FRANCISCO, Calif., June 16 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today announced that data related to the enhanced performance of the company s HIV tropism assay were presented in an oral presentation at the 17th International HIV Drug Resistance Workshop in Sitges,
- Genetic Immunity to Present at 2008 BIO International Convention
- PRNewswire - June 12, 2008
- MCLEAN, Va. and BUDAPEST, Hungary , June 12 /PRNewswire/ -- Genetic Immunity, a US/Hungarian clinical-stage Company focused on the development of its patented nanomedicines for targeted immune amplification, announced today that the Company will be presenting at the 2008 Bio International Convention to be held June 17-
- Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
- PRNewswire - June 12, 2008
- CAMBRIDGE, Mass., June 12 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported phase I/II data for IDX899, a non-nucleoside reverse transcriptase
- Three Miami Area Brothers and Physician's Assistant Charged In $110 Million Health Care Fraud Scheme
- PRNewswire - June 11, 2008
- WASHINGTON, June 11 /PRNewswire-USNewswire/ -- Three Miami area brothers who allegedly financed 11 corrupt HIV infusion clinics and a physician s assistant who worked at those clinics have been charged in a $110 million HIV infusion fraud scheme, the Department of Justice s Criminal Division and the U.S. Attorney s Off
- NeurogesX Announces Publication of NGX-4010 Phase 3 HIV-Neuropathy Study Results in Neurology
- PRNewswire - June 10, 2008
- SAN MATEO, Calif., June 10 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced today the publication of Phase 3 data of its lead product candidate, NGX-4010, in the journal Neurology. The paper, titled,
- The Female Health Company / HLL Receive National AIDS Control Organization of India Order for 1.5 Million FC2 Female Condoms
- PRNewswire - June 10, 2008
- CHICAGO, June 10 /PRNewswire-FirstCall/ -- The Female Health Company (AMEX:FHC) which manufactures and markets the FC and FC2 Female Condoms(R), today announces that its technical collaboration with Hindustan Latex Ltd (HLL) has been successful in winning an order from the National AIDS Control Organization of
- MTV and SpinVox Partner to Launch First Ever Integrated Voice Powered Cause-Related Social Networking Campaign 'Stand By What You Say'
- PRNewswire - June 10, 2008
- CAMPAIGN VOICED BY SUPERSTAR KELLY ROWLAND CAUSES PROMOTES CAMPAIGN TO ITS 12 MILLION MEMBERS LONDON and NEW YORK, June 10 /PRNewswire/ -- MTV s Staying Alive Foundation, SpinVox and Causes on Facebook today announced the launch of their joint campaign, Stand By What You Say . The groundbreaking initiative encourages y
- CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference: Findings Suggest New Way to Stimulate the Immune System to Fight Viral Diseases
- PRNewswire - June 9, 2008
- VIENNA, Va., June 9 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (AMEX:CVM) and researchers at Northeastern Ohio Universities Colleges of Medicine and Pharmacy jointly announced favorable new developments in the LEAPS(TM) heteroconjugate vaccine technology developed by CEL-SCI at the FOCIS Immunology meeting in Boston
- Now Playing: Spike Lee Stands with Earvin 'Magic' Johnson, Cookie Johnson and Abbott to Launch National PSA Campaign
- PRNewswire - June 9, 2008
- LOS ANGELES, June 9 /PRNewswire-FirstCall/ -- Today, Earvin Magic Johnson (http://www.magicjohnson.com/index.php?/foundation/), Cookie Johnson, Abbott (http://www.abbott.com/) (NYSE:ABT) and the Magic Johnson Foundation launched a public service announcement campaign as part of the I Stand With Magic Program, part of
- Record-Breaking AIDS/LifeCycle Pedals into Los Angeles, Raising AIDS Awareness, $11.6 Million for HIV/AIDS Services: Riders from 12 Countries, 42 States Complete 545-Mile Trek from San Francisco
- PRNewswire - June 7, 2008
- LOS ANGELES, June 7 /PRNewswire/ -- After a week experiencing the physical and emotional challenges of a 545-mile journey from San Francisco to Los Angeles, the 3,000 participants in AIDS/LifeCycle (ALC) rolled to a victorious finish in West Los Angeles today, having raised some $11.6 million from more than 60,000 dono
- Kaiser Permanente Sued By Executive for AIDS Discrimination
- PRNewswire - June 5, 2008
- SAN FRANCISCO, June 5 /PRNewswire/ -- Jeffery Sterman, Public Affairs Director and voice of Kaiser Permanente in San Francisco for ten years is claiming AIDS discrimination and breach of contract. A person with AIDS, Sterman is one of those who helped create the hospital s response to HIV and AIDS. David J. St. Louis,
- Alternative Extends Partnership With Elizabeth Glaser Pediatric AIDS Foundation
- PRNewswire - June 5, 2008
- -- Premium Lifestyle Brand Supports Foundation s Signature Los Angeles and New York Events for Second Year in a Row with Eco-Friendly Apparel and Green Forest Activity Area LOS ANGELES, June 5 /PRNewswire/ -- Alternative (http://www.alternativeapparel.com), premium fashion statements inspired by and created for free-th
- WHO Report Says 9.7 Million at Risk of Death from AIDS Today; AHF Renews Call for US Congress to Commit to Scale up Treatment to Seven Million Lives
- PRNewswire - June 5, 2008
- LOS ANGELES, June 5 /PRNewswire-USNewswire/ -- The release of a World Health Organization / UNAIDS /UNICEF report on Monday documents appreciable global progress in the effort to deliver lifesaving antiretroviral treatment (ARVs) to people living with HIV/AIDS in developing countries; however, it also underscores the c
- World Class Athlete to Attempt 'Death Valley 810' in Support of AIDS Orphans: Lisa Smith-Batchen to Run 302 Miles, Bike 508 to Benefit 'AIDS Orphans Rising'
- PRNewswire - June 5, 2008
- GRAND TETONS, Idaho, June 5 /PRNewswire/ -- Dreamchasers Outdoor Adventures (http://www.dreamchaserevents.com/doac/index.htm), an organization that helps athletes of all abilities conquer the world s toughest running events, today announced that its founder has planned an unprecedented running and cycling event to rais
- White Ribbon Alliance for Safe Motherhood Challenges World Economic Forum on Africa to Invest in Women's Health: Says Maternal Deaths Indicator of Failures to Provide Basic Health Care to Women
- PRNewswire - June 5, 2008
- CAPE TOWN, South Africa , June 5 /PRNewswire-USNewswire/ -- The White Ribbon Alliance for Safe Motherhood today made public its challenge to world leaders gathered at the World Economic Forum on Africa to invest in women s health as necessary to save the lives of women needlessly lost in pregnancy and childbirth. Whil
- Monogram Biosciences Announces Immediate Availability of Enhanced Sensitivity Trofile(TM) HIV Tropism Assay: Now 100% Sensitive at Detecting CXCR4 HIV-1 Levels as Low as 0.3%
- PRNewswire - June 5, 2008
- SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today announced immediate availability of enhanced sensitivity in its Trofile assay. Trofile was introduced commercially upon FDA approval of Selzentry(TM) (maraviroc), Pfizer s first in class CCR5 antagonist, in Augu
- Nation's High School Students Showing Overall Improvements in Health-Related Behaviors: However, Hispanic Students Not Showing Progress in Some Key Areas
- PRNewswire - June 4, 2008
- PRNewswire-USNewswire -- June 4/ Today s high school students are less likely to engage in many health risk behaviors than high school students in the early 1990s, according to the 2007 National Youth Risk Behavior Survey (YRBS), released today by the Centers for Disease Control and Prevention (CDC). Although the study
- Lymphoma Experts Herald 10 Years of the "Magic Bullet" -- Award and Lecture Mark Anniversary of Monoclonal Antibodies
- PRNewswire - June 4, 2008
- LUGANO, Switzerland , June 4/PRNewswire/ -- Today, physicians and patient group representatives from around the world celebrated the presentation of the San Salvatore Foundation award for outstanding achievement in the field of malignant lymphoma and the Henry Kaplan Memorial Lecture at the 10th International Conferenc
- Viacom to Receive Leadership Award for Business Excellence from The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria for Its 25 Years of Work on HIV/AIDS Education and Advocacy
- PRNewswire - June 4, 2008
- -- Viacom Executive Chairman Sumner M. Redstone to Accept Award At June 9 Event NEW YORK, June 4 /PRNewswire-FirstCall/ -- The Global Business Coalition on HIV/AIDS, Tuberculosis and Malaria (GBC) announced today that it will recognize Viacom (NYSE:VIA)(NYSE:and)(NYSE:VIA.B) with its prestigious Leadership Award for Bu
- Growing Generations Announces Surrogacy Program for Men with HIV
- PRNewswire - June 3, 2008
- LOS ANGELES, June 3 /PRNewswire/ -- Growing Generations, the nation s largest surrogacy agency, has launched a new program that provides surrogacy and egg donation services to men with HIV and allows them to use their own sperm to create biological families. The new program is made possible due to advances in technolog
- AdvanDx Submits Yeast Traffic Light PNA FISH(TM) for FDA 510(k) Clearance for Detection of Candida species in Positive Blood Cultures
- PRNewswire - June 3, 2008
- WOBURN, Mass., June 3 /PRNewswire/ -- AdvanDx today announced the FDA 510(k) submission of Yeast Traffic Light PNA FISH(TM) for detection of Candida yeast species from positive blood cultures. Yeast Traffic Light(TM) is the latest addition to AdvanDx s easy-to-use, molecular-based PNA FISH(TM) diagnostics platform that
- New Abbott Aluvia(R) Tablet for Treatment of HIV Available in South Africa
- PRNewswire - June 3, 2008
- -- More than 5 Million South Africans Living with HIV Gain Access to First and Only Co-formulated, Non-refrigerated Protease Inhibitor JOHANNESBURG, South Africa, June 3/PRNewswire/ -- Abbott (NYSE: ABT) today announced that the new tablet formulation of its protease inhibitor Aluvia(R) ( lopinavir
- NeurogesX Opens Investigational New Drug Application for Capsaicin Liquid Formulation NGX-1998
- PRNewswire - June 3, 2008
- SAN MATEO, Calif., June 3 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, announced that it submitted an investigational new drug application (IND) to the U.S. Food and Drug Administration for the clinical de
- New Publication of Phase 2 Data Shows Maribavir Markedly Reduced the Rate of Cytomegalovirus Infection and Disease in Bone Marrow Transplant Patients
- PRNewswire - June 2, 2008
- -- Prevalent in Immunosuppressed Patients, Cytomegalovirus Infection and Disease is Associated with a Range of Life Threatening Complications - EXTON, Pa., June 2 /PRNewswire-FirstCall/ -- ViroPharma Incorporated (NASDAQ:VPHM) today announced the publication of results of its previously described Phase 2 study showing
- Driven By The Use of Premium-Priced Branded Agents, The HIV Drug Market Will Experience Robust Annual Growth Through 2012
- PRNewswire - June 2, 2008
- -- New Products From Novel Drug Classes Are Addressing Key Unmet Needs for Highly Treatment-Experienced Patients, According to a New Report from Decision Resources WALTHAM, Mass., June 2 /PRNewswire/ -- Decision Resources, one of the world s leading research and advisory firms for pharmaceutical and healthcare issues,
- Abbott Releases 2007 Global Citizenship Report Highlighting Strong Commitment to Access to Health Care: Company's Report Entitled, 'Ingenuity at Work,' Discusses Abbott's Contributions to Access, Innovation, Science Education and the Environment
- PRNewswire - June 2, 2008
- ABBOTT PARK, Ill., June 2 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today released its 2007 Global Citizenship Report, Ingenuity at Work, which is available online at http://www.abbott.com/citizenship. The report highlights Abbott s commitment to access to care, innovation, science education and the environment. N
- Three Miami Area Doctors and Six Others Charged in $56 Million Health Care Fraud Schemes
- PRNewswire - May 29, 2008
- WASHINGTON, May 29 /PRNewswire-USNewswire/ -- Three Miami area doctors and six others have been charged in four separate indictments for their roles in HIV infusion fraud schemes totaling $56 million, the Department of Justice Criminal Division and U.S. Attorney s Office for the Southern District of Florida announced t
- MyClyns(TM) Now Available in Single Units
- PRNewswire - May 29, 2008
- UNION, Ky., May 29 /PRNewswire/ -- Union Springs Pharmaceuticals, LLC, announced today it will now offer MyClyns in individually wrapped single units. These new packages provide enhanced tamper-proof protection for each MyClyns unit and also afford customers greater purchasing flexibility. Each sealed package will cont
- New England Journal of Medicine Publishes Results From a RELISTOR Phase 3 Clinical Study: Study Demonstrated Efficacy of RELISTOR for Use in Advanced-Illness Patients with Opioid-Induced Constipation
- PRNewswire - May 28, 2008
- COLLEGEVILLE, Pa. and TARRYTOWN, N.Y., May 28 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE:WYE), and Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) today announced the publication of results from a pivotal phase 3 trial of RELISTOR(TM) (methylnaltrexone bromide) subcutaneous injection in th
- Fact Sheet: Department of Justice Efforts to Combat Health Care Fraud and Abuse
- PRNewswire - May 28, 2008
- WASHINGTON, May 28 /PRNewswire-USNewswire/ -- The Department of Justice, in cooperation with the Department of Health and Human Services, has guided the enforcement efforts of the national Health Care Fraud and Abuse Control Program (HCFAC) since its inception in 1997. The program was designed to coordinate federal, st
- Caribbean People International Collective Inc to Host 8th Annual AIDS WALK CARIBBEAN
- PRNewswire - May 28, 2008
- BROOKLYN, N.Y., May 28 /PRNewswire-USNewswire/ -- Caribbean People International Collective Inc (CPIC) will host AIDS WALK CARIBBEAN (R) 2008. This 8th annual community event is set for Sunday, June 8th 2008--Caribbean American HIV/AIDS Awareness Day. The walk will begin with an opening sunrise ceremony at 9:30 A.M. an
- amfAR Appoints Dr. Annette Sohn as Vice President of Global Initiatives: Renowned pediatrician will lead AIDS research foundation's international program, including its TREAT Asia initiative
- PRNewswire - May 28, 2008
- NEW YORK, May 28 /PRNewswire-USNewswire/ -- amfAR, The Foundation for AIDS Research, has appointed Annette Sohn, MD, as vice president for global initiatives and director of TREAT Asia (Therapeutics Research, Education, and AIDS Training in Asia), announced Kevin Robert Frost, amfAR s chief executive officer. Dr. Sohn
- Bavarian Nordic Enters Clinical Trials with HIV Multiantigen Vaccine
- PRNewswire - May 27, 2008
- WASHINGTON DC, May 27/PRNewswire-FirstCall/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, has initiated a Phase I/II clinical study with its HIV vaccine candidate: MVA-BN(R) HIV multiantigen. Enrolment in a Phase I/II safety and immunogenicity study in 15 HIV-infected patients (CD4 counts >350 ul/ml)
- Successful Community-Driven Efforts Against HIV/AIDS Highlighted in Conference Panel
- PRNewswire - May 27, 2008
- -- Total Control of the Epidemic has reached Eight Million People in Africa and Asia WASHINGTON, May 27 /PRNewswire/ -- Only the People can Liberate Themselves from AIDS -- this is what reality has taught us and it represents the building block of our model to fight HIV & AIDS, says Marie Lichtenberg, Director of I
- 2,500 Riders in AIDS/LifeCycle Set to Leave San Francisco June 1, Bound for Los Angeles, Raising a Record $11+ Million for HIV/AIDS Services
- PRNewswire - May 27, 2008
- SAN FRANCISCO, May 27 /PRNewswire-USNewswire/ -- What: More than 2,500 cyclists and 500 volunteer roadies begin a 7-day, 545-mile bike ride to Los Angeles on Sunday, June 1. Participants in the 7th annual AIDS/LifeCycle will have raised more than $11 million for the San Francisco AIDS Foundation and L.A. Gay & Lesb
- Family Health International Featured at Global Health Council Conference
- PRNewswire - May 27, 2008
- RESEARCH TRIANGLE PARK, N.C., May 27 /PRNewswire-USNewswire/ -- Family Health International s staff will make several key presentations and the organization will introduce a number of new publications at the annual Global Health Council s International Conference May 27-31, 2008, at the Omni Shoreham Hotel in Washingto
- An Inspiring Summer Read: Biography of Judy Taylor - The Woman Who Could Not Eat
- PRNewswire - May 27, 2008
- TORONTO, May 27/PRNewswire/ -- With long summer days ahead and the delights of a good book to be enjoyed, readers around the world are picking up Lifeliner: The Judy Taylor story, the debut book from Shireen Jeejeebhoy. An inspiring summer read, it tells the poignant story of a young Canadian mother who made medical hi
- Africa day - great reasons to celebrate this Africa day!
- PRNewswire - May 25, 2008
- London, 25 May/GNN/ -- DEPARTMENT FOR INTERNATIONAL DEVELOPMENT News Release issued by The Government News Network on 25 May 2008 DFID MEDIA BRIEFING Every year, the African Union celebrates Africa Day. This year, people in the UK will join in the celebrations at the Mayor s event in Trafalgar Square on Monday 26th May
- Real Time, Face-to-Face Doctor Visits Now Available Online
- PRNewswire - May 23, 2008
- MIAMI, May 23 /PRNewswire/ -- MDWebLive.com, offering live video medical consultations via webcam between patients and board-certified doctors from multiple specialties has been launched in Miami by AmeriGroup Holdings, Inc. The service allows patients the opportunity to interact with their doctors from home, office, h
- Ardea Announces Progress with HIV Non-Nucleoside Reverse Transcriptase Inhibitor Program: Lead Candidate, RDEA806, Demonstrated No Reproductive Toxicity in Preclinical Study
- PRNewswire - May 22, 2008
- -- RDEA427 Selected as Clinical Candidate, Demonstrated a 40 Hour Half-Life with Potential for Once Daily Oral Dosing SAN DIEGO, May 22 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced preclinical data on its lead non-nucleoside reverse transcriptase inhibitor (NNRTI) candidate, RDEA806,
- Teens Traveling to Africa as Volunteers and Empowered Global Citizens: United Nations Association of the USA HERO Youth Ambassadors to volunteer in HIV/AIDS-affected communities in Africa
- PRNewswire - May 21, 2008
- NEW YORK, May 21 /PRNewswire-USNewswire/ -- HERO: a Campaign of the United Nations Association of the USA, with partners beinggirl.com and CosmoGIRL!, has announced its 2008 HERO Youth Ambassadors. This July, 22 American and Canadian high school and college students will travel to South Africa and
- HIV-AIDS and Women Equals Misogyny Finds On The Issues Magazine Online; New Computer Technology Makes Worldwide Accessibility
- PRNewswire - May 21, 2008
- NEW YORK, May 21 /PRNewswire-USNewswire/ -- HIV-AIDS is crossing the gender divide and targeting women while the world looks the other way. What is a woman worth? asks On The Issues Magazine Online in a series of probing articles and art that explore the deadly cocktail of sexism, silence and HIV. The feminization of H
- The Social Entrepreneur's Cup Awards Finalists Announced: Social Venture Partners Minnesota Announces Finalists for the 2008 Social Entrepreneur's Cup
- PRNewswire - May 21, 2008
- MINNEAPOLIS, May 21 /PRNewswire/ -- Social Venture Partners is proud to announce the five finalists for its Social Entrepreneur s Cup awards. The Social Entrepreneur s Cup is a first of its kind event in Minnesota in which five of Minnesota s most innovative and effective social entrepreneurs compete for recognition an
- BARC Announces Long-Term Cooperation In South African Biobanking for HIV Vaccine Trials
- PRNewswire - May 21, 2008
- JOHANNESBURG, South Africa , May 21 /PRNewswire/ -- BARC, a global central laboratory today announced a broad biobanking agreement to support HIV vaccine trials currently being performed in South Africa by the HIV Vaccine Trials Network (HVTN). The HVTN vaccine trials are designed to answer scientific questions that wi
- Speaker of the U.S. House of Representatives Nancy Pelosi Joins the Fight Against HIV/AIDS Stigma in A&PI Communities
- PRNewswire - May 21, 2008
- SAN FRANCISCO, May 21 /PRNewswire-USNewswire/ -- Speaker of the U.S. House of Representatives Nancy Pelosi appeals to Asian & Pacific Islanders (A&PI) to help end HIV stigma in their communities in the most recent Public Service Announcement (PSA) launched today by The Banyan Tree Project, a groundbreaking nati
- Quest Diagnostics Chooses Roche's Fully Automated, Real-Time HIV-1 Viral Load Monitoring Test For Its Customers in Laboratories Nationwide
- PRNewswire - May 19, 2008
- INDIANAPOLIS, May 19 /PRNewswire/ -- Roche Diagnostics today announced that Quest Diagnostics (NYSE:DGX), the nation s leading provider of diagnostic testing, information and services, has signed a multi-year agreement to use the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HIV-1 Test for HIV viral load testing. Physicians
- Sangamo BioSciences Announces Presentation of Phase 1 Data of ZFP Therapeutic at International Society for Cellular Therapy (ISCT) Meeting
- PRNewswire - May 19, 2008
- -- Progenitor Cell Mobilization Observed in Subjects with Critical Limb Ischemia Treated with ZFP Therapeutic MIAMI, May 19 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) announced today the presentation of data from a Phase 1 clinical trial of a zinc finger DNA-binding protein activator of vascular
- Pharmasset Nominates PSI-7851 as a Lead Development Candidate for the Treatment of Chronic Hepatitis C: IND or foreign regulatory equivalent filing anticipated in 1Q 2009
- PRNewswire - May 19, 2008
- PRINCETON, N.J., May 19 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) has nominated PSI-7851 as a lead development candidate for the treatment of chronic hepatitis C virus (HCV). PSI-7851 is a proprietary nucleotide analogue polymerase inhibitor of HCV that is being advanced into Good Laboratory Practice (GL
- Ardea Biosciences Identifies Lead Development Candidate for Gout, RDEA594
- PRNewswire - May 19, 2008
- -- RDEA594 Data to Be Presented at the 2008 Annual European Congress of Rheumatology Organized by the European League Against Rheumatism (EULAR) -- Initiation of Phase 1 Human Study of RDEA594 Planned in Second Half of 2008 SAN DIEGO, May 19 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announce
- Tuesday Congressional Briefing Relays Need for National AIDS Strategy
- PRNewswire - May 19, 2008
- WASHINGTON, May 19 /PRNewswire-USNewswire/ -- The following is being issued by AIDS Action: WHAT: Congressional Briefing It s Time to End the Epidemic at Home: The Need for a National AIDS Strategy WHEN: Tuesday, May 20, 2008 -- 1-2 p.m. (Lunch provided at 12:45 p.m.) WHERE: Rayburn Building, Room 2325 Honorary Con
- Tibotec Therapeutics Launches New Dosage Strength for PREZISTA(TM): New dosage strength reduces number of PREZISTA tablets taken daily
- PRNewswire - May 19, 2008
- BRIDGEWATER, N.J., May 19 /PRNewswire/ -- Tibotec Therapeutics today announced the availability of a new 600 mg tablet strength for PREZISTA(TM) (darunavir), a protease inhibitor (PI). The new dosage strength was approved by the U.S. Food and Drug Administration ( FDA ) on February 25, 2008. The recommended oral dose o
- Ronald Winston Retires From His Executive Role at Harry Winston Diamond Corporation, Named Honorary Chairman
- PRNewswire - May 19, 2008
- NEW YORK, May 19 /PRNewswire/ -- Ronald Winston announced his retirement today from his executive role at the world famous Harry Winston Inc., and his appointment as Honorary Chairman of the corporation. Mr. Winston is the son of the founder of the House of Harry Winston and has been the loyal steward of the brand sinc
- South Bay Asian and Pacific Islander Community Plans 'Express ARTself' for the 4th Annual National Asian & Pacific Islander HIV/AIDS Awareness Day
- PRNewswire - May 19, 2008
- SANTA CLARA, Calif., May 19 /PRNewswire-USNewswire/ -- FLARE Santa Clara HIV County Collaborative: PACE Clinic, Asian Americans for Community Involvement (AACI), The Billy DeFrank Center Lesbian and Gay Community Center, Song That Radio, Santa Clara County Public Health Department, Asian & Pacific Islander Wellness
- Banyan Tree Project Feature Asian & Pacific Islander Stars in Latest HIV/AIDS Anti-Stigma Public Service Announcements
- PRNewswire - May 19, 2008
- SAN FRANCISCO, May 19 /PRNewswire-USNewswire/ -- The Banyan Tree Project is helping put an end to HIV/AIDS-related stigma and discrimination. The program has released four 30-second public service announcements (PSAs) featuring three major Asian & Pacific Islander (A&PI) stars: Joan Chen, Amy Hanaiali i Gilliom
- World Hepatitis Alliance Calls on Governments to Take Urgent Action to Tackle Chronic Viral Hepatitis B & C Epidemic
- PRNewswire - May 19, 2008
- -- Shocking Lack of Global Statistics Prompts Creation of First Global Resource on Hepatitis: The Hepatitis Atlas GENEVA, Switzerland , May 19/PRNewswire/ -- The World Hepatitis Alliance, a newly formed Non-Governmental Organisation, today called on governments around the world to do more to drive improvements in preve
- PEGASYS(R)/COPEGUS(R) Show Benefit in Hard-to-Treat Latino Population with Hepatitis C
- PRNewswire - May 18, 2008
- -- Largest prospective study in under-treated and under-studied population (The LATINO Study) provides important insights SAN DIEGO, Calif., May 18 /PRNewswire/ -- Roche today announced results from the LATINO study, the largest prospective study to evaluate the response of Latino whites infected with genotype 1 hepati
- AIDS Walk New York Raises $7.05 Million: World's Largest AIDS Fundraising Event Attracts 45,000 Participants and Raises Record Sum.
- PRNewswire - May 18, 2008
- -- Results Defy Economic Downturn and Remind Policy Makers that AIDS is Still a Crisis at Home NEW YORK, May 18 /PRNewswire-USNewswire/ -- The 23rd Annual AIDS Walk New York, on Sunday May 18, was the largest and most successful AIDS Walk ever held, setting a fundraising record even in the face of a troubled economy. O
- Body Positive Marks a New Era With Continued Commitment and a New Name: The Southwest Center for HIV/AIDS
- PRNewswire - May 18, 2008
- -- Arizona is Home to the Only HIV/AIDS Service Organization in the United States to Combine Research, Prevention/Education and Wellness Under one Roof PHOENIX, May 18 /PRNewswire/ -- In order to reflect its expanding reach and awareness, Body Positive christened its new name on Saturday, May 17, at Night for Life, t
- AIDS Action Urges Everyone to Help End the AIDS Epidemic by Being Part of the Search for an HIV Vaccine
- PRNewswire - May 16, 2008
- -- Rebecca Haag s Statement for National HIV Vaccine Awareness Day, May 18 WASHINGTON, May 16 /PRNewswire-USNewswire/ -- Twenty-six years into the AIDS epidemic, someone is newly infected with HIV every 13 minutes in the U.S. On Sunday, May 18, HIV Vaccine Awareness Day, AIDS Action, one of five national partners in th
- World AIDS Vaccine Day 2008 - Debunking the Myth 25 Years Later: An AIDS Vaccine is Possible and Still Urgently Needed
- PRNewswire - May 16, 2008
- NEW YORK, May 16 /PRNewswire-USNewswire/ -- Twenty-five years since the discovery of HIV, the world has made considerable advances in addressing the AIDS pandemic. Scientists have learned a tremendous amount about HIV, perhaps more than any other pathogen, and have developed more drugs to treat AIDS than all other vira
- NeurogesX Reports First Quarter 2008 Results
- PRNewswire - May 15, 2008
- Highlights: - IND for liquid formulation, NGX-1998, expected to be opened and commencement of clinical development expected in second quarter of 2008 - NDA submission for dermal patch, NGX-4010, in PHN expected in second half of 2008 - NGX-4010 MAA under EMEA review for peripheral neuropathic pain
- Pharmasset Reports Financial Results for Quarter Ended March 31, 2008
- PRNewswire - May 15, 2008
- PRINCETON, N.J., May 15 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported unaudited financial results for the second fiscal quarter ended March 31, 2008. Pharmasset re
- Immunizing Against Misinformation and Shortsightedness: AVAC Report Injects a Dose of Reality into the Debate on the State of AIDS Vaccine Research
- PRNewswire - May 15, 2008
- NEW YORK, May 15 /PRNewswire-USNewswire/ -- The AIDS Vaccine Advocacy Coalition (AVAC) today released a new report that provides a comprehensive review of recent developments in AIDS vaccine research. AVAC Report 2008: The Search Must Continue explores the issues that have been raised in the wake of the failure of Merc
- Golden Rainbow Takes a Musical Journey for Its 22nd Annual 'Ribbon of Life' Production Show: HIV/AIDS Fundraising Spectacular Takes Place June 14 & 15 at Paris Las Vegas
- PRNewswire - May 15, 2008
- LAS VEGAS, May 15 /PRNewswire/ -- It s an all-original, all-singing, all-dancing musical journey across America when Las Vegas-based HIV/AIDS charity Golden Rainbow presents its 22nd annual Ribbon of Life fundraising production show. The spectacular is staged June 14 and 15 in Le Theatre des Arts at Paris Las Vegas.
- Pharmasset Commences Dosing R7128 Cohorts 3 and 4 for the Treatment of Chronic Hepatitis C
- PRNewswire - May 14, 2008
- -- Two 4-week cohorts will evaluate R7128 1000mg BID in HCV genotype 1 treatment-naive patients and R7128 1500mg BID in HCV genotypes 2 or 3 treatment-experienced patients PRINCETON, N.J., May 14 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS) has commenced dosing two additional cohorts of a 4-week Phase 1 stu
- Hosting Summer's Sexiest Benefit, AIDS Service Center NYC Teams With Playboy Playmates, 'Project Runway' Stars, 'Naked Boys Singing'
- PRNewswire - May 14, 2008
- NEW YORK, May 14 /PRNewswire-USNewswire/ -- The following is an announcement by AIDS Service Center NYC of Safer Sex in the City, its much-anticipated annual benefit: WHEN: Thursday, June 19, 2008, 7:30pm-10:00pm VIP Cocktail Reception and performances, hosted by Bravo Project Runway stars Jack Mackenroth and Kevin Chr
- The Female Health Company Reports 267% Increase in Second Quarter Earnings: Diluted E.P.S. of $0.07 in First Half of FY2008
- PRNewswire - May 14, 2008
- Second quarter highlights: - 20% Revenue Increase - 31% Gross Profit Increase - 137% Operating Profit Increase - 267% Bottom line Improvement - Tax Benefit of $377 k adds 1 cent to E.P.S.
- Peregrine Pharmaceuticals Reports Studies Published in 'Science' Highlight Key Role of Phosphatidylserine (PS) in Viral Infections
- PRNewswire - May 13, 2008
- -- Two New Studies Provide Further Evidence that PS Plays a Critical Role in Some Viral Infections -- Peregrine s Anti-PS Antibody Bavituximab is Currently Being Assessed in a Clinical Trial in HCV Patients Co-Infected with HIV TUSTIN, Calif., May 13 /PRNewswire-FirstCall/ -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPH
- TrimWater Makes it Fashionable to Care: Healthy Alternative Beverage joins forces with Jeffrey Fashion Cares to benefit AIDS Research
- PRNewswire - May 13, 2008
- NEW YORK, May 13 /PRNewswire/ -- TrimWater has announced a partnership with Jeffrey Kalinsky, of the Jeffrey high-fashion stores in NY and Atlanta, to support the fundraising efforts of the Jeffrey Fashion Cares non-profit organization. TrimWater was present as a sponsor for this year s Fashion Cares event in NYC Chair
- Tuesday, May 13th Is the Latino Commission on AIDS' Annual Gala Cielo Latino 2008 - Unidos Podemos Cielo Latino To Honor Advocates of HIV/AIDS
- PRNewswire - May 13, 2008
- WHO: The Latino Commission on AIDS honors four distinguished individuals during the 13th annual Cielo Latino benefit and pays tribute to the life of its leader, Dennis deLeon, who has been living with HIV for 20 years. -- Bill Roedy, MTV International, Business Leadership Award -- Arisa Batista-Cunningham,
- U.S. Global AIDS Coordinator to Present President's Emergency Plan for AIDS Relief to San Francisco Doctors on May 14th
- PRNewswire - May 12, 2008
- Ambassador Mark Dybul, MD, U.S. Global AIDS Coordinator, will be in San Francisco on May 14, 2008, to discuss the President s Emergency Plan for AIDS Relief (PEPFAR) with the leadership of the San Francisco Medical Society (SFMS). The group will meet for lunch at noon at California Pacific Medical Center (CPMC) and mem
- GeoVax Secures $10 Million Financing Commitment
- PRNewswire - May 12, 2008
- ATLANTA, May 12 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta- based HIV/AIDS vaccine development company, announced today that it has entered into a $10 million common stock purchase agreement with Fusion Capital Fund II, LLC, a Chicago-based institutional investor. The Company may se
- Napo Presents at ISPOR Meeting in Toronto
- PRNewswire - May 12, 2008
- SOUTH SAN FRANCISCO, Calif., May 12 /PRNewswire-FirstCall/ -- Napo Pharmaceuticals, Inc., , announces that it presented a poster in collaboration with QualityMetric, Inc. describing the development of a patient reported outcomes questionnaire focused on the Health-Related Quality of Life (HR-QoL) aspects of chronic dia
- Starpharma Reports Positive VivaGel(R) Clinical Study Results
- PRNewswire - May 12, 2008
- MELBOURNE, Australia , May 12/PRNewswire/ -- Starpharma Holdings Limited (ASX: SPL, OTCQX: SPHRY) today announced positive results of a clinical trial that achieved all its objectives demonstrating that 3% SPL7013 Gel (VivaGel(R)) was safe and well-tolerated in sexually abstinent women when administered vaginally, twic
- 'Miles From Home' Market Debut at the 2008 Cannes Film Festival
- PRNewswire - May 9, 2008
- -- Official Screening to Take Place May 21st at 5:30pm at the Palais Theater J LOS ANGELES, May 9 /PRNewswire/ -- Miles from Home, a film, produced by writer/director, Ty Hodges, cinematographer/editor Todd Segal, Meagan Good and Marlon Ollivierre, will make its international debut at the 2008 Marche du Film Festival i
- Ardea Biosciences Appoints John W. Beck Chief Financial Officer, Announces Clinical Development Progress and Reports First Quarter 2008 Financial Results
- PRNewswire - May 9, 2008
- SAN DIEGO, May 9 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA), a company focused on the discovery and development of small- molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout, today announced that John W. Beck has been appointed Senior Vice President, Fin
- AIDS.gov Goes 2.0: Government HIV/AIDS Website Now Features a Blog, Podcasts, and More
- PRNewswire - May 7, 2008
- WASHINGTON, May 7 /PRNewswire-USNewswire/ -- The HHS Office of HIV/AIDS Policy announced today that the Web site AIDS.gov, a gateway to all federal domestic HIV /AIDS information and resources, now has an innovative look and feel that incorporates a blog, podcasts, and other new media tools. The blog (http://blog.aids.
- Canadian Company Receives Final Tender Approval From Rwanda For Vital AIDS Drug
- PRNewswire - May 7, 2008
- TORONTO, May 7 /PRNewswire/ -- Apotex Inc., Canada s largest generic pharmaceutical company has successfully bid and been awarded a tender from the Rwandan Government for the life saving triple combination AIDS drug Apo Triavir . Apotex is the first company to provide this medicine to Africa under the provisions of the
- Pathway Diagnostics Announces Commercial Availability of Second Generation SensiTrop(TM) II Molecular HIV Co-receptor Tropism Assay
- PRNewswire - May 7, 2008
- -- SensiTrop II accurately classifies Dual/Mixed tropic HIV patients with samples provided by Pfizer MALIBU, Calif., May 7 /PRNewswire/ -- Pathway Diagnostics announces nationwide availability of its patented second generation molecular SensiTrop(TM) II assay, combining the sensitivity of molecular heteroduplex trackin
- USAID and British Work to Improve Sexual Health
- PRNewswire - May 6, 2008
- PHNOM PENH, Cambodia , May 6 /PRNewswire-USNewswire/ -- A new program aimed at reducing the rate of new HIV infections and child mortality and improving reproductive and sexual health for Cambodians begins May 6 thanks to the joint efforts of the U.S. Agency for International Development and the British Department for
- 46664 Concert Honouring Nelson Mandela at 90; A Gathering of 46,664 Great Friends and Supporters; London, Hyde Park, June 27, 2008
- PRNewswire - May 6, 2008
- -- Presale tickets at http://www.46664.com | Tickets on public sale Friday, May 9 at http://www.livenation.co.uk LONDON, May 6 /PRNewswire/ -- Many of the world s most powerful and instantly recognisable figures and a concert audience of 46,664 will pay their tributes to one of the world s most loved leaders, Nobel Pea
- Diplomat Specialty Pharmacy Develops and Launches Best-In-Class Electronic Navigator (eNAV(TM)) Patient Care System
- PRNewswire - May 5, 2008
- SWARTZ CREEK, Mich., May 5 /PRNewswire/ -- Diplomat Specialty Pharmacy announced today that their proprietary and exclusive Electronic Navigator (eNAV(TM)) patient care system is now live and being utilized to manage their multiple sclerosis patients. The company plans to use eNAV(TM) as a disease management tool for a
- This Mother's Day, Surprise Mom With a New Way to Give: From baby chicks to gardens, Oxfam America Unwrapped offers unique gifts for Mom
- PRNewswire - May 5, 2008
- BOSTON, May 5 /PRNewswire-USNewswire/ -- Year after year, gift-givers are faced with the same dilemma: What to get mom? From flowers to macaroni necklaces, she always loves a gift that comes from you on Mother s Day. This year, Oxfam America Unwrapped provides a unique way to give the perfect gift and make a difference
- Mothers and Offspring Can Share Cells Throughout Life
- PRNewswire - May 2, 2008
- SEATTLE, May 2 /PRNewswire-USNewswire/ -- Cutting the umbilical cord doesn t necessarily sever the physical link between mother and child. Many cells pass back and forth between the mother and fetus during pregnancy and can be detected in the tissues and organs of both even decades later. This mixing of cells from two
- Largest Ever Regional AIDS Conference to Review Epidemic Status and Changing Challenges in the Response
- PRNewswire - May 2, 2008
- -- Broadest range of public and non-governmental sector participants ever to address the changing face of HIV in the region and the critical crossroad the response faces MOSCOW, May 2 /PRNewswire/ -- Starting tomorrow, the second Eastern Europe and Central Asia AIDS Conference (EECAAC II), the largest AIDS-focused even
- Black Enterprise Unveils America's Leading Doctors: May 2008 Special Report Highlights 140 Doctors Changing the Face of Medicine
- PRNewswire - May 1, 2008
- NEW YORK, May 1 /PRNewswire/ -- The May issue of BLACK ENTERPRISE (BE) unveils its 2008 report on the best and brightest in medicine. In America s Leading Doctors, BE names 140 top-notch physicians responsible for saving millions of lives through the revolutionary treatment of diseases, from cancer and diabetes to hear
- Monogram Announces 2008 First Quarter Financial Results
- PRNewswire - May 1, 2008
- 57% Revenue Growth; New VeraTag Assays Available for Clinical Development - Conference call today at 4:30 p.m. ET - SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today reported financial results for the quarter ended March 31, 2008.
- Sangamo BioSciences Reports First Quarter 2008 Financial Results
- PRNewswire - April 30, 2008
- RICHMOND, Calif., April 30 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (NASDAQ:SGMO) today reported first quarter 2008 financial results and accomplishments. For the first quarter ended March 31, 2008, Sangamo reported a consolidated net loss of $8.0 million, or $0.20 per share, compared to a net loss of $5.4 m
- mtvU & Kaiser Family Foundation Launch POSorNOT.com to Challenge Stigma, Fight Spread of HIV/AIDS
- PRNewswire - April 30, 2008
- -- Wyclef Jean, Fall Out Boy, Will.i.am, Alyssa Milano, Say Anything, Perez Hilton, Angels & Airwaves, Atmosphere and Many More Helping Fuel Game s Viral Spread -- Developed in Partnership With POZ Magazine, Pos or Not Confronts Stereotypes Through Personal Stories of Americans Living With and Without HIV/AIDS NE
- OPEN LETTER: Medical Journal Calls Upon Barack Obama to Set the Record Straight on AIDS Virus
- PRNewswire - April 30, 2008
- NEW ROCHELLE, N.Y., April 30 /PRNewswire-USNewswire/ -- Jeffrey Laurence, M.D., editor-in-chief of the peer-reviewed medical journal, AIDS Patient Care and STDs (http://www.liebertpub.com/apc), and the journal s publisher, Mary Ann Liebert, are calling upon Senator Barack Obama to set the record straight about the AIDS
- Indevus Pharmaceuticals Announces Second Quarter Fiscal 2008 Financial Results
- PRNewswire - April 30, 2008
- LEXINGTON, Mass., April 30 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (NASDAQ:IDEV) today announced its consolidated results of operations for the second quarter of fiscal 2008, ended March 31, 2008. The Company will host a conference call and webcast today beginning at 9:00 am eastern time (details follow
- i.HUG Event Raises Hope ... and $25,000
- PRNewswire - April 29, 2008
- NEW YORK, April 29 /PRNewswire/ -- The I Help Uganda Grow (i.HUG) Foundation recently hosted its first Benefit Gala, raising more than $25,000 to help disadvantaged and orphaned children of Kabalagala, Uganda. Kabalagala is a slum community near Kampala that has been stricken with HIV/AIDS and extreme poverty. The
- Next Steps in Controlling HIV in Africa: Behavior, Biology, or Both?
- PRNewswire - April 29, 2008
- The Johns Hopkins Population Center and the Population Reference Bureau are pleased to announce their annual symposium on population and health: What: Next Steps in Controlling HIV in Africa: Behavior, Biology, or Both? When: Thursday, May 1, 2008, 2:00 p.m. - 3:30 p.m. Where: National Press Club, 529 14th Street, NW,
- Patient Groups and Other Stakeholders Call for Rethink on Public Health, Innovation and Access to Medicines
- PRNewswire - April 29, 2008
- GENEVA, Switzerland , April 29/PRNewswire/ -- Developing countries need more than just access to medicines, and should not be fooled into thinking there is a quick fix for their health needs, the AIDS Institute, Alliance for Health, Education, and Development (AHEAD), patient groups and other experts from around the wo
- Idenix Pharmaceuticals Reports First Quarter 2008 Financial Results
- PRNewswire - April 29, 2008
- CAMBRIDGE, Mass., April 29 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the first quarter ended March 31,
- Clinical Update - Debio 025 in Hepatitis C: Presentation of Phase IIa Efficacy Results
- PRNewswire - April 28, 2008
- LAUSANNE, Switzerland , April 28/PRNewswire/ -- Debiopharm Group (Debiopharm), a global independent biopharmaceutical development specialist focusing on serious medical conditions, particularly oncology, presented positive efficacy results of a phase IIa study with Debio 025, a selective cyclophilin (Cyp) inhibitor wit
- Three Studies Presented at 43rd EASL Strongly Indicate Better Efficacy for PEGASYS in Curing Hepatitis C: Roche Also Provides Comment on Results of "IDEAL" Trial
- PRNewswire - April 26, 2008
- BASEL, Switzerland , April 26/PRNewswire/ -- Roche today announced that compelling new data from three studies indicate that chronic hepatitis C patients who received PEGASYS(R) (peginterferon alfa-2a) plus COPEGUS(R) (ribavirin) had a greater chance of being cured of their disease than those who received combination t
- Roche's Investigational Hepatitis C Polymerase Inhibitor, R1626, Demonstrated Significant End-of-Treatment Response in Phase IIa Study
- PRNewswire - April 26, 2008
- -- 84 percent of patients had undetectable levels of HCV at end of treatment MILAN, Italy , April 26 /PRNewswire/ -- Roche s investigational therapy for chronic hepatitis C virus (HCV) infection, R1626, has shown a significant end-of-treatment response rate when given in combination with PEGASYS(R) (peginterferon alfa-
- BARACLUDE(R) (Entecavir) Treatment Resulted In Greater Viral Load Suppression Compared to Adefovir at 96 Weeks In Antiviral-Naive Adult Chronic Hepatitis B E-Antigen Positive Patients
- PRNewswire - April 26, 2008
- MILAN, Italy , April 26 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE:BMY) today announced new data from the E.A.R.L.Y. study (ETV-079), in which treatment of antiviral-naive adult chronic hepatitis B patients with BARACLUDE(R) (entecavir) resulted in greater long-term viral load reduction than adefovir
- Prominent Advocate on HIV/AIDS Issues Joins Altarum Institute: Jesse Milan Joins Nonprofit Health Systems Research Institute as New Vice President
- PRNewswire - April 25, 2008
- WASHINGTON, April 25 /PRNewswire/ -- Jesse Milan, Jr., prominent leader and advocate on HIV/AIDS issues, has joined the nonprofit Altarum Institute as Vice President and Director of its Community Health Systems Group. When we began the search for someone to lead our Community Health Systems Group, I hoped to find an in
- Government and Corporate Support Together Help Africans Battling Malaria, AIDS
- PRNewswire - April 25, 2008
- -- McKesson Corp. Executives and Zambian Caregiver Speak with U.S. Leaders for World Malaria Day -- World Vision urges U.S. Senate to pass Global AIDS, TB and Malaria Bill WASHINGTON, April 25 /PRNewswire-USNewswire/ -- A volunteer nurse from Zambia and executives from the healthcare company McKesson Corp. spoke with l
- Disinfecting Water Saves Lives in Rwanda
- PRNewswire - April 25, 2008
- WASHINGTON, April 25 /PRNewswire-USNewswire/ -- The United States Agency for International Development (USAID) is pleased to announce the relaunch of Sur Eau, a safe-water solution that reduces the risk of diarrhea. Sur Eau is a water purification solution that prevents waterborne diseases. The chlorine solution can be
- Pharmasset Presents Results of 4-Week Combination Study of R7128 for the Treatment of Chronic Hepatitis C
- PRNewswire - April 25, 2008
- - 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg BID with Pegasys(R) plus Copegus(R) - - Safety and tolerability comparable to placebo administered with Pegasys plus Copegus - - EASL presentation available on Pharmasset website - - Conference call scheduled for Frid
- Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance
- PRNewswire - April 25, 2008
- BASINGSTOKE, England and PHILADELPHIA, April 25/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the three months to March 31, 2008. Q1 2008 Financial Highlights
- Get INSPI(RED) This Mother's Day: The Best Gifts to Receive This Season are Those That Give Back and Support the Fight Against AIDS in Africa
- PRNewswire - April 24, 2008
- NEW YORK, April 24 /PRNewswire/ -- Christy Turlington Burns kicked off the Mother s Day festivities a few weeks early at the INSPI(RED) Mothers Brunch in New York City on April 20th. Turlington, a (RED) ambassador, was joined by Helena Christensen, Liya Kebede, Mya, and other (RED) supporters to celebrate motherhood an
- Why the World Should Ask 'Am I Number 12?': More Than 200 Patient Groups Launch Global Viral Campaign
- PRNewswire - April 24, 2008
- GENEVA, Switzerland , April 24/PRNewswire/ -- The World Hepatitis Alliance and over 200 patient groups around the world are asking Am I Number 12? (http://www.aminumber12.org) to increase awareness of the shocking statistic that one in 12 people on the planet are living with hepatitis B or hepatitis C and yet the major
- Pharmasset Adds Two Cohorts to R7128 Hepatitis C Study
- PRNewswire - April 24, 2008
- -- Two 4-week cohorts will be enrolled to evaluate R7128 1500mg BID in HCV genotypes 2 and 3 prior non-responders and R7128 1000mg BID in HCV genotype 1 treatment-naive patients -- Conference call scheduled for Friday, April 25, 2008 at 1:00 PM ET (US) and 7:00 PM CEST (Milan) PRINCETON, N.J. and MILAN,
- FDA Clears First Medical Product Made From Yulex(R) Natural Rubber: FDA provides 510(k) on examination gloves made from U.S.-sourced guayule rubber that is naturally safe for people with Type I latex allergy
- PRNewswire - April 24, 2008
- MARICOPA, Ariz., April 24 /PRNewswire/ -- Yulex Corporation, a company that produces natural rubber found to be safe for medical devices, received 510(k) clearance from the U.S. Food and Drug Administration ( FDA ) to market the first medical device made from guayule, a desert crop native to the U.S. Southwest. The exa
- Amnesty International Lobby Day on Capitol Hill Focused on Global Violence Against Women
- PRNewswire - April 24, 2008
- WASHINGTON, April 24 /PRNewswire-USNewswire/ -- Some 200 Amnesty International activists -- from across the United States and from Nepal , Tunisia , the Democratic Republic of Congo and Zimbabwe -- will hold discussions wit
- ACTwatch, to Improve Malaria Treatment, to Be Launched on World Malaria Day
- PRNewswire - April 24, 2008
- NAIROBI, Kenya , April 24 /PRNewswire-USNewswire/ -- A multi-country project called ACTwatch, which will monitor the availability and affordability of effective malaria treatment, will be launched in Nairobi Friday -- World Malaria Day. Over the next five years, ACTwatch, which is funded by a grant from the Bill &
- Strong Double-Digit Net Sales Growth and Solid Earnings Growth Highlight First Quarter for Bristol-Myers Squibb Company
- PRNewswire - April 24, 2008
- - Reports Broad-Based Net Sales Growth of 20% from Continuing Operations Driven by Strong Performance of Pharmaceutical Business - Records Pre-Tax Earnings from Continuing Operations of $1.3 Billion Representing an Increase of 51% From First Quarter 2007 - Posts First Quarter 2008 GAAP EPS from Continuing Operations of
- Schering-Plough Reports Financial Results for First Quarter of 2008: OBS Acquisition Contributes to First Quarter Performance; Company Taking Actions to Address New Challenges
- PRNewswire - April 23, 2008
- KENILWORTH, N.J., April 23 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported financial results for the first quarter of 2008, reviewed progress on its ongoing integration of Organon BioSciences N.V. (OBS) (acquired in November 2007) and addressed recent events affecting the Merck/Schering-
- Mandela's Portrait, Painted by Artist Peter Engels, put up for "46664" Charity
- PRNewswire - April 23, 2008
- BRUSSELS, April 23/PRNewswire/ -- Nelson Mandela will be 90 soon. Time for the most impressive painted tribute , says artist Peter Engels. The result is a breath-taking canvas of 78.7 x 39.4 inch (=200 x 100 cm), painted with the pallet knife, which is Peter Engels unique signature. Mandela s birthday will be celebrate
- Increase in Travel to China Creating New Health and Security Risks
- PRNewswire - April 23, 2008
- -- New China White Paper from MEDEX Global Group Offers Tips for Travelers BALTIMORE, April 23 /PRNewswire/ -- Infectious disease, poor sanitary conditions and substandard healthcare are among the serious medical concerns found in China, according to a new white paper recently released by MEDEX Global Group, a worldwid
- Idenix Pharmaceuticals Presents Positive Preclinical Data on HCV Programs at The Annual Meeting of The European Association for the Study of the Liver (EASL)
- PRNewswire - April 23, 2008
- CAMBRIDGE, Mass., and MILAN, Italy , April 23 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced preclinical data from the company s polymerase
- Number of HIV-Positive State and Federal Inmates Continues to Decline
- PRNewswire - April 22, 2008
- -- About 44 percent of state inmates and 39 percent of federal inmates have medical problems WASHINGTON, April 22 /PRNewswire-USNewswire/ -- Between 2005 and 2006 the number of state and federal prisoners who were HIV-positive decreased 3.1 percent -- from 22,676 to 21,980 inmates, according to a report by the Justice
- Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology: Data Supports Use of HIV-specific T cell Precursors with High Proliferative Capacity (PHPC) Marker to Predict Reduction of Viral Load
- PRNewswire - April 21, 2008
- MCLEAN, Va., and BUDAPEST, Hungary , April 21 /PRNewswire/ -- Genetic Immunity(R), a US/Hungarian clinical-stage company focused on patented nanomedicines for immune amplification, announced today that the Journal of Immunology published findings on a key biomarker currently being used in clinical studies of its lead H
- Strativa Pharmaceuticals Announces Phase III Results for Loramyc(R) to Treat Oropharyngeal Candidiasis
- PRNewswire - April 21, 2008
- WOODCLIFF LAKE, N.J., April 21 /PRNewswire-FirstCall/ -- Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE:PRX) today announced that its development partner, BioAlliance Pharma reported preliminary, top-line results for a Phase III study of Loramyc(R) (miconazole La
- SurgiLance Safety Lancet Part of Major HIV Testing Initiative in Sub-Saharan Africa
- PRNewswire - April 17, 2008
- NORCROSS, Ga., April 17 /PRNewswire/ -- The SurgiLance safety lancet, an industry-leading medical safety product manufactured by MediPurpose, has been selected for inclusion in an HIV kit distributed throughout Africa by Nigerian-based Bundi International Diagnostics. Long established in the Americas and Europe, SurgiL
- AlphaVax Announces Initial Analysis of Data From CMV Phase 1 Clinical Trial
- PRNewswire - April 17, 2008
- RESEARCH TRIANGLE PARK, N.C., April 17 /PRNewswire/ -- AlphaVax, Inc. announced today an initial analysis of data from a Phase I clinical trial of a cytomegalovirus ( CMV ) vaccine that is based on its platform alphavirus replicon vector technology. The trial is a placebo-controlled, randomized, double-blind, singl
- Abbott Reports Double-Digit Sales and Earnings Growth in First Quarter and Reaffirms Full-Year Growth Outlook
- PRNewswire - April 16, 2008
- - Worldwide Sales Growth of 13.8 Percent - - Worldwide Pharmaceutical Sales Increased 14.3 Percent - - Worldwide Medical Products Sales Increased 13.7 Percent - - Five New Product Approvals in the First Quarter - ABBOTT PARK, Ill., April 16 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) today announced financial results f
- ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528
- PRNewswire - April 16, 2008
- FREDERICK, Md., April 16 /PRNewswire/ -- ImQuest Life Sciences today presented important new results on the development of their lead anti-HIV therapeutic development candidate, IQP-0410, and lead topical microbicide development candidate, IQP-0528. ImQuest scientists Robert W. Buckheit, Jr., Ph.D. (Executive Vice Pres
- Ted Allen, Judge on Bravo's 'Top Chef' Talks About Dining Out For Life: The Subaru Sponsored One Day Event is Expected to Raise Over $3 Million in the Fight Against AIDS
- PRNewswire - April 16, 2008
- WHAT: Emmy Award winning TV personality, Ted Allen, is the 2008 Spokesperson for the Subaru of America, Inc. sponsored Dining Out for Life. As spokesperson for the event, Allen will speak to the issue that too many people wrongly believe the HIV/AIDS crisis no longer IS a crisis. Mr. Allen is available for interviews u
- i'm Initiative Participants Select UNICEF as Top Charity in First Year of Microsoft's Initiative: U.S. Fund for UNICEF nets $255K for Child Survival programming
- PRNewswire - April 15, 2008
- NEW YORK, April 15 /PRNewswire-USNewswire/ -- Officials with the U.S. Fund for UNICEF celebrated the first anniversary of the i m Initiative by announcing UNICEF s designation as the top charity selected by users of Windows Live Messenger which netted $255,000 for the international children s organization. Twelve month
- Schering-Plough Initiates Phase II Study With Vicriviroc in Treatment-Naive HIV-Infected Patients: Novel Nucleoside-Sparing Regimen Designed to Avoid Risk of Toxicity Associated with Nucleoside Class of HIV Drugs
- PRNewswire - April 15, 2008
- KENILWORTH, N.J., April 15 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today announced that it has initiated a Phase II clinical study with vicriviroc, its investigational CCR5 antagonist, for use in first-line therapy of adult treatment-naive HIV-infected patients with R5-type virus only. Vicrivi
- Once There Was a Country: Revisiting Haiti - Award Winning Documentary on Haiti to Air on WPBT-TV, Miami PBS Station
- PRNewswire - April 15, 2008
- -- A Film by Noted Philanthropist Kimberly Green; Documentary Profiles the Economic and Healthcare Crisis in Haiti MIAMI, April 15 /PRNewswire/ -- On April 15th at 9PM, Miami s WPBT-TV, Channel 2, will broadcast the award winning documentary, Once There Was a Country: Revisiting Haiti. Narrated by former U.S. poet lau
- Ardea Biosciences Presents Data Demonstrating Favorable Pharmacokinetics and Efficacy for Mitogen-Activated ERK Kinase (MEK) Inhibitors
- PRNewswire - April 15, 2008
- -- Lead MEK inhibitor, RDEA119, demonstrates potential for once daily oral dosing in preliminary Phase 1 results -- Next generation MEK inhibitor, RDEA436, to enter Phase 1 trials second half of 2008 SAN DIEGO, April 15 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data was presen
- hakia Adds Credibility Dimension to Online Health Search: Web Searchers Can Now Use hakia.com to Add a New Dimension to Their Health Search, and Access Information That's Credible and Fresh
- PRNewswire - April 14, 2008
- NEW YORK, April 14 /PRNewswire/ -- hakia.com, the Web s pioneering semantic search engine, today announced an update to its BETA site that will help users looking for the most credible and fresh health content on the Web. For the first time, users will start to get credibility-stamped search results in full view, inste
- Jaman.com Acquires Film Titles from BBC Worldwide America to Distribute Online
- PRNewswire - April 14, 2008
- SAN MATEO, Calif., April 14 /PRNewswire/ -- Underscoring its position as the leading online destination for quality international and independent entertainment, Jaman.com today announced the acquisition of an acclaimed collection of films from BBC Worldwide America. The Jaman site fosters a vibrant and active community
- ItGirl PR Partners With Hot in Hollywood for Their Third Annual Fundraising Event With America Ferrera Hosting
- PRNewswire - April 14, 2008
- -- It Girl PR will Promote Third Annual Hot In Hollywood, Slated for August 16th Benefiting Aids Healthcare Foundation and Real Medicine and Hosted by Emmy and Golden Globe winner America Ferrera LOS ANGELES, April 14 /PRNewswire/ -- It Girl PR partners with the hippest fundraiser in Hollywood; Hot In Hollywood. ItGirl
- Ardea Presents Preclinical Data on Novel Next Generation Non-Nucleoside Reverse Transcriptase Inhibitors Demonstrating Potent Anti-HIV Activity Against Resistant Viruses
- PRNewswire - April 14, 2008
- -- Lead NNRTI RDEA806 to begin Phase 2b trial in the second quarter of 2008 MONTREAL and SAN DIEGO, April 14 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA) today announced that preclinical data was presented on the Company s next generation non-nucleoside reverse transcriptase inhibitor (NNRTI) family
- White Ribbon Alliance Calls for International Monetary Fund and World Bank to Invest in Women's Health: Says Deadly Delays and Broken Promises Make Pregnancy and Childbirth #1 Killer of Women in World Today
- PRNewswire - April 11, 2008
- WASHINGTON, April 11 /PRNewswire-USNewswire/ -- The White Ribbon Alliance for Safe Motherhood today made public its appeals to the International Monetary Fund and World Bank to drastically increase investments in women s health. Citing recent reports that the UN Millennium Development Goal to reduce maternal mortality
- Napo Announces Successful Clinical Results in Phase 2 Study of Crofelemer in Acute Adult Infectious Diarrhea
- PRNewswire - April 10, 2008
- SOUTH SAN FRANCISCO, Calif., April 10 /PRNewswire/ -- Napo Pharmaceuticals, Inc., is pleased to announce the positive results of a successfully completed Phase 2 trial for CRO-ID (crofelemer for the treatment of acute adult infectious diarrhea) conducted by its partner, Glenmark Pharmaceuticals Limited . The primary en
- More Companies Are Creating Programs to Help Alleviate Worldwide HIV/AIDS Epidemic, The Conference Board Reports
- PRNewswire - April 10, 2008
- NEW YORK, April 10 /PRNewswire/ -- Major companies are creating a wide variety of programs to help employees deal with the global HIV/AIDS epidemic, according to a report released today by The Conference Board, the global business research and membership organization. The report finds that 82 percent of the 134 major f
- Pregnancy and Cancer Top the List Of the Most Commonly Searched Health Conditions
- PRNewswire - April 10, 2008
- -- Pfizer s Smoking Cessation Treatment, Chantix, Emerges as the Number One Most Frequently Searched Prescription Brand RESTON, Va., April 10 /PRNewswire-FirstCall/ -- comScore, Inc. (Nasdaq: SCOR), a leader in measuring the digital world, today released a listing of the 20 most commonly searched health conditions as w
- Aeras, Crucell and South African Tuberculosis Vaccine Initiative Announce Encouraging Preliminary Results of Tuberculosis Vaccine Clinical Trial in South Africa
- PRNewswire - April 9, 2008
- ATLANTA, April 9, 2008 /PRNewswire-USNewswire/ -- Dutch biotechnology company Crucell N.V., the Aeras Global TB Vaccine Foundation and the South African Tuberculosis Vaccine Initiative (SATVI) present a progress update and immunology data from a Phase I Ad35 tuberculosis vaccine study at the biennial Tuberculosis Vacci
- ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India
- PRNewswire - April 8, 2008
- FREDERICK, Md., April 8, 2008 /PRNewswire/ -- ImQuest scientists Robert W. Buckheit, Jr., Ph.D. and Karen M. Watson, M.S. presented the results of studies performed with products licensed by ImQuest Life Sciences, Inc. at the recent Microbicides 2008, an international conference held in New Delhi, India
- USA TODAY Hollywood Hero Award Honors Earvin 'Magic' Johnson for His Work With the Magic Johnson Foundation
- PRNewswire - April 8, 2008
- MCLEAN, Va., April 8, 2008 /PRNewswire-USNewswire/ -- NBA Legend, entrepreneur and philanthropist Earvin Magic Johnson will be honored May 6 as the recipient of the third annual USA TODAY Hollywood Hero Award being presented by USA TODAY President and Publisher Craig A. Moon. The award recognizes his work in entertainm
- Rubber Hits the Road as Trojan(R) Campaigns for Sexual Health in America to Evolve: Condom Maker Launches Nationwide Bus and Concert Tour During STI Awareness Month
- PRNewswire - April 8, 2008
- PRINCETON, N.J., April 8, 2008 /PRNewswire/ -- Starting today in Atlanta, the Trojan Evolve tour will travel across the U.S. raising awareness regarding the poor state of sexual health in America and urging Americans to petition for change. The fact is, this is not a sexually healthy nation, and the Evolve tour is desi
- WOCN: Around the World in 40 Years: Wound Ostomy & Continence Nurses Society Celebrates 40 Years of Specialized Care in the U.S. and Abroad April 13-19
- PRNewswire - April 7, 2008
- MT LAUREL, N.J., April 7, 2008 /PRNewswire/ -- The year 1968 was pivotal in the history of the United States , the world and Enterostomal Therapy (ET) Nursing. The end of the Kennedy/Johnson presidencies, the assassination of Martin Luther King and the beginning of the end of the Vietnam
- New Abbott Kaletra(R) (lopinavir/ritonavir) Lower-Strength Tablet for Pediatric Use Approved in Europe
- PRNewswire - April 7, 2008
- -- Lopinavir/ ritonavir Tablet is the First and Only Co-Formulated Protease Inhibitor Tablet Approved for Use in Children with HIV ABBOTT PARK, Illinois, April 7 /PRNewswire/ -- Abbott announced today that it has received marketing authorization from the European Commission for the new, lower-strength tablet formulatio
- Ardea to Present Data on HIV Non-Nucleoside Reverse Transcriptase Inhibitor and Two MEK Inhibitors at Upcoming Medical Conferences
- PRNewswire - April 7, 2008
- SAN DIEGO, April 7, 2008 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data will be presented on its second generation non-nucleoside reverse transcriptase inhibitors (NNRTIs), at the 21st International Conference on Antiviral Research (ICAR). Additionally, data on two of the Comp
- African Journey of a Lifetime With Alicia Keys! - Documentary Follows Keep a Child Alive's Outreach to Communities Affected With HIV/AIDS
- PRNewswire - April 7, 2008
- -- A Portion of the Documentary to Debut During IDOL GIVES BACK Wednesday, April 9, on FOX NEW YORK, April 7, 2008 /PRNewswire/ -- Alicia in Africa: Journey to the Motherland is the breathtaking documentary of Grammy Award-winning musician and Keep a Child Alive (KCA) Co-Founder Alicia Keys month-long trip to Africa to
- Vical Receives NIH Grant for an Immunotherapeutic Herpes DNA Vaccine; Herpes Experts at University of Washington and University of Texas to Conduct Preclinical Development
- PRNewswire - April 3, 2008
- SAN DIEGO, April 3, 2008 /PRNewswire-FirstCall/ -- Vical Incorporated (NASDAQ:VICL) today announced that it has been awarded a two-year, $2.0 million Phase II Small Business Technology Transfer (STTR) grant from the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health
- Owner of Medicare Billing Service Sentenced to 10 Years In Prison For Role in $170 Million Medicare Fraud Scheme
- PRNewswire - April 2, 2008
- WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- Miami resident Rita Campos Ramirez, 60, was sentenced to 10 years in prison for her role in a $170 million scheme to defraud Medicare, Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District o
- House Overwhelmingly Approves Renewal and Tripling of Successful U.S. Global AIDS Prevention Effort
- PRNewswire - April 2, 2008
- WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- Thanks to a bipartisan compromise brokered by Foreign Affairs Committee Chairman Howard L. Berman (D-CA), the House today voted overwhelmingly to expand the landmark U.S. effort to combat HIV/AIDS worldwide that, during the past five years, has saved millions of live
- Pelosi on Global HIV/AIDS Bill: 'There is a Moral Imperative to Combat This Epidemic'
- PRNewswire - April 2, 2008
- WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- Speaker Nancy Pelosi spoke on the House floor this afternoon in support of the U.S. Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act, which provides $50 billion over five years for programs to combat those diseases around the world. Below are the Speaker s
- Education and Media Key to Improving HIV/AIDS Awareness and Knowledge Levels in Afghanistan, New InterMedia Report Says
- PRNewswire - April 2, 2008
- WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- InterMedia, a Washington, D.C.-based research, evaluation and consulting organization, today released findings from a nationwide survey of Afghanistan that finds low awareness and knowledge levels about HIV/AIDS, but also shows that education and access to media are
- Seven Miami-Area Residents Charged in $11 Million Medicare Fraud Scheme
- PRNewswire - April 2, 2008
- WASHINGTON, April 2, 2008 /PRNewswire-USNewswire/ -- Seven Miami-area residents have been indicted in connection with an $11 million Medicare fraud scheme involving HIV infusion clinics, Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of
- Shirley Manson Accepts M-A-C AIDS Fund Cheque on Behalf of Waverley Care
- PRNewswire - April 2, 2008
- -- International Singer, Previous M-A-C Viva Glam Ambassador and Waverley Care Patron Shirley Manson to Make Personal Appearance at the M-A-C Counter at Harvey Nichols in Edinburgh LONDON, April 2/PRNewswire/ -- International Singer, past M-A-C Viva Glam Ambassador and Patron of the AIDS Charity Waverley Care Shirley M
- Bavarian Nordic Update - 2007 Annual Results, IMVAMUNE(R) Delivery Contract, Strategy Process
- PRNewswire - April 2, 2008
- WASHINGTON DC, April 2 /PRNewswire-FirstCall/ -- Bavarian Nordic, the Danish-based biopharmaceutical company, recently published its 2007 Annual Report. Below is an extract of the most significant matters in the report as well as events after the balance sheet date.
- ImQuest Publishes Results of Important Structure Activity Relationship Program on Dual Acting Pyrimidinediones
- PRNewswire - April 1, 2008
- FREDERICK, Md., April 1, 2008 /PRNewswire/ -- ImQuest BioSciences, Inc. announced today the publication of the results of an important structure- activity relationship study to investigate the efficacy and toxicity of a series of pyrimidinedione analogs against HIV-1 and HIV-2. The manuscript, published in the journal
- Major Deficiencies in Design; Funding of Clinical Trials Affects Future of Scientific Innovation
- PRNewswire - April 1, 2008
- -- Report Issued to Improve Policies Affecting How Human Studies Are Conducted WASHINGTON, April 1, 2008 /PRNewswire-USNewswire/ -- At the same time that medical science is making possible new therapies for treating AIDS, cancer, and other once fatal diseases, a new report finds major shortcomings in the way clinical t
- Monogram Biosciences Provides Progenics Pharmaceuticals with HIV Assays for Use in Clinical Trials: Trofile to be used to screen patients for clinical program of monoclonal antibody to CCR5
- PRNewswire - April 1, 2008
- SOUTH SAN FRANCISCO, Calif., April 1, 2008 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (NASDAQ:MGRM) announced today that it had entered into an agreement with Progenics Pharmaceuticals, Inc. (NASDAQ:PGNX) to provide resistance and tropism testing for Progenics clinical development program of PRO 140, an inve
- ANX-201 Demonstrates a Unique Resistance Profile in Preclinical Tests: ADVENTRX Presents Results at Keystone Symposia HIV Pathogenesis Conference
- PRNewswire - March 31, 2008
- SAN DIEGO, March 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX) announced that it presented preclinical results for ANX-201, the Company s broad-spectrum antiviral product candidate at the Keystone Symposia HIV Pathogenesis Conference in Banff, Alberta on March 30, 2008. The preclinical results
- Monogram HIV Antibody Assay Is Key Component of Innovative Vaccine Development Program
- PRNewswire - March 31, 2008
- -- Collaborators from Maxygen, Inc. Present Abstracts at Prominent HIV Vaccine Meeting SOUTH SAN FRANCISCO, Calif., March 31 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today announced that company researchers have co-authored with collaborators from Maxygen, Inc. and Aldevron LLC several importa
- The Stadium Named 'Peace' Becomes Launchpad for Pastor Rick Warren's P.E.A.C.E. Plan: Nearly 20,000 Gather in Rwanda's Amohoro Stadium to Participate in National 40 Days of Purpose Campaign Kick-Off
- PRNewswire - March 31, 2008
- KIGALI, Rwanda , March 31 /PRNewswire/ -- Dr. Rick Warren, pastor of Saddleback Church in Lake Forest, Calif., began a nine-day trip to Rwanda -- his 10th visit -- with an event at Amohoro (translated Peace ) Stadium, celebrating the first three years of the P.E.A.C.E. Plan and the initiation of the first national 40 D
- VIRxSYS Presents Data on HIV Vaccine at Keystone HIV Vaccine Symposia: HIV-Based Lentiviral vector VRX1023 Shows Promising Results
- PRNewswire - March 28, 2008
- GAITHERSBURG, Md., March 28 /PRNewswire/ -- VIRxSYS Corporation will present initial scientific data for VRX1023 today at the Keystone Symposia Conference in Banff, Alberta. VRX1023 is part of a new vaccine approach -- using HIV-based lentivector as vector boost. VRX1023, an HIV antigen expressing lentiviral vector, ha
- CureHIV Reaches Out to Bill and Melinda Gates to Fund LiSAVIOR
- PRNewswire - March 28, 2008
- HILTON HEAD ISLAND, S.C., March 28 /PRNewswire/ -- Dr. Roger Kenneth Hershline PhD MD, the CEO of Global Humanceuticals, Inc. and founder and chairman of the not-for-profit public charity CureHIV.us, announces today that he is reaching out to Bill and Melinda Gates for funding from their Grand Challenges in Global Heal
- Will Congress Do More for HIV Prevention?
- PRNewswire - March 28, 2008
- WASHINGTON, March 28 /PRNewswire-USNewswire/ -- With the full House and Senate poised to vote on the President s Emergency Plan for AIDS Relief (PEPFAR) reauthorization bill, a five-year, $50 billion initiative to combat HIV/AIDS, tuberculosis and malaria worldwide, Congress must address the critical HIV prevention sho
- Remarks Prepared for Delivery by Attorney General Michael B. Mukasey at the Tech Museum of Innovation
- PRNewswire - March 28, 2008
- SAN JOSE, Calif., March 28 /PRNewswire-USNewswire/ -- The following is a transcript of remarks prepared for delivery by Attorney General Michael B. Mukasey at the Tech Museum of Innovation: Good morning. The technological advances that have occurred over the last few years, and the ways in which those changes have affe
- Beringer Vineyards Announces Sponsorship of DIFFA's (Design Industries Foundation Fighting AIDS) DINING BY DESIGN 2008 National Tour
- PRNewswire - March 28, 2008
- -- The multi-city tour kicks off in New York City on Sunday, March 30th before visiting Kansas City, Los Angeles, Dallas, Atlanta, San Francisco, Chicago and Boston NAPA, Calif., March 28 /PRNewswire/ -- Beringer Vineyards, Napa Valley s celebrated winery raises its glass to top design with its sponsorship of DIFFA s (
- Pharsight Invited to Present on HIV Modeling and Simulation at ASCPT Annual Meeting
- PRNewswire - March 28, 2008
- -- Dr. Bill Poland Will Present on Strategic Use of in Vitro and Literature Data to Predict Effects of New HIV Therapies MOUNTAIN VIEW, Calif., March 28 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory services for optimizing clinical dr
- AIDS Activist Gregg Gonsalves Receives $100,000 Leadership Award: New John M. Lloyd AIDS Leadership Award Recognizes Visionary Advocate
- PRNewswire - March 27, 2008
- LOS ANGELES, March 27 /PRNewswire/ -- The John M. Lloyd Foundation announced today that AIDS advocate Gregg Gonsalves has been selected as the first-ever recipient of the $100,000 John M. Lloyd AIDS Leadership Award. An AIDS activist for 17 years, Gonsalves has played a major role in international efforts to accelerate
- Laureate Announces Second Manufacturing Agreement with Cytheris: Laureate to Manufacture Cytheris' Lead Product Candidate, INTERLEUKIN-7, currently in clinical trials for treatment of HIV, HCV and cancer
- PRNewswire - March 27, 2008
- PRINCETON, N.J. and PARIS, March 27 /PRNewswire-FirstCall/ -- Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, announced today that it has entered into a cGMP contract manufacturing agreement with Cytheris SA, a clinical stage biopharmaceutical company focused on resea
- BD and Direct Relief International Launch Second Volunteer Service Trip to Improve Healthcare in Ghana
- PRNewswire - March 27, 2008
- FRANKLIN LAKES, N.J., March 27 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, and Direct Relief International, a humanitarian medical aid nonprofit organization, today announced the second joint volunteer initiative to strengthen healthcare in
- 'Last Dance' & 'It's Raining Men' Composer Paul Jabara's Memory Lives On: Remembrance of His 60th Birthday with Release on iTunes and New Musical
- PRNewswire - March 27, 2008
- NEW YORK, March 27 /PRNewswire/ -- Commemorating Oscar-winning composer Paul Jabara s 60th birthday year, we launched a dedicated website (http://www.pauljabara.com/), a musical is in the works, and Paul Jabara s Greatest Hits (and Misses) is available on iTunes, announced Claudette Jabara Hadad and Henry Hadad, manage
- InforMedix's Med-eMonitor, Med-eXpert Systems Achieve 89.5% Medication Adherence in HIV Patients
- PRNewswire - March 26, 2008
- ROCKVILLE, Md., March 26 /PRNewswire-FirstCall/ -- InforMedix Holdings, Inc. (BULLETIN BOARD: IFMX) , announced that results presented by Dr. David Bangsberg, an internationally renowned expert on medical adherence, at the Third International Conference on HIV Adherence, showed that HIV+ patients using its Med-eMonitor
- NeurogesX Reports Fourth Quarter and Year-End 2007 Financial Results
- PRNewswire - March 26, 2008
- Highlights:-- NDA filing for dermal patch NGX-4010 in PHN expected in 2008 -- IND filing for liquid formulation NGX-1998 expected in first half of 2008 -- NGX-4010 MAA under EMEA review for neuropathic pain - Closed $25 million private placement SAN MATEO, Calif., March 26 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (Nas
- National Health Education Tour to Kick-Off in Atlanta
- PRNewswire - March 25, 2008
- ATLANTA, March 25 /PRNewswire/ -- On April 10th, a music event four years in the making will kick off at the Woodruff Arts Center in Atlanta. Complete with well known artists Ben Kweller, Ari Hest, Toby Lightman and screaming fans, this concert will also have an element not always present -- a purpose. The Music Inspir
- Shire plc: IFRS Results for the Year Ending December 31, 2007
- PRNewswire - March 25, 2008
- BASINGSTOKE, England, March 25/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces its preliminary results prepared under International Financial Reporting Standards ( IFRS ) for the twelve months to December 31, 2007. On February 21, 2008 Shire announce
- Responsibility is VIVA GLAMOROUS: M.A.C COSMETICS' Newest VIVA GLAM VI Spokesperson, FERGIE, Remixes Her Hit Song 'GLAMOROUS' To Raise Awareness For HIV/AIDS
- PRNewswire - March 25, 2008
- -- LIMITED NUMBER OF FREE DOWNLOADS AVAILABLE AT MACCOSMETICS.COM NEW YORK, March 25 /PRNewswire/ -- Three-time Grammy Award winning artist and latest M.A.C VIVA GLAM spokesperson, Fergie, is using her voice to further raise awareness about the HIV/AIDS crisis in youth. Along with PoetNameLife, she has recorded VIVA GL
- VH1 and Sundance Channel to Air Original Four-Part Documentary Series From Perry Films, 'Sex: The Revolution' Premiering on VH1, Monday, May 12 - Thursday, May 15 at 10pm* Each Night
- PRNewswire - March 24, 2008
- -- Newest VH1 Rock Doc Charts Seismic Changes In American Sexual Attitudes, Laws And Practices From 1950s-1980s With Rarely Seen Footage And New Interviews -- Film Airs On Sundance Channel May 19th and May 20th at 12:00am and 1:00am NEW YORK, March 24 /PRNewswire/ -- VH1 and Perry Films in association with Sundance Cha
- R&D Spending by U.S. Biopharmaceutical Companies Reaches Record $58.8 Billion in 2007
- PRNewswire - March 24, 2008
- SAN FRANCISCO, March 24 /PRNewswire/ -- New statistics just released reveal that R&D investment in new medicines by the biopharmaceutical industry was $58.8 billion in 2007, according to a combined analysis conducted by Burrill & Company, a San Francisco based global leader in life sciences whose principal acti
- Ardea Biosciences Reports Progress of Clinical Development Programs; Provides 2008 Outlook; Announces 2007 Financial Results and Provides 2008 Financial Guidance
- PRNewswire - March 24, 2008
- SAN DIEGO, March 24 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (Nasdaq: RDEA), a company focused on the discovery and development of small- molecule therapeutics for the treatment of HIV, cancer and inflammatory diseases, including gout, today reported significant accomplishments in 2007, provided key milestones
- Statement from Kent Hill, USAID Assistant Administrator for Global Health, on the Observance of World Tuberculosis Day 2008
- PRNewswire - March 24, 2008
- WASHINGTON, March 24 /PRNewswire-USNewswire/ -- The following are remarks by Kent Hill, USAID Assistant Administrator for Global Health, on the observance of World Tuberculosis Day 2008: Although a cure for Tuberculosis (TB) has existed for more than half a century, TB remains one of three leading causes of death world
- Sangamo BioSciences and Sigma-Aldrich Announce Publication of Study Demonstrating Zinc Finger Technology for Rapid Generation of 'Knock-Out' Cell Lines
- PRNewswire - March 24, 2008
- -- ZFN Technology has Broad Applications in Research, Drug Development and Therapeutics ST. LOUIS and RICHMOND, Calif., March 24 /PRNewswire-FirstCall/ -- Sigma-Aldrich Corporation (Nasdaq: SIAL) and Sangamo BioSciences, Inc. (Nasdaq: SGMO) announced today the publication of data demonstrating the use of Sangamo s zinc
- DAUGHTRY to Perform Live Acoustic Set at The Beatles REVOLUTION Lounge in Las Vegas: Charity auction of tickets to benefit the ONE Campaign (ONE.org)
- PRNewswire - March 24, 2008
- LAS VEGAS, March 24 /PRNewswire/ -- Grammy-nominated 19/RCA recording artist DAUGHTRY will perform a live acoustic set at The Beatles REVOLUTION Lounge at The Mirage Sunday, April 13. All proceeds from the ticket sales will go to the ONE Campaign (ONE.org) to fight the emergency of global AIDS and extreme poverty. DAUG
- GeoVax Further Strengthens Management Team
- PRNewswire - March 24, 2008
- ATLANTA, March 24 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , http://www.geovax.com/, an Atlanta based AIDS vaccine development company, is very pleased to announce the addition of Dr. Robert McNally as President and CEO effective 01 April 2008. Current President/CEO and company co-founder Don
- BARACLUDE(R) (entecavir) Data Continue to Demonstrate Low Incidence of Resistance Through Five Years of Treatment in Nucleoside-naive Chronic Hepatitis B Patients
- PRNewswire - March 24, 2008
- -- Data Indicate Pre-existing Lamivudine Resistance Predisposes Patients to Higher Rates of BARACLUDE Resistance PRINCETON, N.J., March 24 /PRNewswire-FirstCall/ -- New BARACLUDE(R) (entecavir) data presented today demonstrated a continued low incidence of resistance in nucleoside-naive patients through five years of t
- HIV Vaccine Funding: 'Enough is Enough,' Says AHF in Baltimore Sun: US' Largest AIDS Group Calls for Funding Suspension After Trial Failures
- PRNewswire - March 23, 2008
- WASHINGTON, March 23 /PRNewswire-USNewswire/ -- In a Baltimore Sun opinion piece today (http://www.baltimoresun.com/news/opinion/oped/bal-op.aidsvaccine23mar23,0,3426636.story), AIDS Healthcare Foundation (AHF) called for the suspension of costly HIV vaccine research funding and the re- allocation of resources into eff
- XTL Biopharmaceuticals Signs $108 Million Deal for the Licensing of its Pre- Clinical Program in Hepatitis C to Presidio Pharmaceuticals
- PRNewswire - March 20, 2008
- VALLEY COTTAGE, N.Y., March 20 /PRNewswire-FirstCall/ -- XTL Biopharmaceuticals Ltd. (NASDAQ:XTLB)(NASDAQ:TASE:)(NASDAQ:XTL) announced the licensing of its pre-clinical program in Hepatitis C focused on the NS5A target (the Program ) to San-Francisco based Presidio Pharmaceuticals, Inc. Presidio is a private biotechnol
- Statement By Robert McSwain, Acting Director, Indian Health Service, Regarding National Native HIV/AIDS Awareness Day 2008
- PRNewswire - March 19, 2008
- WASHINGTON, March 19 /PRNewswire-USNewswire/ -- The following release is being issued by the Indian Health Service: March 20, 2008 marks the second annual National Native HIV/AIDS Awareness Day. This day gives us another opportunity to recognize that HIV/AIDS is a critical and growing health issue within our Native pop
- GSK Charitable Support Valued at $564 Million in 2007
- PRNewswire - March 19, 2008
- LONDON, March 19 /PRNewswire-FirstCall/ -- GlaxoSmithKline (NYSE:GSK) today reported its 2007 global giving to charitable initiatives totaled $564 million, equivalent to almost 4% of pre-tax profits for the company (with the FTSE 100 average around 1%). Donations of albendazole treatments for the company s flagship pro
- Resources Top 400,000 in Hopkins International Information Service: One Source Database Includes Research From Around the World, Supports Public Health Abroad
- PRNewswire - March 18, 2008
- BALTIMORE, March 18 /PRNewswire-USNewswire/ -- An information service containing thousands of scientific articles by African and Asian health researchers, among others, has topped 400,000 resources, announced the Johns Hopkins Bloomberg School of Public Health Center for Communication Programs. The new total makes the
- TorreyPines Therapeutics Initiates Phase II Study of Muscarinic Agonist NGX267 for Treatment of Xerostomia
- PRNewswire - March 18, 2008
- LA JOLLA, Calif., March 18 /PRNewswire/ -- TorreyPines Therapeutics, Inc. (NASDAQ:TPTX) today announced it has initiated a Phase II study of NGX267, a muscarinic agonist in development for xerostomia, or dry mouth, secondary to Sjogren s syndrome. The company is conducting a randomized, double-blind, placebo-controlled
- ADP Launches New Campaign to Reduce Meth Use in California
- PRNewswire - March 17, 2008
- SACRAMENTO, Calif., March 17 /PRNewswire-USNewswire/ -- The California Department of Alcohol and Drug Programs (ADP) today unveiled a new media campaign to fight methamphetamine use in the gay, bisexual, and other men who have sex with men (G/B/MSM) communities. Methamphetamine use is a problem in California and we are
- Ardea Biosciences Reports Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating up to 2.0 Log Reduction in Plasma Viral Load
- PRNewswire - March 17, 2008
- -- Company on Track to Initiate Phase 2b in Second Quarter of 2008 -- Conference Call Tomorrow at 8:00 a.m. Eastern Time SAN DIEGO, March 17 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced positive preliminary results from its ongoing Phase 2a proof-of-concept study of RDEA806, its novel
- Planet Aid Highlighted at White House Compassion in Action Roundtable: Focus on Combating Hunger at Home and Abroad
- PRNewswire - March 17, 2008
- WASHINGTON, March 17 /PRNewswire/ -- The White House Office of Faith-Based and Community Initiatives (OFBCI) convened a Compassion in Action policy roundtable this month highlighting innovative policies and partnerships to alleviate hunger in the U.S. and abroad. Hosted by OFBCI Deputy Director Jedd Medefind and keynot
- California Medicaid Establishes Coverage for Trofile(TM): All California public payers now cover Monogram's Trofile assay
- PRNewswire - March 17, 2008
- SOUTH SAN FRANCISCO, Calif., March 17 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that the California Medicaid program (Medi-Cal) has established coverage and reimbursement for Monogram s Trofile Assay. Medi-Cal is the state medical assistance program in California established to
- GeoVax Labs, Inc. Reports Fourth Quarter and Year-End 2007 Financial Results
- PRNewswire - March 14, 2008
- ATLANTA, March 14 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biotechnology company focused on development of an HIV/AIDS vaccine, today announced its financial results for the fourth quarter and year ended December 31, 2007.
- CDC Data Show 80 Percent Increase in HIV Among Young African American Men Who Have Sex With Men
- PRNewswire - March 14, 2008
- WASHINGTON, March 14 /PRNewswire-USNewswire/ -- Yesterday, the Centers for Disease Control and Prevention finally released data it had long held internally that demonstrate an alarming increase in the number of HIV/AIDS cases among African American young men who have sex with men (YMSM). The report, CDC HIV/AIDS Update
- Ortho Biotech Statement on U.S. Food and Drug Administration Oncologic Drugs Advisory Committee Vote
- PRNewswire - March 13, 2008
- GAITHERSBURG, Md., March 13 /PRNewswire/ -- Ortho Biotech is concerned by the Advisory Committee s recommendations to restrict access to erythropoiesis-stimulating agents (ESAs) for chemotherapy-induced anemia (CIA) in patients with metastatic breast and head and neck cancer, and patients treated with curative intent.
- Accordia Global Health Foundation Convenes Inaugural Infectious Diseases Summit: Global leaders across for- and non-profit sectors gather to identify 'on-the-ground' solutions; Julie Gerberding, Anthony Fauci, Richard T. Clark are Keynotes
- PRNewswire - March 13, 2008
- WASHINGTON March 13 /PRNewswire-USNewswire/ -- Accordia Global Health Foundation, formerly the Academic Alliance Foundation (AAF), today will convene an inaugural summit of global leaders in academia, government, NGOs and industry who have made major contributions to fighting infectious diseases. The summit is designed
- Oncolys BioPharma and Tacere Therapeutics Sign Strategic Alliance and License Agreement to Develop and Commercialize RNAi Hepatitis C Drug
- PRNewswire - March 12, 2008
- TOKYO and SAN JOSE, Calif., March 12 /PRNewswire/ -- Oncolys BioPharma, Inc. (Tokyo, Japan ) and Tacere Therapeutics, Inc. (San Jose, CA, USA) announced today that they have entered into a strategic alliance and license agreement to develop and commercialize throughout Asia, Tacere s RNA interference (RNAi)-based Hepat
- HHS Awards $550 Million for HIV/AIDS Care, Services
- PRNewswire - March 12, 2008
- ROCKVILLE, Md., March 12 /PRNewswire-USNewswire/ -- HHS Secretary Mike Leavitt has announced $550 million in grants to fund primary care and support services for individuals living with HIV/AIDS in 56 cities and major urban areas. The grants are awarded to 22 eligible metropolitan areas (EMAs) with the highest number o
- Lilly Grants $4.4 Million to the WHO for MDR-TB Program Expansion
- PRNewswire - March 12, 2008
- INDIANAPOLIS and LONDON, March 12 /PRNewswire-FirstCall/ -- Today Eli Lilly and Company announced its four-year grant of $4,384,000 to the World Health Organization (WHO) for scaling up its global capacity to manage multi- drug resistant tuberculosis (MDR-TB) programs. The grant covers four activities, starting wit
- Microbicide Developer Receives License for Novel HIV Microbicide Candidate From Merck & Co., Inc.
- PRNewswire - March 11, 2008
- SILVER SPRING, Md., March 11 /PRNewswire-USNewswire/ -- In a boost to HIV prevention research, Merck & Co. , Inc., has agreed to provide a royalty-free license to the non-profit International Partnership for Microbicides (IPM) to develop a novel antiretroviral compound for use as a potential vaginal microbicide.
- Skoll Foundation Adds Eleven Pioneering Organizations to its Global Portfolio of Leading Social Entrepreneurs: Unrestricted Grants to Allow Each Organization to Expand its Impact to Achieve Sustainable Change
- PRNewswire - March 11, 2008
- PALO ALTO, Calif., March 11 /PRNewswire-USNewswire/ -- The Skoll Foundation today announced Skoll Awards for Social Entrepreneurship for 11 organizations working around the world in the areas of tolerance and human rights, health, environmental sustainability, peace and security, and economic and social equity. The rec
- Totality of Available Data Reaffirms PROCRIT(R) (Epoetin alfa) Is Safe and Effective When Used Appropriately as Labeled to Treat Chemotherapy-Induced Anemia
- PRNewswire - March 11, 2008
- BRIDGEWATER, N.J., March 11 /PRNewswire/ -- The totality of scientific data submitted in recent months to the U.S. Food and Drug Administration ( FDA ) in preparation for the March 13th Oncologic Drugs Advisory Committee Meeting (ODAC) reaffirms that erythropoiesis-stimulating agents (ESAs) are safe and effective when
- Monogram Biosciences and Avexa Announce Exclusive Collaboration to Support New HIV Drug Discovery and Development Efforts: Monogram Assays to be used by Avexa to select patients and optimize background therapy in phase III program
- PRNewswire - March 10, 2008
- SOUTH SAN FRANCISCO, Calif., March 10 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc., (NASDAQ:MGRM) announced today that the Company has signed an agreement with AVEXA Limited to be the exclusive provider of HIV resistance and tropism testing technology in support of Avexa s drug discovery and development program
- "15by2015" - A Campaign to Strengthen Primary Healthcare Around the World
- PRNewswire - March 10, 2008
- LONDON, March 10 /PRNewswire/ -- Tanzania , 2007. A male patient is admitted to a hospital with pneumonia and possibly HIV. Due to staffing problems and improper handling, the patient is not seen for a week. Upon finally being seen, he is found to be HIV negative. Because he does not have HIV he has to pay for all expe
- Ortho Biotech Modifies Prescribing Information for PROCRIT(R) (Epoetin alfa): Label change based on data previously reported, communicated in late 2007
- PRNewswire - March 7, 2008
- BRIDGEWATER, N.J., March 7 /PRNewswire/ -- Ortho Biotech Products, L.P. today modified prescribing information for PROCRIT(R) (Epoetin alfa), following guidance from the U.S. Food and Drug Administration ( FDA ) to revise labeling for all drugs within the erythropoiesis-stimulating agent (ESA) class. Modifications
- Hagens Berman: Eleven Defendants Settle in Average Wholesale Price Litigation: Two major defendants - AstraZeneca and Bristol-Myers Squib - not part of settlement
- PRNewswire - March 7, 2008
- BOSTON, March 7 /PRNewswire/ -- Today eleven major pharmaceutical companies, including Abbott Laboratories (NYSE:ABT) and Watson Pharmaceuticals (NYSE:WPI), agreed to a $125 million nationwide settlement in the average wholesale price (AWP) litigation filed in 2002 by consumers and insurance companies, which claimed th
- NBC News Anchor Brian Williams Convenes Black Pastors for a 'DAY OF DIALOGUE': African American Pastors Gathered at NBC News World Headquarters to Discuss Issues Affecting the Black Community
- PRNewswire - March 7, 2008
- NEW YORK, March 7 /PRNewswire/ -- Five prominent African American pastors convened in New York City on Thursday, March 6 for a Day of Dialogue with NBC Nightly News Anchor and Managing Editor Brian Williams to draw the network s attention to key issues affecting the Black community. The pastors, including bishops Charl
- AANA Condemns Unsafe Injection Practices: Nurse anesthetists association entreats other healthcare professionals to work together to solve infection control problems that put patients at risk
- PRNewswire - March 6, 2008
- PARK RIDGE, Ill., March 6 /PRNewswire-USNewswire/ -- In a decisive response to recent incidents in Nevada and New York in which patients were infected with hepatitis C allegedly through the reuse of needles and syringes, the American Association of Nurse Anesthetists (AANA) today called on healthcare professionals acro
- Idenix Pharmaceuticals Reports Fourth Quarter and Year-End 2007 Financial Results
- PRNewswire - March 6, 2008
- CAMBRIDGE, Mass., March 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (Nasdaq: IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported unaudited financial results for the fourth quarter and year ended
- Anthem Blue Cross and Blue Shield Acts to Support Las Vegans Impacted by Endoscopy Center Practices
- PRNewswire - March 6, 2008
- -- $50,000 grant to the Nevada Health Centers to offer free testing to those requiring services -- Immediate Termination of Endoscopy Center of Nevada clinics -- Online information Available to Public LAS VEGAS, March 6 /PRNewswire/ -- Anthem Blue Cross and Blue Shield in Nevada announced today that the Anthem Blue Cro
- Annie Lennox Is Stepping Up and Singing Out in the 2008 'Sing' Campaign Against HIV/AIDS in South Africa and Around the World
- PRNewswire - March 6, 2008
- -- From Her Album Songs Of Mass Destruction, Sing Is An Anthem For National Women and Girls HIV/AIDS Awareness Day On March 10th NEW YORK, March 6 /PRNewswire/ -- For multi-platinum superstar Annie Lennox, one of pop music s leading voices in the fight against HIV/AIDS, this Monday brings her the opportunity to Sing o
- Founding Father of Modern Cosmetic Dermatology Seeks to Warn Public of Misrepresented Data and Inappropriate Use of Botox
- PRNewswire - March 6, 2008
- BEVERLY HILLS, Calif., March 6 /PRNewswire/ -- World-renowned dermatologist, Dr. Arnold Klein, is on a mission to inform the public about the dangers surrounding one of the most popular injectable cosmetic agents: Botox. According to Forbes.com, Botox is the second-most recognized prescription drug brand in the world b
- Religious Leaders Join The Balm In Gilead to Support The Big Coffee Project, to Help Fight HIV/AIDS in the United States and in Africa
- PRNewswire - March 6, 2008
- -- New Initiative Launched During the 19th Annual Black Church Week of Prayer for the Healing of AIDS, March 2-8, 2008 NEW YORK, March 6 /PRNewswire/ -- The Balm In Gilead introduced today, The Big Coffee Project, a partnership between The Balm In Gilead and Sweet Unity Farms Gourmet Coffee, a Tanzania-based company, t
- New Findings Support Alternatives to Pap Test: Simple, affordable cervical cancer exams may be the answer in developing world
- PRNewswire - March 5, 2008
- WASHINGTON, March 5 /PRNewswire/ -- The Alliance for Cervical Cancer Prevention (ACCP), a partnership of five international public health research organizations, today announced key findings and recommendations resulting from eight years of studies in more than 20 countries in Africa, Asia, and Latin America. At the to
- Hospital Testing for Drug-Resistant Infections Dramatically Lowers Mortality Rates and Costs
- PRNewswire - March 4, 2008
- -- New Study Shows Benefits in Patients Diagnosed with Staphylococcal, HIV, Tuberculosis and Other Infectious Diseases WASHINGTON, March 4 /PRNewswire-USNewswire/ -- Testing hospitalized patients for drug-resistant infections can reduce mortality, decrease length of stay and reduce cost of care, according to a new repo
- Nventa Evaluation Complete for First Three Cohorts in HspE7 Phase 1 Cervical Dysplasia Trial: HspE7 Well Tolerated; Fourth Cohort to be Dosed Shortly
- PRNewswire - March 3, 2008
- SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Nventa Biopharmaceuticals Corporation (TSX: NVN) today announced the completion of the safety and tolerability assessment of its third cohort of patients in a Phase 1 clinical trial of new HspE7 (HspE7 + Poly-ICLC) in patients with cervical intraepithelial neoplasia (CIN). T
- Gates Foundation Seeks Proposals for Innovative Global Health Research
- PRNewswire - March 3, 2008
- -- First round of Grand Challenges Explorations to support bold, unconventional ideas to fight infectious diseases SEATTLE, March 3 /PRNewswire/ -- The Bill & Melinda Gates Foundation announced today that beginning March 31, 2008, it will accept grant proposals for the first funding round of Grand Challenges Explor
- HUD Announces Free Homeownership Clinics in Prince George's County on March 5 to Help Families Keep Their Homes
- PRNewswire - March 3, 2008
- -- Lenders, counselors to be on hand to help first-time buyers and troubled homeowners WASHINGTON, March 3 /PRNewswire-USNewswire/ -- The U.S. Department of Housing and Urban Development and several partners are sponsoring free homeownership clinics at 2:00 p.m. and 5:00 p.m. at the Show Place Arena in Upper Marlboro,
- Catholic Bishops Welcome New Bill for Global HIV/AIDS Relief
- PRNewswire - March 3, 2008
- WASHINGTON, March 3 /PRNewswire-USNewswire/ -- The United States Conference of Catholic Bishops (USCCB) welcomes the House Committee on Foreign Affairs February 27 approval of a new, bipartisan bill to combat HIV/AIDS, tuberculosis and malaria. House debate is expected in March. Bishop Thomas G. Wenski of Orlando, Flor
- Gates Foundation Statement on House Committee Action on Global AIDS, TB, and Malaria
- PRNewswire - February 29, 2008
- SEATTLE, Feb. 29 /PRNewswire-USNewswire/ -- Dr. Tachi Yamada, president of the Bill & Melinda Gates Foundation s Global Health Program, released the following statement today on the passage of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorizatio
- USAID Implements Behavior Change and Social Marketing Program in Rwanda
- PRNewswire - February 29, 2008
- WASHINGTON, Feb. 29 /PRNewswire-USNewswire/ -- The American people, through the United States Agency for International Development (USAID) and a consortium of four partners, will assist in building the capacity of Rwandan institutions to implement HIV/AIDS prevention, malaria and child survival programs. The Behavior C
- African American Health Disparities: Increase Awareness During Black History Month
- PRNewswire - February 29, 2008
- WHAT: Health Disparities among African Americans when compared to other American citizens were first identified by W.E.B Du Bois in the 1800s. The distinct and often dramatic differences in health status persist in 2008. -- Heart Disease In 2004, the death rate for heart disease was about 30 percent higher for African
- USAID Implements Behavior Change and Social Marketing Program in Rwanda
- PRNewswire - February 29, 2008
- WASHINGTON, Feb. 29 /PRNewswire-USNewswire/ -- The American people, through the United States Agency for International Development (USAID) and a consortium of four partners, will assist in building the capacity of Rwandan institutions to implement HIV/AIDS prevention, malaria and child survival programs. The Behavior C
- PhRMA Applauds House Committee on Foreign Affairs Commitment to Continuing Efforts to Fight AIDS, Tuberculosis, and Malaria Epidemics
- PRNewswire - February 28, 2008
- WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President and CEO Billy Tauzin today released the following statement on the passage of the Tom Lantos and Henry J. Hyde United States Global Leadership Against HIV/AIDS, Tuberculosis and Malaria Reauthorization
- Test for Life Campaign Screens Record Number of DC Residents for HIV/AIDS
- PRNewswire - February 28, 2008
- -- More than 275 residents screened for HIV during three testing days in February WASHINGTON, Feb. 28 /PRNewswire-USNewswire/ -- During the month of February, Test for Life worked with the Washington Wizards, Congresswoman Eleanor Holmes Norton (D-DC), Mayor Adrian Fenty and Verizon Washington, DC to offer free and con
- The Female Health Company Receives USAID DELIVER PROJECT Order for 6.1 Million Units
- PRNewswire - February 28, 2008
- CHICAGO, Feb. 28 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC) announced it has received an order from John Snow, Inc., which implements the USAID | DELIVER PROJECT, for the delivery of 6.1 million female condoms (FC) for the United States Agency for International Development (USAID) programs. For
- Jaman Congratulates 'The Pussycat Preacher'
- PRNewswire - February 27, 2008
- -- Winner of Cinequest Film Festival Audience Favorite Award SAN MATEO, Calif., Feb. 27 /PRNewswire/ -- Jaman.com, the leading online destination for American international and independent entertainment, makes available today the controversial documentary The Pussycat Preacher, which won the Audience Favorite Award at
- Bipartisanship Trumps Liberal Agenda in PEPFAR Reauthorization
- PRNewswire - February 27, 2008
- WASHINGTON, Feb. 27 /PRNewswire-USNewswire/ -- Today, the U.S. House Foreign Affairs Committee passed by voice vote the reauthorization of PEPFAR, the U.S. Global Leadership Against HIV/AIDS, Tuberculosis, and Malaria Reauthorization of 2008. Tony Perkins, President of Family Research Council, released the following st
- NeurogesX Announces Preliminary Results from Second Phase 3 Clinical Trial in HIV-DSP: Primary and Secondary Endpoints Do Not Achieve Statistical Significance
- PRNewswire - February 27, 2008
- -- Company Affirms Plans to File NGX-4010 NDA in 2008 -- Schedules Investor Conference Call at 5:00 p.m. EST SAN MATEO, Calif., Feb. 27 /PRNewswire-FirstCall/ -- NeurogesX, Inc. (NASDAQ:NGSX), a biopharmaceutical company focused on developing and commercializing novel pain management therapies, today announced prelimin
- Catholics Reject Influence of US Bishops in Congressional HIV/AIDS Funding Battle
- PRNewswire - February 27, 2008
- WASHINGTON, Feb. 27 /PRNewswire-USNewswire/ -- As people of faith who believe in social justice, Catholics around the United States will be very disappointed with the influence the Catholics bishops invested in gutting practical, life-saving programs during the drafting of the Lantos/Hyde HIV/AIDS Global Leadership Act
- Implementers, Advocates, Researchers Call on Congress to Honor Lantos' Commitment to Public Health and Human Rights by Placing Evidence over Ideology
- PRNewswire - February 26, 2008
- WASHINGTON, Feb. 26 /PRNewswire-USNewswire/ -- On Wednesday, February 27, 2008 the House Foreign Affairs Committee will convene for the first time since the death of Chairman Tom Lantos to take up what Lantos himself referred to as the most important piece of legislation before the committee this year -- reauthorizatio
- Mayor Hula Hoops at City Council Meeting: NALA Honors Las Vegas Mayor Oscar Goodman for His Support of a New Playground
- PRNewswire - February 26, 2008
- LAS VEGAS, Feb. 26 /PRNewswire/ -- Mayor Oscar Goodman was honored by NALA, the Las Vegas social service agency, during a ceremonial session of the Las Vegas City Council meeting. NALA thanked Mayor Goodman for his support of their child care program and their playground fundraising efforts. Mayor Goodman was presented
- Nasal Vaccine for Smallpox Confers High Levels of Immunity Without Safety Risks
- PRNewswire - February 26, 2008
- -- Data published in February issue of Clinical and Vaccine Immunology ANN ARBOR, Mich., Feb. 26 /PRNewswire/ -- Scientists at NanoBio Corporation and the University of Michigan have demonstrated their nasally delivered vaccinia vaccine can protect animals against 77 times the potentially lethal dose of smallpox, and w
- Lilly and Partners In Health, Brigham and Women's Hospital Team Up to Fight MDR-TB in Former Soviet Republics
- PRNewswire - February 26, 2008
- -- The Eli Lilly and Company Foundation Provides $4 Million to Underwrite PIH/BWH Education and Training Programs in Countries that are Part of New WHO Report on Drug Resistant TB WASHINGTON, Feb. 26 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) and Partners In Health (PIH) today announced a series of mult
- Public Health Experts Argue for Integrated Services to Avert 7 Million HIV Infections by 2010
- PRNewswire - February 25, 2008
- BALTIMORE, Feb. 25 /PRNewswire-USNewswire/ -- Public health professionals argue changes are needed in health systems to scale up HIV prevention with a goal of averting 7 million HIV infections by 2010. Major strides are needed to reach this goal envisioned by the President s Emergency Plan for AIDS Relief (PEPFAR). The
- Michael Aram Supports The NAZ Foundation
- PRNewswire - February 25, 2008
- NEW YORK, Feb. 25 /PRNewswire-USNewswire/ -- Metalsmith Michael Aram will lend his support to another noteworthy cause, The Naz Foundation ( India ) Trust, when he opens up the doors to his flagship store on March 13th for a special benefit event. The Naz Foundation (India) Trust is a New Delhi based charity that was e
- GeoVax Vaccine Only 5th AIDS Vaccine Moving to Phase 2 Human Trials
- PRNewswire - February 25, 2008
- ATLANTA, Feb. 25 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), www.geovax.com, an Atlanta based biotechnology company, announced their HIV/AIDS vaccine is one of the select few to move forward into Phase 2a human trials by the HIV Vaccine Trials Network (HVTN), a network supported by the Natio
- 16th Annual Elton John AIDS Foundation Party Celebrating The Academy Awards Raises $5.1 Million
- PRNewswire - February 25, 2008
- -- Sir Elton John s Band Performed With Special Guests Mary J. Blige and Jakes Shears of Scissor Sisters LOS ANGELES, Feb. 25 /PRNewswire/ -- Sir Elton John and David Furnish hosted the 16th Annual Elton John AIDS Foundation (EJAF) Academy Awards(R) Viewing party. The event was held on Sunday, February 24, 2008 at the
- Ric Weiland Leaves $65 Million to Support Gay Rights and HIV/AIDS Organizations: Largest Single Bequest Ever to the Lesbian, Gay, Bisexual and Transgender (LGBT) Movement By Early Microsoft Employee
- PRNewswire - February 24, 2008
- -- Pride Foundation to Distribute Weiland s Groundbreaking Bequest SEATTLE, Feb. 24 /PRNewswire/ -- Pride Foundation of Seattle is honored to announce the establishment of a sizable new fund from the estate of Ric Weiland. Mr. Weiland s gift of $65 million is the largest single bequest ever to the lesbian, gay, bisexua
- AHF Sues L.A. Housing Dept. to Prevent Closure of AIDS Site: Former AIDS Hospice Now Serves as HIV/AIDS Care Hub
- PRNewswire - February 24, 2008
- LOS ANGELES, Feb. 24 /PRNewswire/ -- AIDS Healthcare Foundation (AHF) announced its filing of a lawsuit against the City of Los Angeles and the Los Angeles Housing Department (LAHD) for breach of contract and for a judicial determination regarding the validity of a years-old loan agreement between LAHD and AHF, the US
- Diageo Chateau & Estate Wines Renews Official Wine Sponsorship of Elton John Aids Foundation(R)
- PRNewswire - February 22, 2008
- -- Alliance Continues with Donation of Wine-themed Auction Lot and Unique 9L Collectors Wines for 80th Academy Awards(R) Viewing Party to Benefit EJAF NAPA, Calif., Feb. 22 /PRNewswire/ -- Diageo Chateau & Estate Wines Company, a leading producer of premium wines, and a sponsor of the Elton John Aids Foundation, wi
- Bishop T. D. Jakes Receives The Black Aids Institute 2008 Heroes in the Struggle Award: Mega Pastor's Mission to Eradicate AIDS Garners Recognition
- PRNewswire - February 21, 2008
- DALLAS, Feb. 21 /PRNewswire/ -- Each year, roughly 40,000 people in the United States are infected with HIV. In an effort to stop the spread of the disease, Bishop T. D. Jakes, senior pastor of The Potter s House of Dallas, has initiated HIV/AIDS prevention and awareness programs. For his continuous commitment to HIV/A
- Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
- PRNewswire - February 21, 2008
- BASINGSTOKE, England and PHILADELPHIA, February 21/PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY) the global specialty biopharmaceutical company announces results for the twelve months to December 31, 2007 - a year which has seen significant growth in launched products.
- StemCyte Presents Six Abstracts on the Applications of Plasma-Depleted Umbilical Cord Blood Stem Cell Products at BMT Tandem Meetings
- PRNewswire - February 21, 2008
- SAN DIEGO, Feb. 21 /PRNewswire/ -- The benefits of plasma-depleted cord blood stem cell products were the subjects of six abstracts presented this week by StemCyte, Inc. and collaborators at the Bone Marrow Transplant (BMT) Tandem Meetings in San Diego. The abstracts reported data obtained in both pediatric and adult p
- Gen-Probe Submits U.S. Regulatory Application for Additional Approval of PROCLEIX(R) ULTRIO(R) Blood Screening Assay
- PRNewswire - February 21, 2008
- SAN DIEGO, Feb. 21 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (NASDAQ:GPRO) has submitted to the U.S. Food and Drug Administration ( FDA ) a supplemental regulatory application for the additional use of the PROCLEIX(R) ULTRIO(R) assay to screen donated blood for the hepatitis B virus (HBV), the Company announced
- amfAR Announces Funding for HIV Services and Research Aimed at Men Who Have Sex With Men in Developing Countries
- PRNewswire - February 21, 2008
- -- More Than 100 Groups Apply for Grants to Assist Men Who Have Sex With Men in Developing Countries NEW YORK, Feb. 21 /PRNewswire-USNewswire/ -- In an ambitious move to significantly bolster global HIV program efforts targeting populations especially vulnerable to HIV, amfAR, The Foundation for AIDS Research, has anno
- Pharsight to Host Webinar on Hepatitis C Virus (HCV) and HIV Drug-Disease Modeling
- PRNewswire - February 20, 2008
- -- Dr. Bill Poland Will Discuss Best Practices in HCV and HIV Drug-Disease Modeling and Simulation to Support Clinical Drug Development Decision Making MOUNTAIN VIEW, Calif., Feb. 20 /PRNewswire-FirstCall/ -- Pharsight Corporation (NASDAQ:PHST), a leading provider of software, strategic consulting, and regulatory servi
- Breaking Down Barriers: A Woman's Path to Reducing HIV Stigma in the Arab American Community
- PRNewswire - February 20, 2008
- DEARBORN, Mich., Feb. 20 /PRNewswire-USNewswire/ -- HIV/AIDS is still a taboo topic among many Arab Americans, but one determined woman is working hard to change this. For Dinah Ayna, talking about HIV and addressing the stigma among the women in her community is a challenging, yet a rewarding part of her daily routine
- BET Networks Announces the Launch of BET in the UK
- PRNewswire - February 20, 2008
- -- Black Entertainment Television Delivers High Quality Programming, Including Top-Rated Shows 106 & PARK, American Gangster, College Hill and Meet the Faith, to British Audiences Beginning on Thursday, February 28 NEW YORK, Feb. 20 /PRNewswire/ -- BET Networks, a division of Viacom Inc. (NYSE:VIA)(NYSE:VIA.B), tod
- NYC Department of Health's 'Get Some NYC Condoms' Sends Wrong Message and Misuses Tax Dollars, says MIM President Bob Peters
- PRNewswire - February 20, 2008
- NEW YORK, Feb. 20 /PRNewswire/ -- On February 13, the NYC Department of Health unveiled a brand new look for the NYC Condom and launched a cutting- edge media campaign to encourage New Yorker s to get some. The Release said further that street teams would hand out free condoms at busy crossroads, that the campaign woul
- Young Athlete Aims to Break World Record: Running a Marathon on Seven Continents for Seven Charities
- PRNewswire - February 20, 2008
- NEW YORK, Feb. 20 /PRNewswire-USNewswire/ -- Erin Sprague (age 24) is in the running to become the youngest person in the world to complete a 26.2 mile marathon on all seven continents, including Antarctica . Erin has completed five out of seven marathons/continents, and will run next in Antarctica in March 2008.
- Randone Trasylol Lawsuit Profiled on CBS' '60 Minutes'
- PRNewswire - February 19, 2008
- NEW YORK, Feb. 19 /PRNewswire/ -- On November 5, 2007, under increasing government pressure, Bayer Pharmaceuticals Corporation said that it had halted worldwide sales of its drug Trasylol after a Canadian clinical study found the drug could be linked to a higher risk of death than other drugs. The Food and Drug Adminis
- Ready two Go(TM) Brings New Stylish FUN to Safer Sex
- PRNewswire - February 19, 2008
- -- The modernizer of stylish and discreet safer sex kits offers a design-forward, convenient way to put the FUN back into safer sex for everyone MINNEAPOLIS, Feb. 19 /PRNewswire/ -- Ready two Go(TM) has created a new line of stylish and discreet safer sex kits that allows you to be spontaneous and safe every time. The
- Disabled people reap the rewards of the Disability Discrimination Act
- PRNewswire - February 19, 2008
- London, 19 February/GNN/ -- DEPARTMENT FOR WORK AND PENSIONS News Release (ReferenceDRC-062) issued by The Government News Network on 19 February 2008 Public knowledge of the Disability Discrimination Act (DDA) increased significantly between 1996 and 2006, and according to new research released today, the Act has impr
- Remarks by President Bush and President Kikwete of Tanzania in Joint Press Availability
- PRNewswire - February 17, 2008
- WASHINGTON, Feb. 17 /PRNewswire-USNewswire/ -- The following is a transcript of remarks by President Bush and President Kikwete of Tanzania in a joint press conference: State House | Dar es Salaam, Tanzania | 10:29 A.M. (L) PRESIDENT KIKWETE: Mr. President, welcome. I stand before you with a deep sense of gratitude and
- Remarks by President Bush and President Yayi of Benin in Joint Press Availability
- PRNewswire - February 16, 2008
- WASHINGTON, Feb. 16 /PRNewswire-USNewswire/ -- The following is a transcript of remarks by President Bush and President Yayi of Benin in a joint press conference: Cadjehoun International Airport | Cotonou, Benin | 9:59 A.M. (Local) PRESIDENT YAYI: (As translated.) Ladies and gentlemen, journalists, on this day, Saturda
- Bush AIDS Legacy at Risk, Says AHF: President Praised for Creating PEPFAR; However, Proposed Changes in Priorities Cut Heart from Lifesaving Effort
- PRNewswire - February 16, 2008
- WASHINGTON, Feb. 16 /PRNewswire-USNewswire/ -- As President Bush begins a five-country tour of Africa to visit and highlight programs funded by the President s Emergency Plan for AIDS Relief (PEPFAR), the five year-old US global AIDS program which Congress created at his request, AIDS Healthcare Foundation (AHF) (http:
- Indevus Pharmaceuticals Provides Update on PRO 2000 Program
- PRNewswire - February 15, 2008
- LEXINGTON, Mass., Feb. 15 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today that they have been advised by the United Kingdom s Medical Research Council (MRC) that after review of data from the Phase III clinical trial of PRO 2000, the Company s candidate vaginal microbicide for HIV
- Leading National Patient Advocacy Group Delivers Warning to U.S. Patients: Having Health Insurance Does NOT Mean Your Medical Needs Will Be Covered
- PRNewswire - February 14, 2008
- -- Non-Profit Foundation Has Assisted Over 6 Million Americans Since Its Inception in 1996 With Rejected Insurance Claims and Coverage Denials NEWPORT NEWS, Va., Feb. 14 /PRNewswire-USNewswire/ -- The Patient Advocate Foundation (PAF) - a national non-profit organization providing information and services to millions o
- Pharmasset Reports First Fiscal Quarter 2008 Financial Results
- PRNewswire - February 14, 2008
- PRINCETON, N.J., Feb. 14 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS), a clinical stage pharmaceutical company committed to discovering, developing and commercializing novel drugs to treat viral infections, reported unaudited financial results for the first fiscal quarter of 2008 ended December 31, 2007. Ph
- Sanofi Pasteur and Statens Serum Institut Team Up Against Tuberculosis: Scientific Advances in Vaccine Research may Lead to Improved Vaccine Against Leading Cause of Death in Developing Countries
- PRNewswire - February 14, 2008
- LYON, France , February 14 /PRNewswire-FirstCall/ -- Sanofi pasteur, the vaccines division of the sanofi-aventis Group, announced today that it has signed a collaborative research and license agreement with the Statens Serum Institut of Denmark (SSI) for the development and marke
- Grammy Winner Common, MTV, and Kaiser Family Foundation Launch Lyrics Contest to Promote HIV Testing
- PRNewswire - February 14, 2008
- -- Young People Compete By Submitting Original Lyrics About the Importance of Getting Tested -- Common to Perform Winning Entry on MTV2, mtvU, and itsyoursexlife.com NEW YORK, Feb. 14 /PRNewswire-USNewswire/ -- Today, hip-hop artist and actor Common, in collaboration with It s Your (Sex) Life, a public information part
- AIDS Healthcare Foundation and NCHADS Partnership Adds 8th Cambodian AIDS Treatment Center in Kirivong
- PRNewswire - February 14, 2008
- PHNOM PENH, Cambodia , Feb. 14 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF), which operates free AIDS treatment clinics in the US, Africa, Latin America/Caribbean and Asia, is honored to announce the partnership between the Cambodian Government and AHF and the start of its collaborative AIDS treatment ce
- Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
- PRNewswire - February 12, 2008
- Company Records Strong Performance in 2007 and Notes Achievements over 4-year Period, Progressing with Integration of Organon BioSciences, Preparing for Challenges of 2008 KENILWORTH, N.J., Feb. 12 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today reported financial results for the 2007 fourth qua
- Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
- PRNewswire - February 11, 2008
- -- Data Shows Excellent Safety Profile and Long Lasting Immunity MCLEAN, Va., and BUDAPEST, Hungary , Feb. 11 /PRNewswire/ -- Genetic Immunity, a US/Hungarian clinical-stage biopharmaceutical company focusing on the development of its patented immunotherapeutic platform technology, announced clinical safety and immunog
- Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test: New Agreement Provides for Development and Promotion of OraQuick(R) HCV Test Outside the United States
- PRNewswire - February 11, 2008
- KENILWORTH, N.J., and BETHLEHEM, Pa., Feb. 11 /PRNewswire/ -- Schering- Plough Corporation (NYSE:SGP) and OraSure Technologies, Inc. (NASDAQ:OSUR) today announced an agreement to collaborate on the development and promotion of a rapid oral hepatitis C virus (HCV) test utilizing OraSure Technologies OraQuick(R) technolo
- AIDS Healthcare Foundation Shares World Bank, Global Fund Concerns Over Alleged Corruption at India's NACO: Call on the Prime Minister to Restore the People's Faith in the Government AIDS System
- PRNewswire - February 9, 2008
- NEW DELHI, Feb. 9 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) and AHF/ India Cares today announced its strong support for a Global Fund to Fight AIDS, Tuberculosis and Malaria (GFATM) call for an independent inquiry into allegations made by the World Bank (WB) concerning the second phase of National AID
- Monogram Announces 2007 Year-End Financial Results
- PRNewswire - February 7, 2008
- 34% Year to Year Growth drives Fourth Quarter Revenue to Record Level - Conference call today at 4:30 p.m. ET SOUTH SAN FRANCISCO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (NASDAQ:MGRM) today reported financial results for the quarter and year ended December 31, 2007. The Company had revenue
- Congress Poised to Reauthorize Legislation Aimed at Dramatic Expansion of Global HIV and AIDS Programs
- PRNewswire - February 7, 2008
- -- Draft bill corrects flaws in existing policy; Legislation has overwhelming support of large global AIDS coalition WASHINGTON, Feb. 7 /PRNewswire-USNewswire/ -- Next week, the House Committee on Foreign Affairs will mark up the U.S. Global HIV/AIDS, Tuberculosis, and Malaria Reauthorization Act of 2008 - funding prog
- New 48-Week Efficacy and Safety Data Presented for INTELENCE(TM) (etravirine) as Part of HIV Combination Therapy
- PRNewswire - February 7, 2008
- BRIDGEWATER, N.J., Feb. 7 /PRNewswire/ -- New data showed that at 48 weeks, significantly more treatment-experienced adults with HIV-1 with documented resistance to non-nucleoside reverse transcriptase inhibitors (NNRTIs) and protease inhibitors (PIs) had an undetectable viral load (defined as less than 50 HIV-1 RNA co
- GeoVax Labs, Inc.'s Promising HIV/AIDS Vaccine Trial Data Presented at Retrovirus Conference: Planning for Phase 2 is Underway
- PRNewswire - February 7, 2008
- ATLANTA, Feb. 7 /PRNewswire-FirstCall/ -- Dr. Harriet Robinson, lead scientist and co-founder of GeoVax Labs, Inc., (OTC Bulletin Board: GOVX) an Atlanta-based biotechnology company developing HIV/AIDS vaccines, co-presented successful Phase I trial results at the 15th Conference on Retroviruses and Opportunistic Infec
- Beating to the Drum of Safe Sex: In Honor of National Condom Week, Legendary Rock and Roll Hall of Famer, Marky Ramone of the world-famous Ramones Debuts Signature Series of Safer Sex Kits to Help Prevent STD's
- PRNewswire - February 7, 2008
- NEW YORK, Feb. 7 /PRNewswire/ -- The American Social Health Association (ASHA) recognizes National Condom Week as February 10-16, 2008, reminding the public that safer sex practices have never been more critical. Despite hundreds of millions of tax dollars spent on abstinence-only education programs, each year in the
- FRC Urges Rejection of Lantos Bill That Funds International Abortionists
- PRNewswire - February 7, 2008
- WASHINGTON, Feb. 7 /PRNewswire-USNewswire/ -- Next week, the House Committee on Foreign Relations will consider the renewal of the President s Emergency Plan for AIDS Relief (PEPFAR). Family Research Council (FRC) President Tony Perkins released the following statement opposing on multiple grounds the draft bill by Rep
- Indevus Pharmaceuticals Announces First Quarter Fiscal 2008 Financial Results
- PRNewswire - February 7, 2008
- LEXINGTON, Mass., Feb. 7 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) today announced its consolidated results of operations for the first quarter of fiscal 2008, ended December 31, 2007. The Company will host a conference call and webcast today beginning at 9:00 am eastern time (details follo
- Data Presented on Monogram HIV Tropism Tests at Retrovirus Conference sets New Standards of Assay Sensitivity
- PRNewswire - February 7, 2008
- -- Company Continues to Lead Tropism Testing Field SOUTH SAN FRANCISCO, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc (NASDAQ:MGRM) today announced that data related to the company s advanced HIV tropism assay have been presented as multiple posters during the 15th Conference on Retroviruses and Op
- Ardea Biosciences Presents Preclinical Data Demonstrating Favorable Resistance Profiles for Non-Nucleoside Reverse Transcriptase Inhibitors for the Treatment of Human Immunodeficiency Virus
- PRNewswire - February 7, 2008
- BOSTON and CARLSBAD, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that data was presented demonstrating the potent activity of the Company s non-nucleoside reverse transcriptase inhibitor (NNRTI) family of compounds against the human-immunodeficiency virus (HIV), the kn
- Vestergaard Frandsen Announces Launch of LifeStraw(R) Family: Instant Microbiological Purifier Provides Homemade Drinking Water with 'Potential to Save Lives and Reduce Suffering on a Massive Scale'
- PRNewswire - February 7, 2008
- WASHINGTON, Feb. 7 /PRNewswire/ -- Vestergaard Frandsen, a European company developing and selling disease control textiles, today announced the launch of LifeStraw(R) Family, a new point-of-use product designed to allow consumers in the developing world to create safe and healthy homemade drinking water. I am thrilled
- AIDS Action Committee Offers and Supports Variety of Events to Honor National Black HIV/AIDS Awareness Day
- PRNewswire - February 7, 2008
- -- Hosts Lunch Forum at HQ, Offers Expanded Hours for Rapid HIV Testing and 2 Film Screenings by MALE Center and Joins Healing Our Land, Inc. and Mass. Black Legislative Caucus on Disparities Panel at Roxbury Comm. College BOSTON, Feb. 7 /PRNewswire-USNewswire/ -- To commemorate the nation s eighth recognition of Natio
- Amigos y Amantes, Valentine's Day-Themed Art Auction to Benefit AIDS Healthcare Foundation's Mexico Clinics
- PRNewswire - February 7, 2008
- LOS ANGELES, Feb. 7 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) is proud to present the 2nd annual Amigos y Amantes (Friends and Lovers), an art exhibition and auction to benefit its free HIV/AIDS treatment, care and prevention services in Mexico — in Tijuana, Puerto Vallarta, Cancun and Chiapas. Showca
- Vicriviroc Demonstrates Potent and Sustained Viral Suppression Through 48 Weeks of Therapy in Treatment-Experienced HIV-Infected Patients
- PRNewswire - February 6, 2008
- -- Results of VICTOR-E1 Phase II Study Presented at 15th Conference on Retroviruses and Opportunistic Infections (CROI) BOSTON, Feb. 6 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE:SGP) today reported that final results of a Phase II clinical study showed vicriviroc, its investigational CCR5 antagonist, d
- VIRxSYS Announces Interim Results from VRX496 Gene Therapy Phase II Trial: Disease Altering Treatment Shows Ability to Prevent HIV from Replicating
- PRNewswire - February 6, 2008
- GAITHERSBURG, Md., Feb. 6 /PRNewswire/ -- VIRxSYS Corporation, a privately held company developing gene therapies for HIV and genetic diseases, presented results from its Phase II trial of VRX496, a gene therapy for the treatment of AIDS, at the 2008 Annual Conference on Retroviruses and Opportunistic Infections (CROI)
- CASTLE Study Showed Similar Efficacy Between Once-Daily REYATAZ(R) (atazanavir sulfate)/ritonavir and Twice-Daily lopinavir/ritonavir at 48 Weeks in Previously Untreated HIV-Infected Adult Patients
- PRNewswire - February 6, 2008
- -- Data also showed differences in gastrointestinal and lipid effects between REYATAZ/ ritonavir and lopinavir /ritonavir among study population PRINCETON, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Bristol-Myers Squibb Company (NYSE:BMY) today announced results from the CAST
- IDX899 Demonstrates Rapid and Profound Inhibition of HIV Replication in a Phase I/II Clinical Trial in Treatment-Naive HIV-Infected Patients
- PRNewswire - February 6, 2008
- CAMBRIDGE, Mass., Feb. 6 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today reported data for IDX899, a non-nucleoside reverse transcriptase inhibitor (N
- PRI Condemns PEPFAR Amendments
- PRNewswire - February 6, 2008
- FRONT ROYAL, Va., Feb. 6 /PRNewswire-USNewswire/ -- Population Research Institute has joined other pro-life groups in condemning amendments to the President s Emergency Plan for AIDS Relief (PEPFAR). PEPFAR is up for reauthorization on Thursday, February 14, 2008, in the House Foreign Affairs Committee. According to PR
- The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
- PRNewswire - February 6, 2008
- CHICAGO, Feb. 6 /PRNewswire-FirstCall/ -- The Female Health Company (Amex: FHC) today announced that the Food and Drug Administration ( FDA ) has determined that the Premarket Approval Application (PMA) it submitted for its second generation product, FC2 female condom, has been accepted for review. The Center for Devi
- Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
- PRNewswire - February 6, 2008
- -- Study concludes there was no evidence of the development of viral resistance to R7128 after 2 weeks of monotherapy in hepatitis C patients PRINCETON, N.J., Feb. 6 /PRNewswire-FirstCall/ -- Pharmasset (NASDAQ:VRUS) and Roche will present the R7128 monotherapy resistance profile at the EASL-AASLD-APASL-ALEH-IASL Confe
- Gucci and Madonna Host 'A NIGHT TO BENEFIT RAISING MALAWI AND UNICEF'
- PRNewswire - February 6, 2008
- -- SPECIAL PERFORMANCES BY ALICIA KEYS, TIMBALAND AND RIHANNA -- Event Satellite Feed to North America, Europe and Asia Pacific OR for Downloadable Video, Pictures & Text, Visit the Following Multi-Media News Release URL: http://dogmatic.com/MNR/GucciMadonna What: Wednesday February 6th, at The North Lawn of the Un
- Opportunity International's Micro Insurance Agency to Develop and Provide Life, Health and Crop Insurance for 21 Million Poor People
- PRNewswire - February 6, 2008
- -- $24.2 million in new funding from the Bill & Melinda Gates Foundation to help agency expand services in 11 new countries OAK BROOK, Ill., Feb. 6 /PRNewswire-USNewswire/ -- Opportunity International, one of the world s largest microfinance organizations, today announced it has received a $24.2 million grant from
- Congresswoman Norton, Mayor Fenty, Verizon and the Washington Wizards Join the Test for Life Campaign to Encourage HIV Screenings in DC: Groups come together for National Black HIV/AIDS Awareness Day this Thursday
- PRNewswire - February 5, 2008
- WASHINGTON, Feb. 5 /PRNewswire-USNewswire/ -- In coordination with National Black HIV/AIDS Awareness Day this Thursday, February 7, Congresswoman Eleanor Holmes Norton (D-DC), Mayor Adrian Fenty, the Washington Wizards and Verizon Washington, DC have teamed up with the Test for Life campaign to provide free and confide
- Sangamo BioSciences Reports 2007 Fourth Quarter and Year-End Financial Results
- PRNewswire - February 5, 2008
- -- Company Ends Year with Cash and Investments of $81.4 Million RICHMOND, Calif., Feb. 5 /PRNewswire-FirstCall/ -- Sangamo BioSciences, Inc. (Nasdaq: SGMO) today reported 2007 fourth quarter and year-end financial results and accomplishments and provided an outlook for 2008. For the fourth quarter ended December 31, 20
- 4SC and AiCuris Begin Collaboration for the Discovery of Anti-Infective Drug Candidates
- PRNewswire - February 5, 2008
- PLANEGG-MARTINSRIED, Germany , February 5/PRNewswire-FirstCall/ -- The Martinsried drug discovery and development company 4SC AG (Frankfurt, Prime Standard: VSC) and the Wuppertal-based AiCuris GmbH & Co KG today announced that they have entered into a research collaboration. The long-term goal of this collaboratio
- We All Walk In Different Shoes: 25 Years of Non-Uniform Thinking
- PRNewswire - February 5, 2008
- NEW YORK, Feb. 5 /PRNewswire-FirstCall/ -- To kick off the company s 25th anniversary, Kenneth Cole has created a provocative Spring 2008 fashion campaign by replacing stereotypical models with bold, unexpected people of substance. The campaign is comprised of a series of 11 emotionally arresting photographs that celeb
- President's FY09 Budget - A Disaster for Domestic AIDS: Congress Must Fund Critical Healthcare Priorities
- PRNewswire - February 4, 2008
- WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- Congress must reject President Bush s Fiscal Year 2009 budget in order to address the critical health needs of the over 1.1 million people living with HIV/AIDS in the United States , commented Dr. Gene Copello, Executive Director of The AIDS Institute. Most of the people w
- AIDS Action Calls President's FY 2009 Budget Request Shameful
- PRNewswire - February 4, 2008
- WASHINGTON, Feb. 4 /PRNewswire-USNewswire/ -- In President Bush s last State of the Union Address, he referred to the administration s unfinished business. One week later, it is clear from the President s FY 2009 Budget Request that the unfinished business of this administration includes a complete failure to address t
- AAHIVM Encouraged by TMC125 Approval: New HIV Medication Could Offer More Options for Treatment-Experienced Patients
- PRNewswire - February 4, 2008
- WASHINGTON, Feb. 4 /PRNewswire/ -- The American Academy of HIV Medicine (AAHIVM), a national organization of HIV-treating physicians, nurse practitioners and physician assistants, praised the accelerated U.S. Food and Drug Administration ( FDA ) approval of the anti-HIV medication TMC125 (etravirine), the first non-nuc
- DHHS Guidelines Support Use of Trofile(TM) Assay Prior to CCR5 Inhibitor Use
- PRNewswire - February 4, 2008
- SOUTH SAN FRANCISCO, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Monogram Biosciences, Inc. (Nasdaq: MGRM) today announced that guidelines issued by the Department of Health and Human Services (DHHS) recommend that a co-receptor tropism test, such as Monogram s Trofile(TM) assay, should be performed whenever the use of a
- Dr. Harriet Robinson Joins GeoVax Team as V.P. of R & D to Accelerate AIDS Vaccine Trials Program
- PRNewswire - February 4, 2008
- ATLANTA, Feb. 4 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (OTC Bulletin Board: GOVX), http://www.geovax.com, an Atlanta based biotechnology company, announced the addition of company co-founder Dr. Harriet Robinson to its staff as Vice President of Research & Development. Dr. Robinson is known worldwide for her o
- Ardea Biosciences Establishes Scientific Advisory Board for HIV Program
- PRNewswire - February 4, 2008
- CARLSBAD, Calif., Feb. 4 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced the formation of a human immunodeficiency virus (HIV) Scientific Advisory Board (SAB) with the appointment of seven members, chaired by David D. Ho, M.D. The SAB will provide independent scientific advice and counse
- 'Sex & the City' Gets Serious About HIV and AIDS in South Africa - Kristin Davis Helps Oxfam Break the Stigma and Close the Treatment Gaps Fuelling AIDS
- PRNewswire - February 1, 2008
- JOHANNESBURG, South Africa , Feb. 1 /PRNewswire/ -- Kristin Davis, star of US hit TV show Sex & the City, will join with Oxfam and leading AIDS activists at a Johannesburg press conference tomorrow, Saturday, February 2, to support community efforts in addressing the HIV and AIDS epidemic in South Africa. Krist
- Genetic Immunity Announces the Appointment of Richard B. Pollard, M.D. as Chief Medical Officer
- PRNewswire - February 1, 2008
- -- Dr. Pollard Brings the Highest Level of Clinical Immunology Expertise MCLEAN, Va. and BUDAPEST, Hungary , Feb. 1 /PRNewswire/ -- Genetic Immunity(R), a US/Hungarian clinical-stage biopharmaceutical company focused on the development and commercialization of its patented immunotherapeutic platform technology, announc
- Bristol-Myers Squibb Company Reports Financial Results for the Fourth Quarter and Twelve Months of 2007
- PRNewswire - January 31, 2008
- -- Posts 33% Sales Growth from Continuing Operations in the Fourth Quarter 2007 -- Revises 2008 EPS Guidance Primarily to Reflect the Sale of Medical Imaging -- Reaffirms Expected Non-GAAP EPS CAGR of at least 15% from 2007 Base Through 2010, Subject to Certain Assumptions -- Completes Sale of Medical Imaging Business,
- West Hollywood: AHF Hosts Grand Opening of HIV/AIDS Pharmacy that Benefits AIDS Patients Worldwide
- PRNewswire - January 31, 2008
- -- Adjacent to AHF s Popular Out of the Closet Thrift Store, Non-profit AHF Pharmacy Offers HIV/AIDS Expertise, Free HIV Testing and the Chance to Make a Difference -- Grand Opening Event to Include Ribbon-Cutting Ceremony, Free HIV Testing LOS ANGELES, Jan. 31 /PRNewswire-USNewswire/ -- This Saturday, February 2nd at
- Internationally-Acclaimed Director Mira Nair Delivers AIDS Jaago Film Project to Global Audience on Jaman
- PRNewswire - January 31, 2008
- SAN MATEO, Calif., Jan. 31 /PRNewswire/ -- Jaman.com, the leading online destination for quality international and independent entertainment, today announced the free, global availability of Mira Nair s AIDS Jaago, four short dramatic films which aim to dismantle myths and raise awareness about HIV/AIDS. The AIDS Jaago
- Research Using Thermo Fisher Scientific RNA-Interference Technology Unveils Potential New Targets for HIV Drugs
- PRNewswire - January 31, 2008
- -- Harvard Medical School Researchers Used Thermo Scientific Dharmacon siRNA to Identify 273 Human Proteins Needed for Reproduction of the Virus that Causes AIDS WALTHAM, Mass., Jan. 31 /PRNewswire-FirstCall/ -- Thermo Fisher Scientific Inc., the world leader in serving science, announced today that its RNA-interferenc
- Tibotec Pharmaceuticals a Respectful Partner to HIV Community in Pricing of Novel New HIV NNRTI, INTELENCE
- PRNewswire - January 31, 2008
- WASHINGTON, Jan. 31 /PRNewswire/ -- The FDA approved Tibotec Pharmaceutical s novel non-nucleoside reverse transcriptase inhibitor (NNRTI) INTELENCE(R). The company also announced introductory pricing for the eagerly anticipated new compound at $21.80 per day, substantially lower than other recently introduced antiretr
- ADVENTRX to Present ANX-201 Preclinical Data at Keystone Symposia HIV Pathogenesis Conference
- PRNewswire - January 31, 2008
- SAN DIEGO, Jan. 31 /PRNewswire-FirstCall/ -- ADVENTRX Pharmaceuticals, Inc. (AMEX:ANX), announced today that data from preclinical studies of ANX-201, the Company s broad spectrum antiviral product candidate, has been accepted for presentation at the Keystone Symposia HIV Pathogenesis Conference, which takes place Marc
- Newly Approved HIV Drug Shows Great Promise: Pricing Level Should Improve Access
- PRNewswire - January 30, 2008
- WASHINGTON, Jan. 30 /PRNewswire/ -- The AIDS Institute, a national public policy research, advocacy, and education organization, is encouraged with the FDA s approval of the first new non-nucleoside reverse transcriptase inhibitor (NNRTI) in nearly a decade. TMC125/etravirine was developed by Tibotec Pharmaceuticals, L
- Breaking the Silence Around HIV in African American Communities
- PRNewswire - January 30, 2008
- WASHINGTON, Jan. 30 /PRNewswire-USNewswire/ -- The 10-year-old African American girl with HIV sat beaming in front of the doctor at the Yale Health Clinic. She made an unforgettable impression on Dr. Garth Graham, a medical student at the time and now the head of the Office of Minority Health (OMH) at the U.S. Departme
- New Patent Awarded for Antigen-Sparing Vaccines that Elicit Robust Immunity
- PRNewswire - January 30, 2008
- ANN ARBOR, Mich., Jan. 30 /PRNewswire/ -- A needle-free vaccine platform that elicits a robust immune response against a wide array of viruses and bacteria has been awarded a U.S. patent. The University of Michigan holds the patent and NanoBio Corporation, a spin-off from the university, licenses the patent and its ass
- IPM Reaches Landmark Agreement with Pfizer to Develop FDA-Approved Antiretroviral Drug as Vaginal Microbicide
- PRNewswire - January 30, 2008
- SILVER SPRING, Md., Jan. 30 /PRNewswire-USNewswire/ - Expanding the pipeline of HIV prevention tools in development, the International Partnership for Microbicides (IPM) today announced that Pfizer Inc. (Pfizer) has agreed to give IPM a royalty-free license to maraviroc, its newly-approved HIV treatment, as a microbici
- Ardea Biosciences to Present Preclinical Data on Three HIV Non-Nucleoside Reverse Transcriptase Inhibitors During 15th Annual Conference on Retroviruses and Opportunistic Infections
- PRNewswire - January 29, 2008
- -- Activity data on lead NNRTI, RDEA806, and next generation compounds to be discussed CARLSBAD, Calif., Jan. 29 /PRNewswire-FirstCall/ -- Ardea Biosciences, Inc. (NASDAQ:RDEA) today announced that preclinical data on the Company s non-nucleoside reverse transcriptase inhibitor (NNRTI) family of compounds, including RD
- New Report Provides Information on HIV Prevalence in the U.S. Household Population
- PRNewswire - January 29, 2008
- PRNewswire-USNewswire - Jan. 29/ -- Approximately half of 1 percent (0.47 percent) of the U.S. household population between the ages of 18 and 49 are living with HIV, according to estimates from CDC s National Center for Health Statistics (NCHS) based on surveys conducted between 1999-2006. The findings are summarized
- Profectus BioSciences Inc. Names Shawn Patrick O'Brien CEO: New leadership brings biotech and large pharma experience to lead commercialization phase for a leading AIDS/HIV R&D company
- PRNewswire - January 28, 2008
- BALTIMORE, Jan. 28 /PRNewswire/ -- Profectus BioSciences Inc., a biotechnology company that develops preventative and therapeutic technologies to reduce the morbidity and mortality of viral diseases, today announced that its board of directors has appointed Shawn Patrick O Brien as the company s president and chief exe
- WebTribes Offers Online Home for Those with Illnesses
- PRNewswire - January 28, 2008
- LOS ANGELES, Jan. 28 /PRNewswire/ -- It s a fact of life that everyone has problems. But, unfortunately, some people have much larger, more complex problems than others. Those with mental illness, addiction, or HIV/AIDS often face challenges that those who have never battled such problems simply don t understand. Deali
- Abbott's Kaletra(R) and Aluvia(R) (lopinavir/ritonavir) New Lower-Strength Tablet for Pediatric Use Receives Positive Opinion from EMEA: Lopinavir/ritonavir tablet is the first and only co-formulated protease inhibitor tablet approved for use in children with HIV
- PRNewswire - January 28, 2008
- ABBOTT PARK, Ill., Jan. 28 /PRNewswire/ -- Abbott (NYSE:ABT) announced today that the European Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has issued a positive opinion recommending approval of a new, lower-strength tablet formulation of the c
- New Initiative Launched to Anticipate Future of AIDS
- PRNewswire - January 28, 2008
- NEW YORK, Jan. 28 /PRNewswire/ -- Government, business, civic and public health leaders attending the World Economic Forum in Davos, Switzerland announced the creation of aids2031, a global initiative dedicated to taking a critical look at what we need to do now in order to change the face of AIDS by 2031. The year 20
- Harm of Abstinence-Only Programs in U.S. and Abroad Subject of Panel Discussion at Two Maine College Campuses: Leading Advocates for Women's Health and Rights call for an End to Government Funding for Failed Abstinence-Only Programs
- PRNewswire - January 28, 2008
- NEW YORK, Jan. 28 /PRNewswire/ -- Legal Momentum, in partnership with the Sexuality Information and Education Council of the United States (SIECUS) and the Center for Health and Gender Equity (CHANGE), will hold panel discussions at Bowdoin College (January 29) and at the University of Southern Maine Portland campus (J
- The First Ever National Latino Hispanic AIDS Leadership Summit in Washington, D.C. Will Be Held January 29-30, 2008
- PRNewswire - January 28, 2008
- -- Our time is now, united we can! Es nuestro momento, unidos podemos! On January 29-30, 2008 in Washington, D.C. a broad and diverse group of Latino leaders working in HIV/AIDS across the United States , Puerto Rico and U.S. Virgin Islands will be coming together to adopt the Latino Hispanic
- Sir Elton John and David Furnish to Host 16th Annual Party Celebrating The Academy Awards(R) Benefiting the Elton John Aids Foundation
- PRNewswire - January 24, 2008
- -- This Year s Co-Sponsors are Chopard and VH1 LOS ANGELES, Jan. 24 /PRNewswire/ -- The 16th Annual Elton John AIDS Foundation (EJAF) Academy Awards(R) Viewing Party hosted by Sir Elton John and David Furnish will be held Sunday, February 24, 2008 at the Pacific Design Center and will be co-sponsored by Chopard and VH1
- New Study Finds Television Stations Donate an Average of 17 Seconds an Hour to Public Service Advertising
- PRNewswire - January 24, 2008
- -- Nearly Half (46%) of All PSAs Air After Midnight WASHINGTON, Jan. 24 /PRNewswire-USNewswire/ -- While the media environment is evolving rapidly, television continues to be the dominant medium used by the American public. TV advertising is therefore still a core component of most major public service campaigns, on to
- Alonzo Mourning and Earvin 'Magic' Johnson Host 4th Annual 'Boost Mobile Zo & Magic's 8-Ball Challenge', Presented By G2 From The Makers Of Gatorade With Returning Host Chris 'Ludacris' Bridges
- PRNewswire - January 24, 2008
- -- Star-Studded Competitive Pool Tournament Benefits Youth and the New Orleans Community Through Alonzo Mourning Charities & The Magic Johnson Foundation NEW ORLEANS, Jan. 24 /PRNewswire/ -- On Thursday, February 14, 2008, the hottest showdown of stars on and off the court will take place at The Sugar Mill during t
- United States Gives $12 Million to Pediatric AIDS Foundation Initiative
- PRNewswire - January 24, 2008
- HARARE, Zimbabwe , Jan. 24 /PRNewswire-USNewswire/ -- The American people, through the United States Agency for International Development (USAID) launched a new $12.5 million HIV/AIDS initiative in Zimbabwe. The initiative, expected to dramatically increase access for women and children to vital HIV prevention services
- AIDS Healthcare Foundation Hosts Grand Opening of Wilton Manors 'Out of the Closet' & 'AHF Pharmacy': Funds Raised Will Benefit HIV/AIDS Patients in Broward County and Statewide
- PRNewswire - January 24, 2008
- -- Community Open House to Include Ribbon-Cutting Ceremony, Refreshments, Free HIV Testing FT. LAUDERDALE, Fla., Jan. 24 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) will mark the opening of its newest Out of the Closet thrift store and AHF Pharmacy location with a grand opening event on-site at 2097 Wil
- Nine Miami Defendants in Strike Force Cases Sentenced for $56.5 Million in Medicare Fraud
- PRNewswire - January 23, 2008
- WASHINGTON, Jan. 23 /PRNewswire-USNewswire/ -- Assistant Attorney General Alice S. Fisher of the Criminal Division and U.S. Attorney R. Alexander Acosta of the Southern District of Florida announced today that owners of nine separate Miami-based health care corporations have been sentenced to prison terms within the pa
- U.S. Patent Office Rejects Key HIV/AIDS Drug Patents at PUBPAT Request: Government Finds Prior Art Submitted By PUBPAT Invalidates All of Gilead Sciences' Claims
- PRNewswire - January 23, 2008
- NEW YORK, Jan. 23 /PRNewswire-USNewswire/ -- The Public Patent Foundation ( PUBPAT ) announced today that the U.S. Patent & Trademark Office has rejected four key HIV/AIDS drug patents held by Gilead Sciences that relate to the drug known generically as tenofovir disoproxil fumarate
- New Web-Based Soap Opera About Sex Lives of Gay Men Makes HIV Prevention/Education More Interactive, Accessible
- PRNewswire - January 23, 2008
- -- L.A. Gay & Lesbian Center Blends Entertainment with Education and Online Discussion Forum to Stimulate Safer Sex Discussions LOS ANGELES, Jan. 23 /PRNewswire-USNewswire/ -- Five young gay guys, living together in an apartment complex where they all face decisions about their sex lives, sounds like the descriptio
- Ten Extraordinary Innovations Line Up For US $100,000 Saatchi & Saatchi Award For World Changing Ideas
- PRNewswire - January 22, 2008
- -- Edward de Bono, Peter Gabriel, HRH Prince Hassan, Malcolm McLaren, Carolyn Porco and Philippe Starck on judging panel NEW YORK, Jan. 22 /PRNewswire/ -- Bob Isherwood, Worldwide Creative Director of Saatchi & Saatchi, today announces the contenders to win the fifth Saatchi & Saatchi Award For World Changing I
- FDA Approves INTELENCE(TM) (etravirine) for HIV Combination Therapy: INTELENCE is the first NNRTI to show antiviral activity in patients with NNRTI-resistant virus
- PRNewswire - January 21, 2008
- BRIDGEWATER, N.J., Jan. 21 /PRNewswire/ -- The U.S. Food and Drug Administration ( FDA ) has granted accelerated approval to the anti-HIV medication INTELENCE (etravirine) tablets -- the first non-nucleoside reverse transcriptase inhibitor (NNRTI) to show antiviral activity in treatment- experienced adult patients with
- Fair Pricing Coalition Lauds Pricing of New Tibotec Drug
- PRNewswire - January 21, 2008
- SAN FRANCISCO and BALTIMORE, Jan. 21 /PRNewswire/ -- The Fair Pricing Coalition (FPC), an ad-hoc community based group that works to constrain the price of drugs for HIV and HCV, today announced its support for the approval and announced price of Tibotec s new drug Intelence (etravirine). The drug is an important and e
- THURSDAY, FEBRUARY 7th IS NATIONAL BLACK HIV/AIDS AWARENESS DAY AFRICAN AMERICANS EVERYWHERE ARE URGED TO GET TESTED FOR HIV
- PRNewswire - January 21, 2008
- ADDITIONAL RESOURCES: Audio, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/31285/press.html NEW YORK, January 21 /PRNewswire/ -- THIS REPORT BROUGHT TO YOU BY GILEAD SCIENCES. THE AIDS EPIDEMIC IS ONE OF THE GREATEST CHALLENGES FACING THE AFRICAN AMERICAN COMMUNITY.
- 41 Million Strong Campaign Goes to Congressional Black Caucus Debates in South Carolina: Women of color unite to raise awareness about and demand an end to Violence Against Women and HIV/AIDS
- PRNewswire - January 18, 2008
- WASHINGTON, Jan. 18 /PRNewswire-USNewswire/ -- The following was released today by ActionAid International USA: What: Women of Color United delegates, representing organizations with over 50,000 members nationwide, gather at the Congressional Black Caucus-sponsored Presidential debates in South Carolina to demand an en
- Abbott Announces Approval of First Fully Automated Blood Screening Test for HTLV-I/HTLV-II
- PRNewswire - January 18, 2008
- ABBOTT PARK, Ill., Jan. 18 /PRNewswire-FirstCall/ -- Abbott (NYSE:ABT) announced today it received approval from the U.S. Food and Drug Administration for its fully automated HTLV-I/HTLV-II blood screening test for use on the ABBOTT PRISM instrument. The test is intended for use by laboratories to screen individual don
- Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
- PRNewswire - January 17, 2008
- FLINT, Mich., Jan. 17 /PRNewswire/ -- Diplomat Specialty Pharmacy, one of the largest privately owned national specialty pharmacies, announced today that it has entered into an agreement with Genzyme Corporation to administer their 2008 Renagel Medicare Part D Assistance Program. Genzyme is one the world s largest biot
- GeoVax Labs, Inc. Selected by Georgia Bio as '2008 Deal of the Year' Award Winner in Life Sciences Industry
- PRNewswire - January 17, 2008
- ATLANTA, Jan. 17 /PRNewswire-FirstCall/ -- GeoVax Labs, Inc. (BULLETIN BOARD: GOVX) , an Atlanta-based biotechnology company developing HIV-1/AIDS vaccines, announced it has been named a 2008 Deal of the Year award winner by Georgia Bio. Georgia Bio recognized GeoVax for receiving a $15 million IPCAVD (Integrated Precl
- Abbott RealTime PCR Test for Detection of New Variant Strain of Chlamydia Receives CE Mark Certification
- PRNewswire - January 17, 2008
- -- Highly Sensitive Assay Detects Mutant Strain First Identified Last Year in Sweden DES PLAINES, Illinois, January 17/PRNewswire-FirstCall/ -- Working in collaboration with leading international researchers in the area of sexually transmitted disease, Abbott has developed a newly formulated molecular test capable of d
- Primarolo: NHS health research shapes up for the future -- DEPARTMENT OF HEALTH News Release issued by The Government News Network on 16 January 2008
- PRNewswire - January 17, 2008
- -- Patient and public involvement are key to success A progress report is published today by the National Institute for Health Research (NIHR), which summarises all the progress that has been made putting in place the infrastructure, programmes and systems to facilitate health research - since the government launched t
- Social Sciences Net, LLC Launches CancerSupportNet.com
- PRNewswire - January 16, 2008
- MONTCLAIR, N.J., Jan. 16 /PRNewswire/ -- Social Sciences Net, LLC, a social media incubator that delivers vertical social networks, today announced the release of the Cancer Support Network, an online cancer support group and research library located at http://www.cancersupportnet.com/. Cancer patients, survivors, frie
- New Kaiser Family Foundation Study on Public Service Advertising on Broadcast and Cable Television
- PRNewswire - January 16, 2008
- Public service advertising on TV has long been a centerpiece of public education campaigns on issues such as alcohol and drug abuse, cigarette smoking, literacy, environmental protection, HIV/AIDS, and drunk driving, among many others. But given how rapidly the media environment is changing, what does the PSA landscape
- Hopegivers International to Adopt 300 Children of Prostitutes
- PRNewswire - January 15, 2008
- COLUMBUS, Ga. and India , Jan. 15 /PRNewswire/ -- The Georgia-based humanitarian organization Hopegivers International plans to rescue 300 children of prostitutes in south India. The effort to take in these children came after a large group of prostitutes -- also known as commercial sex workers -- asked India-based rep
- Roche responds to announcement of 'IDEAL' hepatitis C trial results
- PRNewswire - January 14, 2008
- NUTLEY, N.J., Jan. 14 /PRNewswire/ -- Following an announcement from Schering-Plough , Roche today affirmed the value of PEGASYS(R) (peginterferon alfa-2a) in combination with ribavirin as the market-leading treatment for patients with hepatitis C, in the United States and globally. Despite clear biases in the
- HIV/AIDS in the African American Community
- PRNewswire - January 14, 2008
- ADDITIONAL RESOURCES: Audio, hard copy requests, contact information and more available at: http://www.prnewswire.com/broadcast/31033/press.html NEW YORK, January 14 /PRNewswire/ -- THIS IS A MULTIVU REPORT BROUGHT TO YOU BY THE PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA OR PhRMA. FOR YEARS THE AFRICAN- AMERI
- Teen Pregnancy Epidemic Another Reason for Women to Carry Condoms. Just in Case, Inc. Announces 10,000 Chic Condom Compact Give-Away to Women's Non-Profits Nationwide
- PRNewswire - January 11, 2008
- LOS ANGELES, Jan. 11 /PRNewswire/ -- Just in Case, Inc., the makers of the first high style, discreet condom compacts for women, will donate 10,000 of their compacts to women s Non-Profit Groups Nationwide. They are CALLING FOR ENTRIES this month. Two organizations from each state will be chosen to receive 100 JUST IN
- AHF to Schwarzenegger: 'AIDS Cuts Are Deadly' - AS CDC Prepares to Release Alarming New HIV Rates; Governor Should Cut Bureaucracy, Corporate Loopholes
- PRNewswire - January 10, 2008
- LOS ANGELES, Jan. 10 /PRNewswire-USNewswire/ -- AIDS Healthcare Foundation (AHF) today urged California Governor Arnold Schwarzenegger to reconsider and reverse $11 million of proposed budget cuts in AIDS services that will reduce and threaten vital lifesaving care and services for Californians living with HIV/AIDS as
- Millions Risk Health Buying Drugs Online
- PRNewswire - January 10, 2008
- LONDON, January 10/PRNewswire/ -- Millions of Brits could be playing Russian Roulette with their health buying prescription-only medicines from rogue internet sites, according to research conducted by the Royal Pharmaceutical Society of Great Britain (RPSGB). In response to this growing online danger, the RPSGB today r
- Roche Engages in Four Additional AIDS Technology Transfers to Strengthen Local Manufacturing in World's Poorest Countries: Free-of-charge expertise for factories in Bangladesh, Kenya, Tanzania and Zimbabwe
- PRNewswire - January 9, 2008
- NUTLEY, N.J., Jan. 9 /PRNewswire/ -- Roche today announced that it has entered into four new technology transfers with local manufacturing companies in African and Asian nations where improvements in access to anti-retroviral therapy are needed. These companies are Regal Pharmaceuticals in Kenya , CAPS Holdings i
- Thomson Scientific Introduces a New Quarterly Report Identifying the 'Movers and Shakers' in the U.S. Generics Industry
- PRNewswire - January 9, 2008
- -- Report Draws On Strategic Intelligence and Competitive Analysis Information From Newport Horizon Global(TM) PHILADELPHIA and LONDON, Jan. 9 /PRNewswire-FirstCall/ -- Thomson Scientific, part of The Thomson Corporation (NYSE: TOC; TSX: TOC) and leading provider of information solutions to the worldwide research and b
- Academic Alliance Foundation Announces Publishing of Global HIV/AIDS Medicine
- PRNewswire - January 8, 2008
- WASHINGTON, Jan. 8 /PRNewswire-USNewswire/ -- The Academic Alliance Foundation announces the publishing of Global HIV/AIDS Medicine, the first medical textbook aimed at a comprehensive approach to the management of HIV/AIDS as a global problem. The book reflects a changing landscape in HIV/AIDS prevention, diagnosis, a
- FDA Approves Cialis(R) (tadalafil) for Once Daily Use for the Treatment of Erectile Dysfunction
- PRNewswire - January 8, 2008
- --Approval Makes Available New Daily Dosing Option for the Treatment of ED INDIANAPOLIS, Jan. 8 /PRNewswire-FirstCall/ -- Eli Lilly and Company (NYSE:LLY) announced today that the U.S. Food and Drug Administration ( FDA ) has approved Cialis(R) (tadalafil)(1) for once daily use (2.5 mg and 5 mg), an oral medication tak
- Pharmasset Announces R7128 Achieves 85% Rapid Virologic Response in a 4-week Combination Study for the Treatment of Chronic Hepatitis C
- PRNewswire - January 7, 2008
- -- 85% of patients achieve undetectable HCV RNA levels following 4 weeks of treatment with R7128 1500mg and Pegasys(R) plus Copegus(R) with safety and tolerability comparable to placebo - -- Conference Call Scheduled for 4:00PM ET Today - PRINCETON, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Pharmasset, Inc. (NASDAQ:VRUS)
- Idenix Pharmaceuticals Provides Update on Hepatitis C Pipeline at JP Morgan Healthcare Conference
- PRNewswire - January 7, 2008
- SAN FRANCISCO, Jan. 7 /PRNewswire-FirstCall/ -- Idenix Pharmaceuticals, Inc. (NASDAQ:IDIX), a biopharmaceutical company engaged in the discovery and development of drugs for the treatment of human viral and other infectious diseases, today announced an update on the company s HCV pipeline, including promising second-ge
- Race Against Pain Coming to Florida: Inspirational Pain Survivor Turned Race Car Driver Promotes Educational Initiative Devoted to People in Chronic Pain
- PRNewswire - January 4, 2008
- SEBRING, Fla., Jan. 4 /PRNewswire/ -- The Race Against Pain will kick off its 2008 season in Florida this weekend and next when Mike Roman competes in Sports Car Club of America (SCCA) racing events. Roman, whose right leg was amputated 12 years ago, will race January 5 and 6 at the Winter Vacation National Races at th
- Just in Case Inc. to Donate 10,000 JIC Condom Compacts to Women's Non-Profit Groups Nationwide
- PRNewswire - January 3, 2008
- LOS ANGELES, Jan. 3 /PRNewswire/ -- Just in Case Inc., is CALLING FOR ENTRIES this month to find non-profit Women s Groups across the nation that serve and empower women. Two organizations from each state will be chosen to receive 100 of their JUST IN CASE(R) compacts. Just in time for Valentine s Day -- National Condo
- Black AIDS Institute Releases Report Analyzing Presidential Candidates' HIV/AIDS Records
- PRNewswire -- Wednesday, January 2, 2008
- LOS ANGELES -- The Black AIDS Institute released today the first in a series of educational briefs on electoral politics -- We Demand Accountability: The 2008 Presidential Elections and the Black AIDS Epidemic. The booklet is the latest in a series of reports and news articles, published as a part of the National Black
This information is designed to support, not replace, the relationship that exists between you and your doctor.
©1980, 2008. AEGiS.